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Abstract
ABSTRACT
The effects of malaria and anaemia during pregnancy on infant survival and 
morbidity were investigated in an area of low malaria transmission on the western 
border of Thailand. A cohort of 1,495 mothers and their infants were followed weekly 
from admission of the mother to ante-natal clinics until one year of life o f the infant.
37% (555/1495) o f  the women developed malaria during pregnancy and 77% 
(1134/1468) were anaemic (HCT<30%). Malaria during pregnancy was responsible for 
23% (95% Confidence Interval: 14-30) o f Low Birth Weight (LBW), but did not reduce 
the duration of gestation. Infectious diseases in the week prior to birth were associated 
with premature birth (Population Attributable Fraction: 10%; 95%CI: 6-12).
Infant mortality rate was 78 (88/1127) per 1,000 live births. Risk factors for 
neonatal mortality were prematurity (Hazard Ratio: 9.8; 95%  Cl: 3.8-25.2), LBW (HR: 
2.9; 95%CI: 1.2-7.3), and maternal infection in the week prior to delivery (HR: 4.3; 
95%CI: 2.0-9.2). The latter remained associated with deaths occurring between one and 
three months of age (HR: 4.0; 95%CI: 1.2-13.7), whereas no risk factors could be 
identified for deaths occurring later in infancy. Malaria during pregnancy affected 
neonatal mortality solely by lowering birth weight, whereas fever in the week prior to 
birth had an additional independent effect as well as inducing premature birth.
Malaria incidence rate in infancy was low: 121 (148/1228) per 1,000 child-year 
(95%CI: 103-142). The stage of pregnancy at which malaria occurred influenced 
malaria in infants. Infants bom to mothers who had falciparum malaria during the first 
trimester were 2.8 (1.5-5.1) times more likely to develop malaria in infancy, than infants 
bom to mothers who had malaria later during pregnancy, o r no malaria.
The long-term impact of malaria during pregnancy on the infant was mediated 
through LBW that was associated with higher morbidity, anaemia and impaired growth. 
However, as age increased, socio-economic factors became more important than LBW 
for the development o f infant anaemia and for the risk o f  being underweight and/or 
stunted.
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Chapter 1: Introduction
1.1. Statement of the problem
Malaria during pregnancy is harmful for both the mother and the foetus. 
Pregnant women living in malaria endemic areas have an increased risk o f  developing 
malaria when compared to their non-pregnant counterparts. The clinical features vary 
from asymptomatic infection to severe life-threatening malaria, depending on the level 
of transmission. The most common effect of malaria infection during pregnancy on the 
mother is anaemia. As a consequence, in malarious areas, malaria-attributable anaemia 
is the most important contributor to maternal anaemia. This is most marked in 
primigravidae who are more affected by malaria (Brabin, 1991). Nevertheless, maternal 
anaemia is usually multifactorial, and other factors such as iron deficiency, hookworms 
infestations, haemoglobinopathies, may all contribute (Fleming, 1989a). Their relative 
importance may depend on the number o f pregnancies the mother has had.
Malaria and anaemia during pregnancy act together in reducing birthweight. 
Malaria has long been recognized as an important determinant of low birthweight 
(LBW) (<2500g) (McGregor et al., 1983), as well as anaemia in both malarious and 
non-malarious areas. Until recently, the distinction between full-term and preterm (< 37 
weeks) LBW was not clearly established. Accurate methods for the estimation of 
gestational age can now be employed. Since their introduction, it has been recognized 
that LBW due to malaria and anaemia are mostly due to intra-uterine growth retardation 
(IUGR) rather than preterm deliveries (Meuris et al., 1993; Dolan et al., 1993; Nosten et 
al., 1994a; Steketee et al., 1996b). However the incidence of premature births is also 
increased by severe maternal malaria.
The consequences o f malaria and anaemia during pregnancy on maternal 
morbidity and mortality, and on the newborn are now well described (Brabin, 1991; 
Menendez, 1995). The long term effects on the infant are not so well established. As 
LBW is a major determinant o f  infant mortality (Ashworth & Waterlow, 1982), it has 
been assumed that malaria during pregnancy may indirectly increase infant mortality. In 
the neonatal period, maternal malaria has not been directly associated with perinatal or 
neonatal mortality, but both severe maternal anaemia and LBW have been shown to 
increase the risk of dying within the first month o f life. Thus malaria-related neonatal 
mortality might be important. In the post-neonatal period, maternal anaemia has been
16
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associated with infant mortality (Dolan et al., 1993; Nosten et al., 1994a; Verhoeff & 
Brabin, personal communication), but the effects of malaria per se have not been 
established.
The mechanisms through which maternal anaemia may increase the risk of 
infant death remain unclear. Are the children bom to anaemic mothers more likely to 
develop anaemia during infancy than those bom to non-anaemic mothers? Do they have 
impaired growth and/or an increased morbidity during infancy? What are the relative 
importance o f factors such as the environment, and socio-economic status of the family?
The association between malaria during pregnancy and malaria in infancy is 
difficult to study. Infants have been shown to be susceptible to malaria infection 
(MacDonald, 1950) but protected against clinical malaria during the first months o f life 
(Achidi et al., 1996a; Snow et al., 1998; McGuiness et al., 1998). This protection is 
believed to be multifactorial, but mainly related to transplacentally acquired maternal 
antibodies. Nevertheless, the role o f maternal antibodies in protecting the newborn baby 
remains controversial. Most investigators have used malaria-infection as their markers 
of protection, whereas the protective effect o f  maternal antibodies may only be on the 
development of symptoms. Recently, it has been shown that only some sub-groups of 
antibodies may be protective against clinical disease (Branch et al., 1998). Materno- 
foetal transfer of antibodies and thus potential protection may also vary with the level of 
malaria transmission. There is also some evidence of prenatal immune priming of 
malaria. But, the complex matemo-foetal relationships change during the course of 
pregnancy, and may differ between primi- and multigravidae. Hypothesis have been 
raised to suggest that the response to malaria during infancy may vary according to the 
age of first exposure to malaria in utero (Rasheed, 1994), and whether the infant is the 
first bom child or from a multiparus woman. Longitudinal studies, in which pregnant 
women and their offspring are followed from early pregnancy, and throughout infancy 
are required in order to test these hypotheses. In the studies completed so far, women 
have only been followed from late pregnancy, and the results have often been 
conflicting.
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In our study site on the Thai-Burmese border, malaria transmission is low and 
unstable. Malaria during pregnancy is a  major public health problem. In 1984, it was 
recognized as an important cause o f  maternal morbidity and mortality. The Shoklo 
Malaria Research Unit (SMRU) implemented antenatal clinics (ANC) with weekly 
detection of malaria and treatment o f all parasitaemic women. Since the clinics were 
initiated, maternal morbidity from malaria has been reduced and malaria-attributable 
mortality during pregnancy entirely suppressed (Nosten et al., 1991). Nevertheless, the 
consequences on the infants have not disappeared. Both P.falciparum and P.vivax 
malaria during pregnancy are associated with reduced birthweight. In two randomised 
trials of malaria preventive measures during pregnancy, maternal anaemia at delivery 
and LBW have been shown to be major risk factors for infant mortality (Dolan et al., 
1993; Nosten et al., 1994a). However, in these studies, morbidity during infancy, and 
socio-economic factors were not taken in account. Moreover, studied women were a 
selected group o f all pregnant women and this may have introduced a bias. We therefore 
decided to follow closely all children bom to women attending ANC. They represent 
90% of pregnant women in the site and they often attend ANC early in pregnancy. 
Moreover the SMRU has a long experience of long term prospective studies. The 
longitudinal design would permit assessment of the long-term effects of malaria and 
anaemia during pregnancy, both on infant mortality and morbidity, and whether the 
stage at which malaria infection occurs during pregnancy influences malaria in infancy. 
The study was also designed to describe the main causes and risk factors of infant 
deaths, and when malaria was first acquired in infancy in an area o f low malaria 
transmission. This thesis reports the results of these epidemiological evaluations.
18
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1.2. Objectives
Using a cohort of livebom babies, this work aims to assess the effects of malaria
and anaemia during pregnancy on survival, morbidity and growth o f the infants.
1.2.1. Main objectives:
1. To determine whether malaria and anaemia at various stages o f pregnancy influence 
infant mortality in an area of low malaria transmission.
2. To determine whether malaria infections experienced during pregnancy influence 
malaria in children during the first year of life.
3. To determine whether malaria and anaemia during pregnancy have an impact on 
morbidity, haematological status, and growth of the offspring during the first year of 
life.
1.2.2. Specific objectives
1. To determine whether anaemia at delivery, irrespective of cause, is associated with 
infant deaths after other maternal morbid events during pregnancy and socio­
economic factors are taken in account.
2. To determine the direct and indirect impact of malaria during pregnancy on survival 
of infants.
3. To describe the age distribution and causes of infant deaths in this population.
4. To describe the acquisition of malaria in infants living in an area of low and 
unstable transmission.
5. To determine whether malaria history at various stages o f pregnancy influences 
malaria in infants.
6. To determine whether morbidity during pregnancy influences morbidity and growth 
during infancy
19
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1.3. Organisation of the thesis
This thesis consists o f 9 chapters and the results are divided into four main parts: 
(i) a description o f morbidity during pregnancy and an analysis of the determinants of 
LBW and prematurity; (ii) a description of the level and causes of infant mortality and 
an assessment of the effects of malaria and anaemia during pregnancy on infant deaths; 
(iii) an analysis o f the effects of morbidity during pregnancy on infant morbidity, with a 
special emphasis on the relationships between malaria during pregnancy and malaria 
during the first year of life; (iv) an analysis of the effects of morbidity during pregnancy 
and during infancy on infant growth.
Chapter 1 provides the introduction to the thesis and its objectives.
Chapter 2 reviews the relevant literature for this study and is organized in five parts. 
The first two sections describe the existing knowledge on the consequences of malaria 
and anaemia during pregnancy on the infant. A third part gives briefly available data on 
the risk factors and causes of infant mortality in developing countries. In the fourth 
section, published reports on morbidity and mortality from malaria in infancy are 
reviewed. The fifth section deals with current available data on  the relationships 
between malaria during pregnancy and in infancy.
Chapter 3 describes the Karen Refugee camps where the study was conducted, the 
malaria situation and the main other health problems. The main objectives and the set­
up o f the SMRU are described. Methods employed in ANC, especially the detection and 
treatment of malaria and anaemia during pregnancy, are detailed.
Chapter 4 describes the methods o f  the study.
Chapter 5 provides a description o f  the mothers and their morbidity during pregnancy 
and explores the determinants of LBW and/or premature birth of the newborn.
Chapter 6 reports the results in term of infant mortality and describes the main causes 
of deaths in the cohort and the relationships with maternal characteristics.
20
Chapter 1: Introduction
Chapter 7 reports the results of morbidity during infancy, with a special emphasis on 
malaria and anaemia during the first year of life
Chapter 8 reports the results on growth of this cohort.
Chapter 9 discusses the main findings of the thesis and presents the conclusions.
21
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Chapter 2: Literature Review
2.1. M alaria during pregnancy: consequences on the foetus or the infant
The increased susceptibility of pregnant women, especially primigravidae, to 
malaria has been recognized for more than a century and well described in the fifties 
(Brabin, 1991). In the last 20 years, the idea o f malaria eradication was progressively 
abandoned and replaced by the objective of controlling the disease. Thus, the interest in 
the harmful effects of malaria during pregnancy was renewed, and research in this area 
intensified. The main effects of malaria on the pregnant woman and her offspring have 
been well described and regularly reviewed (Taufa, 1978; Brabin, 1983; McGregor, 
1984; Brabin, 1991; Menendez, 1995; Steketee et al., 1996a). The current review will 
focus on the consequences o f malaria during pregnancy on the foetus or the infant.
2.1.1 Blrthweight
Malaria during pregnancy reduces birthweight and this effect is most marked in 
primigravidae. Mean birthweight is lower in children bom to infected mothers 
compared to newborn from non-infected mothers, and the proportion of babies with 
LBW is higher in the former group than in the latter (Table 2.1). The effects on the 
mother, in terms of morbidity and mortality, depend highly on the level of malaria 
endemicity, whereas the reduction of birthweight seems to be present at all level of 
transmission. Nevertheless, in areas of unstable and low endemicity, second and third 
gravidae are also affected.
In early studies (before 1980) samples sizes were relatively small and 
differences in mean birthweight were not often statistically significant. However, the 
trend toward a reduction o f birthweight in children bom to infected mothers was a 
constant theme. Moreover, the proportion of LBW was significantly higher in infected 
than non-infected mothers in most studies (Odds Ratio (OR) between 2 and 4). 
Nevertheless, the association between malaria during pregnancy and birthweight was 
weak and still questionable. All studies were hospital-based cross-sectional surveys that 
looked at the association between placental and/or peripheral maternal malaria at 
delivery and birthweight. There was therefore no information on malaria history earlier 
in pregnancy. This could lead to an underestimation of the problem.
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McGregor et al. (1983) conducted the first large (N=6427) cross-sectional 
survey that confirmed a statistically significant reduction in birthweight o f infected 
Gambian primigravidae. Babies bom to multigravidae were not affected. Although 
further studies had shown similar results and a consensus was reached towards the 
effects of malaria in reducing birthweights, two studies had controversial results (Brabin 
et al., 1990a; Desowitz et al., 1992). They were conducted in a region of high 
transmission in Papua New Guinea. There were no differences in birthweights between 
children from infected and non-infected mothers, and this remained true after adjusting 
for parity. The authors concluded that maternal anaemia may have a more important 
effect on birthweight than malaria per se.
Information on the effects of malaria during pregnancy on birthweight in areas 
o f low and unstable endemicity remained poor. All studies focused on P.falciparum 
malaria and the consequences of P.vivax malaria infection during pregnancy on 
birthweight were neglected. A prospective study was conducted on the Thai-Burmese 
border, an area of unstable endemicity where placental malaria was rare, despite a 
malaria incidence during pregnancy that reached 30%. Malaria infection, defined as 
peripheral parasitaemia at any time during pregnancy, was associated with a reduction 
in birthweight. Primigravidae were more susceptible to malaria than multigravidae, but 
second and third gravidae were also affected. As a consequence, reduction in 
birthweight was more marked in first bom babies, but was also found in second and 
third pregnancies. There were not enough cases of vivax malaria to study the effects of 
this species on the foetus (Nosten et al., 1991). In India, Nair & Nair (1993) reported a 
reduction in birthweight associated with vivax malaria, but did not mention the results 
o f their statistical tests. After their first report, Nosten et al. (in press) continued to 
recruit pregnant women (N=l 1,004). They published the first evidence that P.vivax 
malaria also has a deleterious effect on birthweight, although smaller than that of 
P.falciparum infection. Primigravidae were more likely to be infected with P. vivax than 
multigravidae. But in contrast to falciparum malaria, the reduction in birthweight was 
greater in multigravidae.
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—Table 2.1: mean reduction in birthweight (g) and odds ratio of LBW newborn in relation to placental or peripheral malaria.
Stndy area Stndy design Gravidae Mean reduction in 
birthweight (g)
OR (95%CI) 
LBW
Reference
South Nigeria Cross-sectional at delivery All gravidae -145 2.1 (1.0-4.5) Bruce-Chwatt, 1952
West Nigeria Cross-sectional at delivery All gravidae -170 2.1 (1.1-3.9) Archibald, 1956
North Nigeria Cross-sectional at delivery All gravidae -298 3.0(1.4-6.4) Archibald, 1958
Nigeria Cross-sectional at delivery All gravidae -310 4.2 (2.4-7.3) Cannon, 1958
East Nigeria Cross-sectional at delivery All gravidae -89 NA Spitz, 1959
Tanzania Cross-sectional at delivery All gravidae -55 2.1 (0.9-4.6) MacLaren et al., 1962
Uganda Cross-sectional at delivery All gravidae -263 2.2 (1.2-4.1) Jelliffe, 1968
Ghana Cross-sectional at delivery All gravidae -178 NA Jilly, 1969
Tanzania Prospective All gravidae -75 1.6 (0.8-2.9) Kortmann, 1972
Ivory Coast Cross-sectional at delivery All gravidae -120 NA Reinhard et al., 1978b
Zimbabwe Hospital-based; all 
admission for malaria
All gravidae -333 NA Herd & Jordan, 1981
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The Gambia Cross-sectional at delivery All gravidae -170 2.5 (2.1-2.9) McGregor, 1983
Keneba, The Gambia Prospective Primigravidae -570 NA Watkinson & Rushton, 1983
Franceville, Gabon Cross-sectional at delivery All gravidae -220 NA Garin et al., 1985
Lagos, Nigeria Cross-sectional at delivery All gravidae -550 NA Nnatu et al., 1987
Papua New Guinea Prospective Primigravidae -26(a) 
-121 (b)
NA Brabin et al., 1990a
Multigravidae [-12; + 244](a) 
+1 (b)
North-West Thailand Prospective All gravidae -123 NA Nosten et al, 1991
Bedeci, Ivory Coast Cross-sectional at delivery All gravidae -409 3.5 (0.3-25.3) Bachschmid et al., 1991
Benin Cross-sectional at delivery All gravidae -270 3.6(1.7-7.5) Ibhanesebhor &Okolo, 1992
India Cross-sectional at delivery All gravidae -520 13.7 (5.7-34.2) (c) Kaushik et al., 1992
Papua New Guinea Cross-sectional at delivery Primigravidae +20 NA Desowitz et al., 1992
Multigravidae -33
Central Sudan case-control All gravidae NA 1.6 (1.2-2.1) (d)
1.7(1.3-2.3) (e)
T ahae/a/., 1993a
Gujarat, India prospective All gravidae -780 P.falciparum 
-390 P.vivax
2.0 Nair & Nair, 1993
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Nord-Kivu, Zaire Cross-sectional at delivery AU gravidae -124(a) 2.8 (1.5-5.4) Meuris et al., 1993
-154(b)
Maputo, Mozambique Cross-sectional at delivery All gravidae -144 1.6 (0.6-4.2) Bergström et al., 1993
Siena Leone Cross-sectional at delivery All gravidae -265 2.7 (1.7-4.5) Morgan, 1994
Burkina Faso Cross-sectional at delivery Primigravidae -276 NA Gazin et al., 1994
gravidae -45
Zanzibar, Tanzania Cross-sectional at delivery All gravidae -177 10.1 (2.9-35.4) Matteelli et al., 1996
Papua New Guinea Cross-sectional at delivery All gravidae -130 NA Allen et al., 1998
North-West Thailand Prospective All gravidae -108 1.7 (1.4-2.1) Nosten et al., in press
(a) : placental malaria
(b) : parasitaemia at deliver}'
(c) : febrile women
(d) : hospital-based
(e) : community-based
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In most studies designed to investigate the relationship between malaria during 
pregnancy and birthweight, potential confounding factors such as smoking, mother’s 
nutrition, pre-eclampsia, socio-economic factors, were not taken in account. Recently, 
smoking was identified as an important determinant of LBW in malarious areas, with an 
effect similar to that described in developed countries (McGready et al., 1998; Allen et 
al., 1998). But these potential confounding factors would act on all pregnancies, 
whereas malaria selectively depresses birthweight to a greater extent in primigravidae, 
and this relates to a higher malaria prevalence in first pregnancies (Brabin, 1991). The 
plausibility of the causal role of malaria was also supported by an observational study in 
the British Solomon Islands where a successful malaria eradication campaign was 
followed by an increase in birthweight (McGregor & Avery, 1974). But this was a 
descriptive study with historical control.
The causal role of malaria in reducing birthweight would be confirmed only by a 
reversible effect in randomised controlled trials of preventive antimalarial measures 
during pregnancy. Gamer & Brabin (1994) reviewed the randomised controlled trials of 
antimalarial drug chemoprophylaxis during pregnancy, published between 1964 and 
1994 (Morley et al., 1964; Hamilton et al., 1972; Martin & Nkwate, 1982; Nahlen et al., 
1982; Harrison et al., 1984; Fleming et al., 1986; Greenwood et al., 1989; Mutabingwa 
et al., 1991; Cot et al., 1992; Nosten et al., 1994a). There was an overall trend towards 
an increased birthweight in children bom to mothers in the prophylaxis groups 
compared to the placebo (or receiving a less efficient drug) control groups. 
Nevertheless, only two trials reported a statistically significant difference when the 
outcome was birthweight in newborn from all parities (Morley et al., 1964; Hamilton et 
al., 1972) and only one (Greenwood et al., 1989) when the authors restricted the 
analysis to birthweight in babies bom to primigravidae. In this study, the difference 
reached statistical significance afler stratification by season and age. Several hypotheses 
were raised to explain these poor results: insufficient sample sizes; prophylaxis started 
too late in pregnancy; P.falciparum resistant to the antimalarial chosen for prophylaxis. 
Results were more encouraging in studies that were published later. Gambian 
primigravidae who received pyrimethamine-dapsone prophylaxis delivered heavier 
newborn than those who received placebo (Menendez et al., 1994a). When prophylaxis 
was given to Cameroonian primigravidae, the risk of having of LBW infant was reduced 
by 62% (95% Confidence Interval: 11-84) and the mean birthweight was significantly
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higher than in the control group (Cot et al., 1995). In Malawi, effective prophylaxis 
during pregnancy was also successful in reducing the proportion of LBW newborn 
(Steketee et al., 1996b). In Mali, although the trial was not randomized, chloroquine 
prophylaxis increased mean birthweight and reduced the prevalence of LBW in para 0 
and 1, but this effect could not be achieved with less than 15-20 weeks of prophylaxis 
(Bouvier el al., 1997b).
LBW may be the result of IUGR, prematurity or both. A high risk of premature 
deliveries (27-60%) has been reported in epidemic situations (Wickramasuriya, 1937) 
and among women hospitalised with symptomatic and severe malaria (Le Van Hung, 
1951; Herd & Jordan, 1981; Endeshaw, 1991; Nair & Nair, 1993). But in areas o f stable 
transmission and in the absence o f symptoms, malaria is thought to be associated with 
1UGR rather than prematurity. In early studies, it was difficult to estimate accurately the 
gestational age, and the definition of prematurity was that o f LBW (<2500g), thus 
including full-term growth retarded infants. Since the introduction of the Dubowitz 
assessment o f  gestational maturity (Dubowitz & Dubowitz, 1977), a few studies of 
malaria during pregnancy were able to control for gestational age. In these studies, 
placental or peripheral malaria was not associated with preterm deliveries (Reinhardt et 
al., 1978b; Watkinson & Rushton, 1983; Dolan et al., 1993; Nosten et al., 1994a; 
Steketee et al., 1996b; Allen et al., 1998). Similarly P.vivax infection during pregnancy 
did not reduce the duration of gestation (Nosten et al., in press). Thus LBW due to 
malaria-infection appeared to be a consequence of IUGR rather than prematurity. 
Nevertheless, in the study conducted in Malawi, cord blood malaria infection was a risk 
factor for preterm LBW. The authors could not suggest any biological mechanism to 
explain their findings (Steketee et al., 1996b). Another controversial result was obtained 
in Sudan. Taha et al. (1993a) showed an association between a maternal history of 
malaria and LBW. The study relied on the woman’s recall of her malaria attacks during 
pregnancy at the time of delivery and had therefore possible misclassifications. 
Surprisingly, the malaria attributable risk of preterm-LBW was higher than that of full 
term LBW (35 and 11% respectively). A possible explanation might be that the method 
used to detect malaria (i.e. woman’s own recall) only allowed to look at the association 
between symptomatic episodes and LBW. In the Gambia, the use of impregnated bed 
net by primigravidae was effective in reducing the proportion of babies classified as 
premature (D ’Alessandro et al., 1996). Again, this could be explained by the prevention
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of symptomatic malaria occurring during the third trimester and leading to premature 
delivery. Another possible explanation is the misclassification of the newborn as 
gestational age was estimated by a simplified method o f assessment, not validated in 
Africa. This effect was also marginal and seasonal.
Meuris et al. (1993) attempted to define which type of IUGR was associated 
with malaria by looking at the effects o f the infection on different anthropometric 
measurements at birth. Circulating malaria parasites and placental infection were 
respectively associated with acute (i.e. effect on birthweight only) and subacute (effect 
on birthweight, head circumference and ponderal index) impairment of foetal growth. 
Gazin et al. (1994) reported an effect of placental malaria on birth height as well as 
birthweight, suggesting a prolonged effect.
2.1.2 Perinatal mortality
In areas of high malaria transmission peripheral or placental malaria was not 
associated with increased perinatal or early neonatal mortality (Bruce-Chwatt, 1952; 
Cannon, 1958; Spitz, 1959; Jilly, 1969). Numbers were small in these early studies and 
could not have reached significance. Moreover prematurity and periods of foetal and 
infant life were not well defined. Nevertheless the absence of association between 
maternal malaria and perinatal mortality was confirmed in larger recent studies 
(McGregor et al., 1983; Taha & Gray, 1993b; McDermott et al., 1996). In the Gambia, 
there were less stillbirths and neonatal deaths in children bom to primigravidae who 
took antimalarial chemoprophylaxis than in those who took placebo, but this was not 
significant (Greenwood et al., 1989). However, Nyitjesy et al. (1993) reported that 
maternal malaria at delivery and neonatal malaria were both associated with an 
increased risk o f perinatal deaths and that the use of chloroquine prophylaxis 
significantly reduced this risk. Nevertheless, this was not a randomized study.
In areas of low or seasonal malaria transmission, severe malaria occurs during 
pregnancy and is associated with high foetal loss. Wickramasuriya (1937) described the 
disastrous effects of malaria during pregnancy during an epidemic in Ceylon. Malaria 
was associated with extremely high rates of abortion, foetal death and premature
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delivery o f  infants. In Saigon, Le Van Hung (1951) recorded a foetal death rate of 14%. 
In Malaysia, Menon (1972) reported a foetal wastage in 35% (6/17; 5 stillbirths and one 
premature infant who died) o f women hospitalised for symptomatic and sometimes 
severe malaria. In Zimbabwe, the foetal mortality rate reached 49% (24 abortions, 2 
stillbirths and 4 LBW infants dying withing 1 hour) in 61 pregnant women admitted to 
hospital with malaria (Herd & Jordan, 1981). In Ethiopia 41% (15/37) pregnancies 
resulted in abortion (6), still birth (1) and preterm delivery with early neonatal deaths 
(8) (Endeshaw; 1991). In India, 4% o f 104 women with symptomatic and sometimes 
severe malaria died, 60% delivered prematurely, 10% had an abortion and 6% a 
stillbirth. Stillbirths and maternal deaths were associated with P.falciparum only, 
whereas abortions and premature deliveries were common with both vivax and 
falciparum malaria (Nair & Nair, 1993). On the Thai-Cambodian border, the foetal loss 
in 193 pregnant women hospitalised with severe malaria was 66% (109 abortions; 10 
stillbirths and 8 premature babies who died) (Meek, 1988). On the Thai-Burmese 
border, foetal deaths occurred in 27% (8/30) of severe malaria cases during pregnancy 
(3 abortions, 4 stillbirths and 1 premature delivery o f twins who died within 48 hours) 
(Luxemburger et al., 1997).
2.1.3. Infant mortality and morbidity (except malaria)
It is assumed that malaria during pregnancy may increase infant mortality, at 
least in first bom infants, through its reduction in birthweight. The indirect effects of 
malaria during pregnancy on child’s survival have been suggested in the report of a 
successful eradication o f malaria in Guyana. During the campaign, neonatal mortality 
decreased from 49 to 12 per 1,000 live births. Neonatal deaths are in most cases related 
to maternal causes and this improvement was likely to be the indirect benefit of 
prevention of malaria during pregnancy. Moreover, in the post-neonatal period, the 
reduction of deaths was higher than expected if only the malaria-attributable deaths had 
been prevented (Giglioli, 1972). Two explanations for this are plausible. Prevention of 
malaria during pregnancy may have reduced the proportions of LBW infants who are 
more likely to die in infancy. Prevention of malaria during infancy may also have 
reduced the mortality indirectly associated with malaria, as did the use of impregnated 
bed nets some 20 years later in The Gambia (Alonso el al., 1991). However, from recent
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prospective studies, there is no evidence o f a direct association between malaria during 
pregnancy and deaths in infancy, either in neonatal or post-neonatal periods (Dolan et 
al., 1993; Nosten et al., 1994a; Bloland et al., 1995; Bloland et al., 1996).
Placental malaria infection has been associated with anaemia in early infancy. In 
a prospective study of pregnant women and their children in rural Malawi, placental 
malaria infection was the strongest risk factor for an infant having anaemia (hct<25%) 
at 2 months of age (Redd et al., 1994). This finding was confirmed by Comet et al. 
(1998) who found that placental malaria was the strongest risk factor for anaemia in the 
six month-old children, independent o f the infant’s malaria history since birth 
(frequency of parasitaemia, parasitaemia at the time of haemoglobin measurement). At 
one year of age, parasitaemia at the time o f haemoglobin measurement and microcytosis 
(reflecting iron deficiency) were significant risk factors for anaemia.
The long-term effects on morbidity from non-malarious causes in infants bom to 
malaria-infected mothers has not been studied. Their growth has been described in only 
one study. In Nigeria, babies bom to mothers who participated in a malaria prophylaxis 
study during pregnancy were prospectively followed from birth to 5 years of age. 
Although the protected mothers produced larger babies than did mothers who did not 
take prophylaxis, the weight differences disappeared within the first few months of life 
(Morley et al., 1968).
2.2. Anaemia during pregnancy: consequences on the foetus or the infant
2.2.1. Anaemia during pregnancy in malaria endemic areas
Anaemia during pregnancy is a major health problem in developing countries 
and its causes are usually multi factorial. Nevertheless, in malarious areas, malaria is 
recognized as the leading cause of anaemia during pregnancy, mainly in primigravidae 
(Gilles et al., 1969; Jilly, 1969; Harrison & Ibeziako, 1973; Rougemont et al., 1977; 
Fleming et al., 1986; Fleming, 1989b; Jackson et al., 1991; Shulman et al., 1996). 
Folate deficiency is often secondary to malarial haemolysis (Fleming, 1989a). Other 
factors, such as iron deficiency and hookworms, are relatively more important in
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multigravidae (Isah et al., 1985; Shulman et al., 1996). The contribution of sickle-cell 
anaemia, thalassemia and Acquired Immune Deficiency Syndrome varies greatly 
between areas. The association between malaria and anaemia during pregnancy has 
been confirmed by several studies in which antimalarial prophylaxis or control 
measures had a beneficial effects on haematological markers (Gilles et al., 1969; 
Kortmann, 1972; Fleming et al., 1986; Spencer et al., 1987; Greenwood et al., 1989; 
Brabin et al., 1990a; Dolan et al., 1993; Mutabingwa et al., 1993a; Nosten et al., 1994a; 
Bouvier et al., 1997a; Cot et al., 1998). In the only detailed report of vivax malaria 
during pregnancy, anaemia was associated with infection with P.vivax (Nosten et al., in 
press). In malarious areas, anaemia and malaria are therefore likely to act together on 
foetal growth.
2.2.2. Birthweight
Several studies conducted in malaria endemic areas have reported an association 
between maternal anaemia and LBW (primarily due to foetal growth retardation) 
(Macgregor, 1963; Ojo, 1965; Harrison and Ibeziako, 1973; Reinhardt, 1978a; Dawodu 
& Latidan, 1985; Oppenheimer et al., 1986; Fleming, 1989b; Brabin et al., 1990a; 
Dolan et al., 1993; Nosten et al., 1994a). Whatever the causes of anaemia, in both 
malarious and non-malaria developing countries, the risk of having LBW infants 
increase with increasing severity of maternal anaemia (Macgregor, 1963; Bhargava et 
al., 1987; Fleming, 1989b; Mavalankar et al., 1992). The duration of anaemia may be an 
important risk factor for delivering lighter babies. In Nigeria, Harrison & Ibeziako 
(1973) treated anaemic pregnant women at 20-28 weeks of pregnancy. At delivery 
women who were still anaemic (haematocrit (HCT) 26-30%) delivered lighter babies 
than those who responded to the treatment and were no longer anaemic (HCT>30%). 
Babies bom to the latter group had similar mean birthweight than those bom to non 
anaemic mothers.
In an attempt to estimate anaemia- and malaria-attributable LBW separately, 
Brabin & Piper (1997) compared two populations of Papua New Guinea. One was 
living in a non-malarious area and the other in a highly malaria endemic area. The 
prevalence of anaemia was much higher in the malaria endemic area than in the region
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with no malaria. In both places, there was a trend towards increased risk o f  LBW with 
decreased haemoglobin level, but this was significant only in the malaria endemic area. 
In the latter study site, up to 40% o f LBW was attributated to malaria whereas 10% 
were attributable to severe anaemia. The findings were similar in primi- and 
multigravidae. The authors concluded that in malaria endemic areas, malaria was a more 
important risk factor than anaemia for LBW.
As mentioned above, malaria-related anaemia during pregnancy has been 
corrected by using antimalarial prophylaxis, but whether this correction has an effect on 
birthweight is difficult to assess. In a randomized double-blind trial o f  antenatal oral 
antimalarial prophylaxis and haematinic supplements in primigravidae in Nigeria 
(Fleming, 1986), anaemia at 6 weeks after delivery was found in 61% o f the women not 
receiving active treatment, in 39% of those protected against malaria but not receiving 
iron supplements and in only 18% of patients receiving both antimalarials and iron. The 
effect of antimalarial prophylaxis in reducing anaemia was higher than that of iron 
supplementation. Moreover, 9 out of 12 women who developed severe anaemia were in 
the group not receiving antimalarials (7) or not compliant to their prophylaxis (2). Folic 
acid had no significant effect on mean haemoglobin. The group receiving no active 
treatment delivered lighter babies and had a higher number of perinatal deaths than the 
women who took antimalarials alone or combined with haematinics but this was not 
significant. In Thailand, the use o f  impregnated bed nets was associated with a 
reduction in maternal anaemia, but had no effect on birthweight (Dolan et al., 1993).
The effects of maternal iron deficiency on outcome of pregnancy are not well 
known in malarious areas but iron deficiency is associated with an increased risk of 
LBW in non-malarious areas (Singla et al., 1997). In a randomized, double-blind, 
placebo-controlled community-based trial in the Gambia, iron supplementation given to 
multigravidae reduced the prevalence o f anaemia (HCT<25%) and of iron deficiency at 
36 weeks of gestation and one week after delivery. Mean birthweight was higher in the 
iron supplementation group than in the control group, but this was not significant. The 
proportion o f children bom with LBW did not change either. The absence of effects on 
birthweight could be related to the late attendance of women to ANC and thus of a short 
period of supplementation. When the analysis was restricted to women who had 
received at least 3 months of iron supplementation, birthweight was significantly higher
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in treatment than in control group (Menendez et al., 1994b). In areas endemic for 
hookworms, mebendazole therapy may also be required. In an area of high prevalence 
of hookworm infestation during pregnancy, the combination of mebendazole with iron 
and folate supplements was more efficient in improving haemoglobin concentration and 
iron-status than haematinics alone (Atukorala el al., 1994). In a recent case-control 
study conducted in Sri Lanka, mebendazole therapy was associated with a 53% 
reduction in the incidence of LBW (de Silva et al., 1999).
Maternal anaemia has been associated with IUGR rather than prematurity. In 
Papua New Guinea, severe anaemia was associated with LBW in primigravidae. The 
majority o f these LBW babies were clinically growth retarded and not premature 
(Brabin et al., 1990a). In the two studies in which the gestational age was assessed using 
the Dubowitz score, gestational age was not affected by maternal anaemia (Reinhardt, 
1978a; Dolan et al., 1993). In Zaire, Meuris et al (1993) reported that all anthropometric 
markers (birthweight, length and head circumference) of children bom to anaemic 
mothers were reduced, but the ponderal index remained normal, indicating that there 
was a chronic impairment of foetal growth. More recently in Rwanda, maternal anaemia 
was an independent risk factor o f having IUGR, but not of being bom prematurely 
(Leroy e t al., 1998).
2.2.3. Infant mortality
There is compelling evidence that the risk of perinatal death increases in 
severely anaemic women. In malarious areas, first reports were done from large series 
of Malaysian pregnant women (Tasker, 1958; Llewellyn-Jones, 1965). Later, in a 
Kenyan hospital where malaria was low, severe anaemia (Haemoglobin (Hb) <7.4 g/dl) 
at delivery was associated with higher perinatal and neonatal mortality rates than 
moderate or absence or maternal anaemia (Hb>=8.9 g/dl) (Macgregor, 1963). Similarly, 
in Papua New Guinea, perinatal deaths were increased from 22 to 55 per 1,000 for 
women with and without severe anaemia (Hb < 8 g/dl) at delivery (Brabin et al., 
1990a).
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Long-term survival of children bom to anaemic mothers may also be impaired. 
In two consecutive prospective studies on the Thai-Burmese border, maternal anaemia 
at delivery was associated with a higher risk of infant deaths (Dolan et al., 1993; Nosten 
et al., 1994a). Although mortality rates for neonatal and post-neonatal periods were not 
specified, examination of the survival curves showed that the effect was more important 
in the post-neonatal period. These were the first published reports of an association 
between maternal anaemia and infant deaths in a malaria endemic area. But other 
potential confounding factors, such as morbidity during infancy and socio-economic 
environment were not taken in account. Nevertheless, a recent study in an area of much 
higher malaria transmission in Malawi, showed a similar association between maternal 
anaemia during pregnancy and post-neonatal mortality (Verhoeff & Brabin; personal 
communication).
2.2.4 Foetal and infant anaemia
Brabin (1992) reviewed published studies o f cord Hb values in developing 
countries and compared findings for populations exposed with those not exposed to 
malaria. In non-malarious areas, maternal iron deficiency anaemia is associated with a 
significant degree of cord anaemia. In malarious areas, where women are likely to also 
have iron deficiency, the foetal anaemia appears to be higher than expected as a result of 
iron deficiency alone. Thus malaria, but also haemoglobinopathies, may contribute to 
foetal anaemia that itself is likely to be related to the risk of anaemia in infancy.
In developed countries, anaemia during pregnancy is a strong risk factor of 
developing iron deficiency in infancy (Colomer et al., 1990). But in developing 
countries, the long term effects of anaemia during pregnancy on anaemia in infancy are 
unknown.
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2.3. Infant mortality in developing countries
Infant and childhood mortality rates remain extremely high in developing 
countries. In a recent attempt to estimate the groups most at risk of dying worldwide and 
the main causes of deaths, Murray & Lopez (1997) demonstrated that a third of all 
deaths occurs in children under 5 years old from developing countries. The probability 
to die before ones fifth birthday is 22% in Sub-Saharan Africa whereas it is only 1% in 
developed countries. Communicable diseases remain a leading cause o f deaths. In an 
earlier review, Ashworth & Waterlow (1982) had demonstrated that it is much more 
important to survey infant than childhood mortality, as the former is much higher than 
the latter. They reviewed 26,508 infant deaths from Latin America and Caribbean 
countries and calculated that 45% of them occurred during the neonatal period and 80% 
within 6 months. The leading cause of post-neonatal death was diarrhoea and the major 
risk factor was LBW (28% o f deaths between 1 and 5 months). The situation was 
similar to  that in 1920 in USA, when infant mortality rate (IMR) reached 117 per 1,000.
2.3.1. Infant mortality rates
In most developing countries reliable statistics are lacking and estimations of 
IMR are questionable (Lumbiganon et al., 1990; Amin et al., 1992). Community-based 
surveys give more realistic information and allow comparisons within areas. Table 2.2 
summarised IMR obtained from such studies. Overall, IMR tend to be higher in Africa 
than in other parts o f  the world and neonatal mortality represents nearly half of infant 
deaths.
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2.3.2 Main causes of infant deaths
In most studies, diagnosis facilities are lacking and infants die at home. 
Moreover, some causes may overlap (respiratory infections and malaria) or induced 
different final episode (deaths from measles may be due to respiratory infections or 
malnutrition). General and imprecise classifications are therefore usually used and the 
diagnosis of the cause of death remains unknown for a large proportion o f  them. This is 
more problematic in the neonatal period, the cause o f death often being reported as 
“LBW” or “premature”.
Nevertheless, there are some similarities within areas (table 2.2). A large 
proportion o f deaths occurs in the neonatal period. Infectious diseases are the most 
common causes of infant or post-neonatal deaths, with two leading causes: acute 
respiratory infections (ARI) and diarrhoea. The importance of tetanus varies largely, 
probably reflecting the immunization coverage in the area. In malaria endemic areas, 
malaria-attributable deaths vary from 0 to 35%.
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Table 2.2.: Infant Mortality Rates and main causes of infant or early childhood deaths in developing countries.
Year o f study Country Method Infant and neonatal 
mortality rates f/1,000)
Main infectious causes 
(% of total deaths)
Reference
1935-1950 Nigeria Vital statistics 
Autopsies
Infant: 140 to 86 ARI: 41%
Malaria: 9% 
Gastro-lntestinal: 5%
Bruce-Chwatt, 1952
1969-1979 Siena Leone Vital statistics 
Survey
NA Tetanus: 17% 
ARI: 15% 
Diarrhoea: 10% 
Malaria: 5%
Kandesh, 1986.
1971-1975 Nigeria Vital statistics Infant: 88 NA Ayeni & Oduntan, 1978
1975-1978 Kenya Longitudinal Infant: 50 ARI: 23% 
Diarrhoea: 23% 
Mealses: 7% 
Malaria 2%
Omondi-Odhiambo et al., 
1990.
1976 Congo Retrospective Infant: 71 
Neonatal: 47
0-5y: Measles: 41% 
Diarrhoea: 11% 
ARI: 3% 
Malaria: none
Carme et al., 1984
1978 Cameroon longitudinal Infant: 53 Malaria: 9% Kuate Defo, 1995
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1980-1984 Nigeria cohort Infant: 42 
Neonatal: 5
0-5 y: Measles 35% 
Malaria: 15% 
Diarrhoea: 15%
Adedoyin & Watts, 1989
1982-1983 The Gambia, 
Farafenni
Surveillance system 
Verbal autopsies
Infant: 142 
Neonatal: 66
1-23 m: ARI23%
Diarrhoea 14% 
Malaria 13%
Greenwood et al., 1987b
1984 Sudan Cohort Infant: 118 Diarhoea: 53% 
ARI: 7% 
Malaria: 7%
Woodruff et al., 1984
1987-1989 Somalia Surveillance system Infant: 142 
Neonatal: 48
0- lm: Tetanus: 80%
1- 1 lm: ARI 28%
Diarrhoea: 28% 
“Fever”: 20%
Ibrahim et al., 1996
1987-1990 Malawi Cohort Infant: 157 
Neonatal: 47
Diarrhoea: 40% 
“Fever”: 18% 
ARI: 15%
Bioland et al., 1996 
Slutsker et al., 1996b
1988-1989 The Gambia, 
North
Surveillance system 
Verbal autopsies
Infant: 97 
Neonatal: 41
ARI 29% 
Diarrhoea: 9% 
Malaria: 8%
De Francisco et al., 1993
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—1988-1989 The Gambia, 
South
Surveillance system 
Verbal autopsies
Infant: 120 1-5 m: ARI22%
Diarrhoea: 11% 
Malaria: 5% 
6-1 lm: Malaria 26% 
Dianboea 26% 
ARI 18%
Alonso et al., 1993
1989-1993 The Gambia, 
East
Surveillance system 
Verbal autopsies
Infant: 80 
Neonatal: 38
ARI 21% 
Malaria 12% 
Diarrhoea 7%
Jaffar et al., 1997
1990-1991 Burundi Longitudinal Infant: 108 Malaria: 35% 
ARI: 16% 
Diarrhoea: 15%
Delacollette & 
Barutwanayo, 1993
1990 Sierra Leone Survey+ cohort Infant: 154 NA Amine/ al., 1992
1991 Nigeria Retrospective NA 0- 1 m: Sepsis 38%
Tetanus 21%
1- 12 m: Malaria 47%
ARI 11% 
Diarrhoea 11%
Ekanem et al., 1994
1994 Tanzania Surveillance system 
Verbal autopsies
Infant: 133 0-5y: Malaria 36% Salum et al., 1994
1982 Brazil Cohort Infant: 39 
Neonatal: 21
ARI: 12% 
Diarrhoea: 12%
Barróse/ al., 1987
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1988-1989 Guatemala Cohort 0-3 months: 30 
neonatal: 12
0-3m: ARI (50%) 
Sepsis (10%)
Bartlett et al., 1991
1975-1977 Bangladesh Surveillance system Infant: 143 Tetanus: 26% 
Diarrhoea: 14% 
ARI: 7%
Chen et al., 1980
1976-1978 Indonesia,
Java
Cohort Infant: 78 
Neonatal: 30
ARI 25% 
Tetanus 10% 
Diarrhoea 8%
Handayani et al., 1983
1976-1977 Bangladesh Cohort Infant: 160 
Neonatal: 71
0- lm: Tetanus: 31%
1- 1 lm: ARI 33%
Diarrhoea: 10%
Islam etal., 1982
1977-1984 Bangladesh Vital statistics 
Verbal autopsies
Infant: 90-130 
Neonatal: 57-67
ARI: 20-22% 
Diarrhoea: 13% 
Tetanus: 7%
Bhatia, 1989
1979 India (urban) Cohort Infant: 47 
Neonatal: 21
NA Ghosh et al., 1979
1982-1984 Indonesia,
Madura
Cohort Infant: 121 
Neonatal: 52
NA Kusin et al., 1989
1982-1985 Papua New 
Guinea
Surveillance system 
Verbal autopsies
Infant: 46 
Neonatal: 22
1-1 lm: ARI 31% 
Measles 13% 
Malaria: 2%
Moire/ al., 1989
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1986-1987 Thailand Cohort Infant: 23 NA Lumbiganon et al., 1990 
Swenson et al., 19951988-1990 Vietnam Demographie and Infant: 33-36 NA
Health Survey Neonatal: 18-24
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2.3.2. Relationship between LBW and infant mortality and morbidity.
LBW is the main risk factor for infant deaths. In developed countries, 
McCormick (1985) showed that LBW was the most important predictor of neonatal and 
post-neonatal mortality. Children bom in the United States with birthweights < 2500g 
had a 40-fold and a five-fold increased risk to die during the neonatal and post-neonatal 
period than infants with birthweights of 3001-3500g. In developing countries, the 
association between LBW and infant deaths was also extensively reported (Ayeni & 
Oduntan, 1978; Rao & Inbaraj, 1978; Ghosh et al., 1979; Barros et al., 1987; Datta et 
al., 1987; Victora et al., 1988; Kusin et al., 1989; Bartlett et al., 1991; Downes et al., 
1991; Greenwood et al., 1992; Dolan et al., 1993; Lira et al., 1996).
It is generally assumed that LBW in developed countries are mainly due to 
preterm births, whereas most LBW in developing countries are due to IUGR (de Onis et 
al., 1998). In the absence of gestational age, populations have been classified by their 
prevalence of LBW: <7.5% is assumed to reflect preterm births and >15% is considered 
as a proxy for IUGR prevalence (World Health Organization (WHO), 1995). Premature 
infants are assumed to be more likely to die than term infants of similar birthweight. If 
this is the case, the risk of infant deaths attributable to LBW in developing countries 
may have been overestimated, as in these countries most LBW are growth retarded 
infants. In a large cohort conducted in Brazil, mortality rates were much higher for p re­
term than for small-for-gestional age infants (Victora et al., 1987). In Indonesia, infants 
weighing less than 2000g at birth remained at higher risk of death during the whole 
infancy, whereas those between 2000 and 2500 had a higher mortality only during the 
neonatal period (Kusin et al., 1989). Similar results were reported in the Gambia. 
Children weighing less than 2000g were at increased risk of both neonatal and infant 
mortality when compared to babies weighing more than 2500g. But newborn weighing 
between 2000 and 2500g had higher but not significant neonatal and infant mortality 
rates than babies weighing more than 2500g (Greenwood et al., 1992). This might 
reflect the different risks of dying of premature and full-term LBW babies as it is likely 
that the group o f children weighing less 2000g comprises many premature infants 
whereas most newborn weighing between 2000 and 2500g were probably growth- 
retarded. But this might also be only the consequence of lower birthweight. On the 
Thai-Burmese border, premature birth, assessed by using the Dubowitz score, was the
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strongest risk factor fo r infant deaths, independent of birthweight but the authors did not 
compared mortality o f  full-term and preterm infants of similar weight (Dolan et al., 
1993). In Malawi, prematurity and LBW were both identified as risk factors for 
neonatal deaths, but only birthweight remained in the multivariate analysis (Bloland et 
al., 1996). In a recent review, Ashworth (1998) demonstrated that term and preterm 
LBW infants of the same birthweight had risks o f neonatal and post-neonatal death of 
similar magnitude. Infants weighing 2000-2499g had a 4-fold increased risk o f neonatal 
deaths and a 2-fold greater risk o f post-neonatal death than infants 2500-2999g. But 
most pre-term infants were from developed countries, whereas most IUGR infants were 
from developing countries and thus a direct comparison was difficult. Moreover, the 
type of growth-retardation might differ greatly between developed and developing 
countries. In conclusion, LBW is the main risk factor for infant deaths, but it is not 
clearly established whether the excess of IUGR in developing countries distorts the 
estimations of risk calculated from developed countries.
LBW infants have been shown to be at higher risk o f death from infectious 
diseases than children with appropriate birthweight. A cohort o f 50,000 US births was 
followed from 7 days to 7 years of age. Moderate LBW (1,500 to 2,499g) was 
associated with an increased risk o f post-perinatal infectious disease mortality and this 
relation was attributable to preterm birth rather than to IUGR (Read et al., 1994). In 
developing countries, LBW is an important determinant o f mortality (Victora et al., 
1988) and morbidity from diarrhoeal diseases (Victora et al., 1990; Bukenya et al., 
1991; Ittiravivongs e t al., 1991; Barros et al., 1992; Lira et al., 1996). LBW has also 
been associated with mortality (Barros et al., 1987; Victora et al., 1988) and morbidity 
from respiratory infections (Victora et al., 1990; Barros et al., 1992). The increased risk 
of LBW infants o f suffering from infectious diseases has been related to the findings 
that they have a severely compromised immune function (Chandra, 1981).
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2.4. Morbidity and mortality from malaria during infancy
The acquisition of malaria infection in infancy has been recognized for long time 
as a marker of the level of malaria transmission in an area. Longitudinal studies using 
infant parasite rates have therefore been established in the 1950’s and 1960’s in order to 
evaluate the effects of the malaria eradication campaigns. But few of them reported on 
clinical malaria. More recently, the attention has focused on morbidity and mortality 
from malaria rather than malaria-infection. But this required longitudinal studies that are 
logistically difficult. Another method for estimating the burden of malaria disease is 
through hospital-based studies, but it comprises an important potential bias: in some 
areas, many children with severe and fatal malaria do not reach a hospital (Greenwood 
etal., 1987a).
Numerous studies have confirmed early anecdotal reports that infants are 
protected against clinical malaria during the first months o f life. In a small longitudinal 
study in Ghana, clinical malaria was absent before 4 months of age (Akanmori et al., 
1989). In Benin, Velema et al. (1991) showed that fever associated with parasitaemia 
was less common in babies under 6 months o f age than in older children. In Liberia, 
parasite rates and densities were low during the first 3 months of life, and then 
maximum from 6 months to 2 years (Petersen et al., 1994). In Ghana, both malaria 
infection (measured by using parasite rates) and malaria illness (measured by parasite 
densities and association with fever) were higher in infants 6-11 months than those 
under 5 months. (Binka et al., 1994). In a small cohort of Nigerian infants, clinical 
malaria did not appear before 2 months of age and was rare until 3 months (Achidi et 
al., 1996a). In a recent study conducted in Ghana, McGuinness et al. (1998) confirmed 
that clinical malaria was truly uncommon in the first 5 months of life, even after a lower 
parasite density threshold for the definition o f clinical malaria in infants was defined 
and applied. Lastly, Snow et al. (1998) compared incidence of malaria hospital 
admissions in four areas of Africa with marked differences in the intensity of 
transmission. In all four areas, children were protected against severe disease in the first 
two months of life. From 6 months onwards, morbidity and mortality from malaria 
varied with the level of transmission (Snow et al., 1997a; Snow et al., 1998). The risk of 
severe disease increased little with age in low to moderate areas whereas reduction of 
risk already appeared after 6 months where the malaria transmission was intense.
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Severe malaria is rare in infancy, although when it does occur, the mortality is 
high. Duren (1951) reviewed hospital-based reports from Congo Beige and found a case 
fatality rate (CFR) of 30%. This situation was unchanged fifty years later when 
Greenberg et al. (1989), in Zaire, reported the highest CFR (32%) in infants followed by 
a regular decrease with age. In an area o f very low malaria transmission on the Thai- 
Burmese border, where severe malaria occur at all ages, CFR for infants was higher 
than that in the children aged 1-4 years (18.2 and 4.4 per 1,000 respectively) 
(Luxemburger et al., 1997).
In areas where P.vivax co-exists with P.falciparum, the former seems 
predominant in infancy. In Pakistan, infants were first infected with P.vivax (Khan & 
Talibi, 1972). In Papua New Guinea, 75% of malaria cases (defined as fever and 
parasitaemia) in infants were due to P.vivax, whereas P.falciparum predominated in 
older age groups (Genton et al., 1995). In infants from Vanuatu, morbidity from vivax 
malaria was higher than that from P.falciparum (0.9 and 0.5 episode per child-year 
respectively) (Maitland et al., 1996).
Malaria is an important factor in the development o f infant anaemia. It was the 
major cause of anaemia in infants from Tchad, although iron deficiency was also 
common (Renaudin & Lombart, 1994). In Ghanian infants, Hb levels fell sharply from 
the first to the second half o f  infancy and this was thought to be mainly caused by the 
increase in malaria, but there was only a weak correlation between parasite density and 
Hb level (Binka et al., 1994). Malaria parasitaemia lowered Packed Cell Volume (PCV) 
levels in infants 4-10 months old living in an area o f high transmission in Nigeria 
(Achidi et al., 1996b). In Tanzania, an area of intense and perennial malaria 
transmission, PCV levels were related to parasite densities. The infants with chronic low 
parasite densities recovered after 7 months and had similar PCV levels to children 
without detectable parasitaemia, whereas children with high parasite densities had 
constantly lower PCV levels than infants with low parasite densities (Kitua et al., 1997). 
Malaria-related anaemia did not develop in Nigerian children protected against malaria 
by chemoprophylaxis, who had higher Hb and HCT levels than those who were not 
protected (Bradley-Moore et al., 1985b).
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Malaria attacks temporarily stop infant growth (Gamham, 1949; Bruce-Chwatt, 
1952; Williams et al., 1997). The long-term effects of malaria on growth are more 
difficult to assess as, in malaria endemic areas, it is not possible to find a control group. 
In most intervention studies, growth was similar in the group o f children protected 
against malaria by the intervention and in the control group. Gambian children 
successfully protected against malaria during the first three years o f  life had an overall 
growth similar to that of their non-protected counterparts, although weight gain of the 
latter showed seasonal variations that could be related to clinical malaria attacks 
(McGregor et al., 1956). Similarly, children receiving pyrimethamin during the first five 
years of life and controls who did not take prophylaxis reached the same weights at 2 
and 4 years of age (Morley et al., 1968). In another study, the protected group was taller 
and had a larger arm circumference than the non-protected one at 1 year of age but 
weight for age and weight for height were similar in both groups (Bradley-Moore et al., 
1985a). Draper & Draper (1960) reported that a successful malaria control in an 
hyperendemic area in East Africa was not associated with any changes in rates of 
growth. But more recently, the use o f impregnated bed nets was associated with a more 
rapid growth in the 5 months post-intervention (Shiff et al., 1996) and a reduction in the 
proportion of stunted children (Snow et al., 1997b).
2.5. Relationship between malaria during pregnancy and malaria in infancy.
2.5.1. Materno-foetal immunological relationship
Various non-immunological factors have been proposed to explain the apparent 
protection of young infants against malaria: the milk diet deficient in /7-amino-benzoic 
acid (Hawking, 1965), selective biting by mosquitoes of different age groups 
(Muirhead-Thompson, 1951) and haematological factors such as an ageing red cell 
population and the presence of foetal haemoglobin (Pasvol et al., 1976; Wilson et al., 
1977). The first two hypothesis did not appear as important factors in the intervention 
study conducted by Colboume (1956) who found that infants supplemented with p- 
amino-benzoic acid acquired malaria as rapidly as those not supplemented, and that all 
infants were bitten by mosquitoes. It is generally assumed that, although protection may 
be multifactorial, in-utero immunological mechanisms are the more important factors.
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Macdonald (1950) and Brabin (1990b) have reviewed the studies of malaria 
parasite rates in infants. Despite differences due to the level of malaria transmission, 
they showed that the increase of parasite rates is regular during the first year of life and 
similar to that expected from a model which does not take into account passively 
acquired immunity. They concluded that infants are susceptible to malaria infection. 
Nevertheless, as pointed out by Greenwood (1991) and confirmed by the recent studies 
already mentioned, protection against clinical attacks of malaria, which is probably 
separated from protection against the infection, does exist in the first months of life 
(Akanmori et al., 1989; Velema et al., 1991; Petersen et al., 1994; Binka et al., 1994; 
Kuate Defo, 1995; Achidi et al., 1996b; McGuiness et al., 1998; Snow et al., 1998; 
Wagner et al., 1998). Moreover, congenital malaria is relatively frequent in malaria 
endemic areas. The prevalence of cord blood infections varies from 0 to 21% and 
parasites are present in 0-29% of infant’s peripheral blood at birth, but newborn rarely 
develop symptomatic and/or severe malaria (Bruce-Chwatt, 1952; Kortman, 1972; 
Reinhard et al., 1978b; Marshall, 1982; Larkin & Thuma, 1991; Nyitjesy et al., 1993; 
Egwunvenga et al., 1995).
The transplacental transfer of P.falciparum-specific antibodies directed against 
sporozoites (Nardin et al., 1981) or blood stages (Richard-Lenoble et al., 1988; 
Chizzolini et al., 1991; Achidi et al., 1995; Rasheed et al., 1995) has been confirmed. 
Collins et al. (1977) and Campbell et al. (1980) have also reported that newborn o f El 
Salvador had transplacentally derived P.vivax antibodies and Biggar et al. (1980) 
detected maternal antibodies against P.malariae and P.ovale in newborn from Papua 
New Guinea. The efficacy of transplacentally acquired maternal antibodies in protecting 
against malaria in infancy is still controversial. In some longitudinal studies, the age at 
first malaria infection in infancy was not associated with the level o f cord antibody titres 
at birth (Campbell et al.. 1980; Mutabingwa et al., 1993b; Achidi et al., 1996a; Wagner 
et al., 1998). Biggar et al. (1980) demonstrated that the first malaria infection in 31 
Ghanian infants appeared when maternal antibodies had already vanished. Yet 
symptoms were absent or mild. They concluded that the moderation of symptoms of 
malaria in infants was due to factors other than maternal transmitted antibodies. On the 
contrary, in Papua New Guinea, most infections (67%) in infants that were detected in 
the presence of maternal antibodies were asymptomatic with scanty parasitaemias, 
whereas 73% of the heavy P.falciparum infections developed when maternal antibodies
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had vanished. The authors concluded that transplacentally transferred antibodies might 
be important for the protection against clinical malaria (Seghal et al., 1989). In other 
studies, the acquisition of infection and clinical malaria clearly followed the 
disappearance o f passively acquired IgG antibodies against P.falciparum blood stages 
(Akanmori et al., 1995; Kitua et al., 1996).
Various hypotheses were proposed to explain these controversial results. Among 
the hypothesis that may explain the limited protective effect of maternally derived 
antibodies against infant’s malaria, is the short half-life of these antibodies. Most 
authors have estimated it to be less than 2 months (Campbell et al., 1980; Biggar et al., 
1980; Omanga et al., 1982; Collins et al., 1987; Hogh et al., 1995) and no longer 
detected by 6 months o f age (Nardin et al., 1981). The levels of antibodies in infants 
may vary widely in areas of low malaria endemicity (Collins et al., 1987). Prolonged 
antimalarial chemoprophylaxis may affect the level of transplacentally acquired 
maternal antibodies in the newborn (Ibeziako & Williams, 1980; Collins et al., 1987). 
Moreover, the transfer through Plasmodium-infected placentas is reduced (Bray & 
Anderson, 1979; Brair et al., 1994; de Moraes-Pinto et al., 1998) and selective to some 
immunoglobulin isotypes (Chizzolini et al., 1991; Deloron et al., 1997) which seem to 
have little importance in the control of the infection. On the contrary, Kitua et al. (1996) 
proposed that maternally derived antibodies act by controlling the asexual stage 
parasites. They showed that the attack rate did not change with age but that the duration 
of infection was shorter in neonates 0-2 months old than in older infants. Thus parasite 
and fever-parasite prevalence, parasite densities increased with age as passively 
transferred immunity vanished and recovery became slower.
More recently, some authors have showed that protection from transplacentally 
derived antibodies against clinical malaria in infancy existed but was associated with 
specific sub-classes o f antibodies. In a prospective study conducted in Cameroon, 
P.falciparum-specific IgGl and IgG3 were transferred to the offspring more often than 
IgG2 and IgG4, but only the IgG2 subclass was associated with a reduced risk of 
acquiring falciparum malaria infection during the first 6 months o f life (Deloron et al., 
1997). This was a surprising result, as in adults only anti-malarial IgG3 and/or IgGl had 
been associated with some degree o f protection (Aribot et a!., 1996; Taylor et al., 1995). 
Hegh et al. (1995) reported a lower risk of developing an episode of clinical malaria
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during the first year o f life in the infants with high levels of anti-MSPli« antibodies at 
birth. The study was conducted in an area o f  high malaria transmission where 96% of 
the mothers and 80% of their infants had anti-MSPli9 antibodies at delivery. The 
proportion o f children with antibodies declined rapidly until 3 months of age (66%) and 
increased again to be higher than at birth (85-93%) from 6 months onwards. Infants who 
had a positive anti-MSPli9 antibody response at birth were less likely to develop 
clinical malaria during infancy than those who had a negative response, after 
adjustement for age and season. The protection was longer than that expected to be 
achieved by transplacentally aquired antibodies but the authors discussed the possibility 
that these antibodies did not interfere with the natural boosting and protected the infant 
until the acquisition of natural immunity. Other maternally derived antibodies (anti- 
schizont antigen antibodies) did not seem to play a role in the risk of acquiring malaria 
infection or disease during infancy. More recently, in a carefully designed prospective 
study o f mothers and infants, the presence o f anti-MSPl i9kD IgG antibodies one month 
prior and at the time o f the first infection in life was associated with a lower parasite 
density, a reduced risk to develop febrile disease, a higher proportion o f parasite 
clearance without treatment and a lower infection-related loss o f haemoglobin. Thus the 
presence o f anti-MSPl wkD IgG antibodies in infants clearly reduced morbidity from 
malaria. As the study was longitudinal, the authors were able to demonstrate that the 
first IgG and IgM peaks coincided with the first malaria infection in infancy in 92% of 
the infants. Therefore IgG present one month prior the first malaria infection were likely 
to be transplacentally derived maternal antibodies. Moreover, mother’s and cord’s IgG 
levels were very similar and the presence o f maternal IgG at the time of delivery was 
associated with a lower incidence and parasite density of placental malaria and a 
delayed time to first infection in infants (Branch et al., 1998).
Soluble P.falciparum antigens are transferred to the foetus (Druilhe et al., 1976; 
Jakobsen et al., 1998) and induce the production of parasite-specific IgM (Chizzolini et 
al., 1991; Achidi et al., 1995; Deloron et al., 1997; King et al., 1998). They also induce 
cell-mediated immunity, as shown by the response o f cord blood cells to P.falciparum 
antigens extracts (Desowitz et al., 1988; Fievet et al, 1996). The blastogénie responses 
of cord blood lymphocytes from newborn o f  Papua New Guinea showed wide variations 
that could be related to the sequence o f  infection during pregnancy (Desowitz et al., 
1988). In one study (Rasheed et al., 1995) mean lymphoprolifération and the proportion
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of responders to P.falciparum antigens were even higher in neonates than in mothers. 
But the neonatal response is believed to be biaised towards Th2-cell (Carlier &Truyens, 
1995) and to produce interleukine 4 (11-4), a cytokine required for the synthesis of IgE 
and IgG4. Th2 cells act antagonistically on the Thl-cell subset involved in the 
activation of macrophages essential in the control of infection. There is also a negative 
regulation in the gene expression of interferon gamma (IFN-y). Overall, this neonatal’s 
biaised towards Th2-cell response may lead to altered anti-parasite immunity. Indeed, 
lymphocytes from babies bom to Pfalciparum-infected mothers have been shown to 
synthesize more IgE antibodies in their response to P.falciparum antigens (Desowitz et 
al., 1993) than did the maternal cells. In Cameroon, the percentage of responders and 
the mean level o f positive responses after stimulation of cord blood lymphocytes by 
malaria antigens were of the same order as those observed in adults from the same area 
for IL-2 production, while proliferation and IL-4 responses were moderately reduced 
and IFN-y highly reduced. Surprisingly these findings were similar in primi and and 
multigravidae and whether mothers presented with a P.falciparum infection at delivery 
or not (Fievet et al., 1996). On the contrary, in another study, the neonatal TH2-biased 
response did not exist. Cytokine responses to blood stage malaria antigen MSP11 9  (IFN- 
y secreting lymphocytes and IL-4) by cord blood lymphocytes o f 92 Kenyan neonates 
were present in 23 and 8 % o f the samples and mirrored that observed in paired maternal 
blood. There were no MSP11 9-specific IgE antibodies in the cord blood but significant 
levels of MSPli9-specific IgM (compared to American cord plasma) in 4.5% of the 
samples. The authors concluded that “prenatal exposure to malaria may not lead to 
tolerance or altered foetal immunity and could stimulate partial protection to malaria in 
infancy” (King et al., 1998).
The vertical transmission of parasite antigens can induce T-cell tolerance and 
this has been clearly shown in filariasis. As a result, children bom to infected mothers 
were two or three times more susceptible to filarial infection than those bom to 
uninfected mothers (Lammie et al., 1991). In the case of filariasis, microfilaraemic 
patients with T-cell hyporesponsiveness are usually asymptomatic. Therefore, 
maternally-induced T-cell tolerance probably conferred a beneficial effect to the 
offspring, by increasing the risk of infection but not that of severe clinical 
manifestations. There are no study supporting this hypothesis in malaria.
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The relationships between malaria during pregnancy and malaria in infants may 
depend on the timing of malaria infection during pregnancy. Rasheed (1994) reviewed 
the knowledge on the influence of maternal infections on infection susceptibility in 
childhood, from published studies in malaria and other infections during pregnancy. The 
time at which in utero exposure occurs w ill depend on the likelihood of maternal 
infection (greater during the second trimester for malaria), on the flow o f products from 
mother to foetus, which is not constant throughout pregnancy (e.g. increased IgG 
transfer close to term), and on the maternal immune status, which changes with time 
(tolerance in the first part of pregnancy) and gravidity (immunosuppression and 
different hormonal environment in primi- compared to multigravidae). The foetal 
response will depend on the maturity of its immune system at the time of exposure. 
Thus a complex matemo-foetal immunoregulation will occur that may lead to either 
tolerance or protection against further infection in infancy.
2.5.2 Malaria during pregnancy and malaria in infancy
A few longitudinal studies following pregnant women and their offspring were 
conducted in order to assess whether malaria during pregnancy was associated with 
higher or lower risk to develop malaria in infancy. In Malawi, Redd et al. (1994) found 
that children bom to mother with placental malaria were more likely to have 
P.falciparunt infection at 2 months of age than those bom to mothers without placental 
infection. Le Hesran et al. (1997) also found that children bom to a mother with 
placental malaria were more likely to have P.falciparunt infection than those bom to 
mothers without placental infection, but this difference occurred later in life, from 4 to 6 
months. From 6 to 9 months, the difference was reduced and from 9 months onwards, 
the children bom to mothers with or without placental malaria had the same risk to 
develop parasitaemia. Throughout infancy, the risk o f  having clinical malaria was 
similar in both groups. Slutsker et al. (1996a) did not find an association between 
malaria during pregnancy and in infants during the first three months of life. Some 
authors compared malaria in infancy in children bom to mothers who received efficient 
antimalarial prophylaxis and in those whom mothers had not received prophylaxis or a 
less efficient drug. Malaria during infancy was not influenced by chemoprophylaxis 
during pregnancy (Spencer et al, 1987; Mutabingwa et al., 1994; Achidi et al., 1996a)
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nor by the number of malaria attacks during pregnancy (Mutabingwa et al., 1994). 
None of these studies could recruit pregnant women in early pregnancy. Therefore they 
could not determine whether malaria at various stages of pregnancy influences malaria 
in infancy.
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3.1. The Karen refugee camps 
3.1.1 Situation and organisation
In 1984, around 18,000 Karen in conflict with the Burmese junta took 
refuge in Thailand. On their arrival, they settled in a few opened camps situated in 
forested areas and accessible through out the year by four-wheel drive vehicles, near the 
Thai town o f Mae Sod (fig 3.1). Since then, the situation in Burma has deteriorated and 
Karen, as well as refugees from other ethnic groups, have continuously arrived in 
Thailand. New camps have been created, located all along the border and the number of 
refugees from Burma is estimated to have reached 100, 000. The Karen were never 
given the status of refugees, and are officially considered as illegal migrants by the Thai 
authorities. These had both negative and positives consequences. The United Nations 
High Commission for Refugees (UNHCR) was not allowed to be in-charge of the 
refugees. The camps were therefore set-up closer to the border than stated by the UN 
security norms. The refugees were not allowed to apply for asylum in a third country. 
The distribution of food rations and the implementation o f a health care system relied 
only on the action of a few Non Governmental Organizations (NGO) that received 
permission from the Thai authorities. On the other hand, the Karen camps were created 
and administered by the Karen. They therefore built houses, schools and health 
structures very similar to that in the Karen state. As the camps were opened and close to 
the border, they maintained their commercial system. Farmers could go back to their 
own farms in Burma or work in Thai farms. Merchants could renew their stock in 
Burma and sell it in the camps. Families regularly moved back to their villages and men 
to the army. At the end of 1994, the Karen split in two groups and during the following 
dry season (February to April 1995), the camps were attacked and sometimes burnt by 
the dissident fraction. The Thai army intervened and, in order to protect the camps, 
restricted population movements, and established a curfew. Some camps were closed 
and their inhabitants relocated to one of the other sites, Maela, which now comprises 
around 25,000 refugees.
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Fig 3.1. M ap of the area
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3.1.2. Population
The refugees are mainly women (54%) and children: 45% of the population is 
under 15 years old. About 90% of the refugees are Karen, most of whom (80%) are 
Buddhists or animists and the others are Christians. The remaining 10% of the refugees 
compose a distinct group, who may have originated in Bangladesh but have been living 
with the Karen for generations. They are Muslims and call themselves the "Black 
Karen". Whilst most of the Karen were farmers prior to fleeing to Thailand, the 
Muslims were usually merchants and run the small markets established in the camps. 
Both groups are well educated, with only 30% illiterate and access to education is equal 
between men and women. As a consequence, all camp administrators, teachers and 
health workers arise from within the community.
A wide range o f background socio-economic status are found. If the differences 
diminish once families arrive in Thailand, there are still obvious degrees of income in 
the camps. Food, school furniture, blankets and mosquito nets are given by a 
consortium of charities based in Bangkok (Burma Border Consortium; BBC). The food 
ration comprises rice, fermented fish paste and salt. Most o f the refugees grow 
vegetables and fruit and some own poultry, pigs and goats. They find roots and leaves in 
the surrounding forest. The families usually send at least one of their members to work 
outside the camps, which gives them small cash income and leads to a local economy in 
the camps.
3.2. Health facilities 
3.2.1 General organisation
Health care is provided by the French medical organization Médecins Sans 
Frontières (MSF) and in two camps, Shoklo and Maela, the SMRU has opened health 
structures in order to treat patients enrolled in the trials. In each camp, all houses are at 
walking distance from a dispensary. Most camps also have an in-patient department 
where patients can stay overnight. More severe cases are transferred to Shoklo or Maela 
hospitals, where most common medical problems can be treated. Patients who need
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surgery or pregnant women with obstetrical complications are referred to the Thai 
hospital o f  Mae Sod. Expatriate physicians were on call around the clock in the main 
camps until 1995. Since 1996, they had to go back to Mae Sod every evening for safety 
reasons. Preventive programmes have been implemented by MSF: Expanded 
Programme of Immunization (EPI) and sanitation. The SMRU has been running ANC 
since 1986. All MSF and SMRU health facilities are run by Karen staff: medical 
assistants, nurses, laboratory technicians and logistic officers. All services are free of 
charge for the refugees and for Thai-Karen from the neighbouring villages. A few health 
workers have private practices in the camps, and medicines are available from the 
shops. Nevertheless, most of the refugees cannot afford them.
3.2.2. The Shoklo Malaria Research Unit
The work described here is part o f  a large community-based malaria research 
project. The SMRU was set-up in 1986 and is part o f the Oxford-Mahidol Tropical 
Medicine Research Programme, directed by Pr. Nicholas J. White. The SMRU is 
directed by Dr. François Nosten. The objectives of the Unit are:
to determine the optimum antimalarial treatment in an area of multi-drug 
resistant P.falciparum.
to describe the epidemiology o f malaria in an area of low and unstable 
endemicity where P.vivax and P.falciparum co-exist.
- To evaluate preventive antimalarial measures such as impregnated mosquito- 
nets or vaccine candidates (SPf66).
to describe malaria during pregnancy and its consequences on mother and 
foetus, in this context of low endemicity, co-existence of Plasmodium 
species and multi-drug resistance.
to assess the efficacy of antimalarial treatments and preventive measures in 
pregnant women with emphasis on potential toxicity on the foetus or infant.
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Equipment, communications and staffing are common for all the trials 
conducted in the Unit. The main base was located in Shoklo camp and partly moved to 
Maela in June 1995. In both places, the Unit comprises a laboratory, a hospital, a 
delivery room, a dispensary, clinics ascribed to specific trials (Antenatal Clinic, Infant 
Clinic, Drug Trials Clinic...), an office with computing facilities and staff houses. 
Electricity is provided by a generator, running water is available in all buildings. Each 
camp has a radio liaison with the office in Mae Sod. Another laboratory is also located 
in Mae Sod. The Karen personal (200 persons) comprises medical assistants, midwives, 
nurses, laboratory technicians, computer data entry clerks and home-visitors. There are 
5 expatriate scientists (4 physicians and 1 technician). Further logistic and 
administrative support is provided at the Mahidol University in Bangkok and at the 
University of Oxford.
3.3. Malaria situation
3.3.1. Overview
In 1984, malaria was immediately identified as the main health problem in this 
community. The camps are located in forested areas, often surrounded by rice fields 
cultivated by the neighbouring Thai-Karen villagers. The average minimum and 
maximum annual temperatures are 21 and 29°C and the relative humidity varies from 65 
to 87%. The monsoon begins in May and lasts until October. Average annual rainfall 
(1987-92) is 1900 mm. Conditions are therefore optimum for anopheline vector 
breeding sites in the stagnant pools along the rivers and in rice fields. The vectors arc 
predominantly Anopheles minimus (44%) and An.maculatus (43%) with relatively few 
An.dirus (2%). Most feed outdoors in the evening (6-10 pm) and in the early morning (4 
am) (McGrcady; personal communication).
Malaria transmission occurs year-round with two seasonal peaks: May-July and 
December-January. Symptomatic and severe malaria cases are seen at all ages. 
Epidemics may arise (8 since 1984). When the Karen settled in the camps, malaria- 
related morbidity and mortality were high. Forty per cent of the consultations at the 
dispensary were due to malaria (P.falciparum: 75%; P.vivax: 20%; mixed infections:
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5%; P.malariae: very rare) as well as 24% o f the deaths registered in the community. 
Multi-drug resistance of P.falciparum necessitated the introduction of mefloquine 
(Nosten et al., 1987). A malaria control programme was established based on early 
diagnosis and treatment (Decludt et al., 1991). For 15 years the population has been 
encouraged to come to the dispensary for any febrile episode. All cases are confirmed 
by microscopic examination of a blood smear prior to treatment. Overall there were 
1,067 malaria cases per thousand refugees in 1984 and 716 in 1994. By 1994, the 
importance of malaria in overall morbidity and mortality had decreased (15-20% of the 
consultations; 10% of the deaths) and the ratio Pfalciparum/P.vivax had changed and 
was closer to 1. Most of the malaria-related deaths were in people coming from 
surrounding areas (MSF unpublished reports). Thus the development of curative 
services combined with laboratories is thought to have had an effect on the malaria- 
related morbidity and mortality in the camps. During the 10 year period, multi-drug 
resistance had increased. In 1994 a three-day combination of artesunate and mefloquine 
was introduced for the treatment of uncomplicated falciparum malaria (Nosten et al., 
1994b). This combination proved highly efficient and artesunate reduced gametocyte 
production (Price et al., 1996). Following the introduction of this treatment on a large 
scale, falciparum malaria transmission was reduced by 70% and the therapeutic 
combination remained highly efficient, indicating that it may protect mefloquine against 
further deterioration of the resistance.
In order to describe the epidemiology of malaria in this area more precisely, the 
SMRU has conducted several cohort studies. Age-specific incidence rates, risk factors 
for malaria infection, risk factors of developing severe malaria, and parasite threshold 
for the development of symptoms were defined. Despite some variations between 
camps and a trend towards reduction with time, the malaria situation in the camps can 
be estimated from this work (Luxemburger et al., 1996). Malaria incidence rate was 
around 1.0 (95% Cl: 0.9- 1.1) infection per person per year. P.vivax causes 54%, 
P.falciparum 36%, and 10% of the infections were mixed. The age-specific incidence 
rates of these two species were very different, reflecting a different transmission pattern 
(fig 3.2). By the age of 4 years, the children had experienced 4 times more P.vivax 
episodes than P.falciparum. But older children and adults still developed symptoms for
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both species. The parasite threshold for developing symptoms was very low (1500/pl 
for P.falciparum-, 200 for P.vivax), reflecting a lack of immunity.
Fig 3.2. Age-specific P.vivax and P.falciparum malaria incidence
age groups (years)
Nevertheless, the risk of getting severe malaria, the malaria attributable 
mortality rate, and the risk of having a recrudescence after an antimalarial treatment 
decreased with age, due to a certain amount of premunition (Luxemburger et al., 1997) 
(flg 3.3). Male, young adults, subjects with a past history o f falciparum malaria and 
those who travel outside the camp had an increased risk of P.falciparum episodes.
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Fig 3.3. Age distribution of hospitalised patients and age-specific risk of 
antimalarial treatment failure (from Luxemburger e t al., 1997 and ter Kuile et al., 
1995).
AGE (YRS)
Early detection and treatment of malaria are clearly the most important part of 
the malaria control programme. Nevertheless, some other measures have been 
introduced. The Thai Malaria Zone Office (MZO) runs an in-house spraying programme 
(DDT every 6 months). Mosquito nets are distributed by the BBC. Since 1996, they are 
impregnated with permethrin. Only 40% o f  the families accept the house spraying and 
its effect has never been evaluated in the area (MZO personal communication). In two 
trials conducted in the camps, permethrin-impregnated bed nets reduced malaria by 42% 
in schoolchildren (Luxemburger et al., 1994) and anaemia by 50% in pregnant women, 
but they had little effect on detectable parasitaemic episodes in the latter group (Dolan 
et al., 1993). Their efficacy after introduction on a large scale and without supervision 
of their use was not clearly established (MSF; unpublished data).
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3.3.2. Malaria during pregnancy
In this area of low malaria endemicity, malaria during pregnancy is associated 
with maternal morbidity and mortality, and reduced birthweight. In 1985, there were 5 
maternal deaths from malaria, giving an estimation of malaria-related mortality rate in 
pregnant women of 20 per 1000 (Nosten et al., 1991). The ANC programme was 
implemented by the SMRU in 1986. All pregnant women were encouraged to attend the 
ANC and by 1989, 90% o f pregnant women were registered. This proportion remained 
stable in recent surveys.
3.3.2.I. Routine data collected from ANC attendees
At their first visit, a questionnaire enquiring about demographic data, past 
obstetrical history and past malaria history is applied to the women. Pregnant women 
are then followed weekly. At each consultation, they are asked to report any symptoms 
during the previous week, a blood smear is performed and they receive a 
supplementation to their food ration (eggs and beans). A blood sample for an 
haematocrit testing is taken fortnightly, and an obstetrical examination (fundal height, 
foetal heart beat, blood pressure) on a monthly basis. All women with a positive malaria 
smear are treated. The majority of women are asymptomatic, because malaria is actively 
detected before they develop fever. In this area, it is well established that most subjects 
with parasites would develop symptoms in the absence of treatment. This may differ in 
pregnant women, but it is considered unethical to leave them untreated. Pregnant 
women are also encouraged to come to the clinics in between two weekly consultations, 
in case of fever. Iron and folic acid treatments are given to all women who develop 
anaemia (HCT less than 30%). Haematinics are given as soon as anaemia is detected 
and continued until delivery. Blood transfusion is given when HCT is below 20% or in 
the presence of clinical symptoms of severe malaria. Other medical conditions, such as 
ARI, urinary tract infections (UTI) and pre-eclampsia are treated when needed. All 
women are encouraged to deliver in the SMRU hospital. At birth, the newborns are 
weighed and a Dubowitz score is performed within 6-24 hours. Home-visitors report on 
deliveries that occur at home, and research staff visit the mother and child within 72 
hours.
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During their entire follow-up in ANC, the women keep a card that they bring 
back at each contact with the health services. All data collected during the period are 
reported on this card: demographic data, past obstetrical and malaria history, weekly 
results of blood smears, fortnightly HCT levels, monthly fundal height, as well as 
complaints, treatments for malaria or other conditions. This card is completed at 
delivery with the type and site of delivery, weight and sex o f the infant, Dubowitz score, 
and collected by the SMRU staff. Data are coded and entered into a database.
3.3.2.2. Summary of the main results
Since 1986, more than 11,000 pregnancies have been followed prospectively. A 
detailed epidemiological description of malaria during pregnancy in this area of low 
transmission (Nosten et al., 1991) and the first report o f the consequences of vivax 
malaria during pregnancy on the mother and newborn (Nosten et al., in press) have been 
published. Three successive randomized trials have been conducted in order to assess 
the efficacy o f preventive antimalarial measures in the area: mefloquine prophylaxis 
(Nosten et al., 1994a), permethrin-impregnated bed nets (Dolan et al., 1993), skin 
mosquito-repellent with DEET (McGready et al., in preparation).
In summary, the incidence of malaria during pregnancy is about 30%. Both 
species, P.falciparum and P. vivax are m ore common in primigravidae than in 
multigravidae and may be associated with symptoms. Pregnant women are more likely 
to develop severe malaria than their non-pregnant counterparts (Luxemburger et al., 
1997). Since the implementation of the ANC programme, malaria-attributable mortality 
has albeit disappeared. Malaria-related anaemia is the most important consequence for 
the mother. Anaemia is present with both species and increases with the number of 
malaria episodes. Both species reduce birthweight, but the effects of P.falciparum are 
more marked than that of P. vivax. Whereas the reduction in birthweight due to 
P.falciparum is present mainly in the first three pregnancies, that due to P.vivax occurs 
in all gravidae, but is relatively more important in multigravidae. Anaemia has no 
apparent independent effect on birthweight. Malaria during pregnancy has no effects on 
the duration of gestation, nor on the outcome. The rate o f stillbirth/late abortions is 5- 
7% and is not influenced by malaria during pregnancy.
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3.3.3. Malaria during the first two years of life
The epidemiology of malaria in young children has been less studied, but 
scattered data suggest a very different picture from that o f malaria in infants in highly 
endemic areas. The parasite rate is close to zero. All falciparum malaria infections are 
symptomatic and often severe (40% of cases). In 1992, the falciparum malaria incidence 
rate was estimated to be 70 per 1000 in children under 1 year old and 164 per 1000 in 
children aged 1 to 2 years. Vivax malaria was acquired at a younger age than 
P.falciparum malaria: median (range) age: 12.5 (5-23) and 14.5 (10-23) months 
respectively. Case fatality rate of falciparum malaria was higher in infants under 1 year 
(34 per 1000; 4/117) than in children 1-4 years (12 per 1000; 11/936).
3.3. Infant mortality and morbidity
IMR is surprisingly high in the camps, despite a good access to health structures, 
a high immunization coverage (90% BCG; 70% complete EPI) and the absence of 
harmful cultural behavior. The first estimation of IMR was obtained from the follow-up 
of infants bom to mothers recruited for the mefloquine prophylaxis and permethrin- 
impregnated bed nets: 170 (49/288) and 160 per 1000 live births (32/196) respectively 
(Nosten et al., 1994a; Dolan et al., 1993). Risk factors for infant deaths were 
prematurity, low birthweight and maternal anaemia at the time of delivery. The causes 
of deaths were unusual. Diarrhoea was not the main killer as in most tropical countries. 
In the first cohort o f infants, thiamin deficiency caused 38% (19/49) of the deaths, 
prematurity, respiratory infections and malaria 8% each, the remainder were 
unexplained. Thiamin deficiency has been well described in similar rice-eating 
populations in the region (Thanangkul & Whitaker, 1966; Pongpanich et al., 1974). It is 
the most common nutritional deficiency in the camps, especially in pregnant women 
and lactating mothers (McGready, unpublished data). A weekly distribution o f vitamin 
B1 for lactating women has been implemented for 2 years, but has not yet been 
evaluated.
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Morbidity was not described in the two studies mentioned previously, but data 
gathered from dispensaries activity show different pattern than that described in other 
developing countries. Respiratory infections account for 20% of the consultations as in 
most places, but diarrhoea incidence is generally low with periodic epidemics. 
Malnutrition is rare (< 5%) and usually reflects social problems or underlying health 
problem such as tuberculosis.
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4.1. Study site and population
The study was conducted in five camps: Shoklo (8,000 inhabitants), Bonoklo 
(6,000), Maesalit (3,500), Klaymuta (1,500) and Maela (21,000). These 5 camps have 
similar general organization and relief programmes, but they differ slightly in their 
population structure, socio-economic factors and malaria situation. Whereas the two 
ethnic groups co-exist in most camps, Black Karen are absent in Maesalit and 
Klaymuta. Maesalit comprises a section inhabited by hilltribe Karen who are less 
educated than expected in the camps. Klaymuta opened in 1994 and refugees in this 
place have only recently arrived in Thailand. The inhabitants from Bonoklo have the 
highest socio-economic level in the camps.
The study started in 3 well-established camps (Shoklo, Maesalit and Bonoklo) 
where the SMRU had been present for seven years. Epidemiological surveillance of the 
malaria situation indicated that malaria transmission was usually higher in Shoklo than 
in the two other camps (MSF reports). ANC was implemented in Klaymuta a few weeks 
after the camp opened, in July 1994, and the first children included in the study were 
bom in September. Malaria was much higher than in other places as is generally the 
case on arrival of new refugees. Moreover an epidemic o f malaria occurred in August- 
September 1994. The situation was radically different in Maela. Although this camp is 
among the oldest in the area, SMRU was not regularly working there. In May 1995, the 
refugees from Bonoklo were relocated there after their camp had been burnt. Thus the 
SMRU started to work in Maela in order to follow pregnant women and infants from 
Bonoklo who were already admitted into studies. Later the refugees from Maesalit and 
Klaymuta were also relocated there, and the development o f SMRU structures followed 
that of the camp (from 4,500 refugees in December 1994 to 21,000 by July 1995). At 
the end o f the study, Maela was the main base of the SMRU. In Macla, as the camp was 
growing, malaria transmission inside the camp nearly stopped and the majority of cases 
were acquired during travel outside the camps. Pregnant women were infected during 
their movements outside the camps, but their children, who usually stay at home, rarely 
developed malaria during infancy.
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All live bom singletons (spontaneous breathing and presence of heart beats) 
whose mothers were followed in ANC were included into the study if their mothers 
gave informed consent. Twins, stillbirths, newborn whose mothers did not attend ANC 
and whose those mothers did not reside into the camps and only stayed during 
pregnancy were excluded from the study.
4.2. Study design
The study was prospective. A birth cohort was followed weekly from birth to 
one year of age in order to calculate the 1MR, to describe the acquisition of malaria, and 
to estimate morbidity rates from malaria and other infectious diseases. Monthly 
measurements o f anthropometric markers and HCT levels were use to compare growth 
and haematological status of infants exposed to different factors in utero. The history of 
malaria and anaemia o f their mothers had also been collected prospectively from their 
admission into the ANC until delivery. Socio-economic markers and parental education 
were scored by means o f  a questionnaire applied to the mother as soon as possible after 
birth.
4.3. Study procedures
4.3.1. Admission
All newborn included into the study were given a unique identification number 
with a letter for the camp and three digits for the child. If the children moved during the 
follow-up they were given a new number, but both identifications were entered in the 
database in order to follow the child’s history. This information was used to determine 
in which camp the mother and her/his child had lived for the longest period and 
therefore to determine the variable “camp” used for the analysis. In most cases, it was 
the camp of infant’s birth. Similarly, “year” was defined as the year of birth.
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As the recruitment for the study lasted for three years, some women delivered 
twice. Identification number of the first bom was reported on the notes of the second in 
order to recognise siblings. Newborn were examined within 72 hours after delivery 
whenever possible. Admission was sometimes delayed in children bom outside the 
camp during a visit o f their mother to Burma or to another camp, or in case of referral to 
a Thai hospital and delivery there. Such births were recorded by home-visitors who 
systematically visited the women who had been absent from the weekly antenatal visits. 
At this first examination, child’s weight (to the nearest 50g), height, head and arm 
circumferences (0.1cm) were measured and a test conducted to assess the gestational 
age (Dubowitz score). The use of the Dubowitz score in the Karen population was 
validated by Dr. Dubowitz in a pilot study conducted before the beginning of this 
cohort. She trained Karen staff and visited the site once a year. Gross external 
malformations were recorded.
ANC cards were collected after their completion by the midwife. All 
information contained in the card was reviewed by the study’s supervisor and 
summarized in the infant’s admission form. This summary contained the following 
information: demographic and obstetrical data of the mother (age, address, gravidity, 
parity); history of previous children (number alive, number dead, interval since last 
birth and survival of the child); history of confirmed malaria before pregnancy (obtained 
by questionnaire); slide-confirmed malaria attacks between conception and first 
antenatal visit (questionnaire and cross-check with dispensary attendance); results of 
antenatal examinations: weekly malaria smear, malaria episodes (parasite count, 
presence or absence o f  symptoms, treatment), fortnightly HCT levels; symptoms and 
treatment of suspected thiamin deficiency; diagnosis and treatment of other morbid 
events; type and site o f  delivery; complications during the post-partum (Appendix 1). 
When the card was not available (lost, burnt), data were extracted from the log books 
filled by the midwives at each ANC visit and kept in the SMRU’s office.
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4.3.2. Socio-economic status (SES)
A questionnaire was applied to the mother as soon as possible after the infant’s 
birth. Interviews were conducted at home and questions were asked in the mother’s 
language. Information was collected on date o f arrival in Thailand, past work in Burma, 
level of education, current work and income, house materials and families properties 
(Appendix 2). Scores for education of each parent and for the current SES (i.e. since 
arrival in the camp) were calculated as indicated in tables 4.1 and 4.2:
Table 4.1: Education score of each parent (0 to 10)
(a) went to school no (0); yes (1)
(b) school level reached none or only kindergarden (0) 
Primary school (1) 
secondary school (2)
(c) can write no (0); yes (1)
(d) number o f languages spoken only mother’s tongue (1)
2-3 local languages (2)
2-3 languages including foreign language (3)
(e) number o f  languages written none(0)
only mother’s tongue (1)
2-3 local languages (2)
2-3 languages including foreign language (3)
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Table 4.2: Score of current economic level (0 to 20).
Family income
(a) mother has income no (0); yes (1)
(b) father has income no (0); yes (1)
(c) family has a garden no (0); yes (1)
(d) number of chicken none (0) 
1-9(1)
£ 10(2)
(e) number of pigs or goats none (0)
K D
* 2 (2 )
(0 number of cows none (0) 
1-2(1) 
£3 (2)
(g) proportion of households fed 
by the food ration distributed
<80 % (0) 
£80% (1)
Hygiene and quality o f life
(a) housing material only leaves (0)
leaves and bamboos (1)
leaves, bamboos and wood (2)
(b) interviewer impression on 
economical level
very poor (0) 
poor(1) 
average (2)
(c) interviewer impression on 
the hygiene of house
dirty (0) 
tidy (1) 
very tidy (2)
(d) watch no (0); yes (1)
(e) radio no (0); yes (1)
(0 furniture none (0)
1 table (1)
£ 2, e.g. table + cupboard... (2)
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4.3.3. Follow-up
Each infant was seen weekly by a home-visitor living in the neighbourhood. 
They enquired about illnesses during the previous week and reported absences from the 
camp (Appendix 3). When they found that the child had been sick, they ensured that 
he/she had been brought to a clinic. As they were living close to the children that they 
followed, they usually knew the events that happened between two visits. Thus most 
deaths that occurred at home or hospitalizations in MSF or Thai structures were 
reported immediately to the study staff.
Mothers were encouraged to bring their sick babies to the SMRU (Shoklo, 
Maela) or MSF (Bonoklo, Maesalit, Klaymuta) dispensaries for any illnesses. 
Complaints, clinical signs, and laboratory results were collected on a standardised form 
(Appendix 4). When the child attended the MSF health facilities, information contained 
on his/her health card was reported to the study notes. In the 3 camps in which the 
SMRU had no permanent health structures (Bonoklo, Maesalit, Klaymuta), research 
staff living in the camp registered all events (births, deaths, dispensary attendance, 
transfer to hospital) that occurred among the studied children in between the weekly 
visits from the SMRU ANC and Infant Clinic mobile teams.
In this setting, most of the children who died presented to the dispensary at one 
stage o f their final illness and a large proportion of deaths occurred in hospital. Hospital 
and dispensary records are kept by MSF. A copy of the file was obtained and cause of 
death was defined after both physicians (from MSF and SMRU) had agreed on a cause. 
When death occurred at home, the mothers were interviewed by the investigators.
All children were seen at one week o f  life and then monthly until 1 year of age 
at the SMRU Infant Clinic. At each visit, anthropometric measurements and HCT levels 
were performed, children were examined, milestones and vaccinations were recorded 
(Appendix 5). Children were seen systematically by a physician at 6 months of age. 
During this visit, mothers were also asked if they were breastfeeding and if they had 
started to give complementary food to the infant (Appendix 6).
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At the end o f the study the follow-up period was determined in days. The 
children either completed the study (365 days) if they attended the Clinic or were seen 
by home-visitors at 12 months of age or they were lost (number of days = date o f  lost -  
date of birth), or they died (number of days = date o f death -  date of birth) before 12 
months of age. Whenever possible, the exact date of death or withdrawal from the study 
was recorded, otherwise the date was arbitrary chosen as the 15lh of the month.
4.3.4. Case definitions
Investigations were limited in the camps, thus most diagnosis were based on 
clinical grounds. The majority of consultations were done by locally-trained medical 
assistants. Case definitions were therefore similar to that used by health agencies 
working on the border when they train health workers or classify morbid events in 
monthly activity surveillance.
Sinule episodes of morbidity: in each individual, consecutive morbid events were all 
numerated if they were from a different diagnosis, but episodes with similar diagnosis 
were counted only when there was a time gap of seven days free o f symptoms between 
the two episodes. This delay is rather short and the two episodes may have been due to 
the same infectious agent, but there was no recognised definitions for single events, and 
many episodes would have been missed with a longer period.
Symptomatic malaria case: presence of asexual forms of plasmodium species on a 
blood smear, associated with fever (axillary temperature above 37.5°C) or history of 
fever during the previous 3 days. This definition was used for infants, but in pregnant 
women symptoms included fever and/or any of the followings: headache, chills, 
arthralgia, myalgia.
Asymptomatic malaria infection: presence of asexual forms of plasmodium species on a 
blood smear without any of the symptoms listed above. Asymptomatic malaria were 
diagnosed only in pregnant women in whom active detection was performed. Therefore 
the infection was sometimes detected before the development of symptoms.
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Severe malaria case: symptomatic malaria case with one or more of the following signs 
of severity: history of convulsions, impairment of consciousness, hyperparasitaemia (> 
4% parasitised red blood cells), severe anaemia (HCT< 20%), intractable vomiting, 
oligo- or anuria, bleeding, pulmonary oedema, shock.
Acute Respiratory Infections (ARI): recent history o f cough and fever. ARI are 
classified in three levels o f severity: (i) mild ARI: respiratory rate < 40/min, presence of 
runny nose, no impairment of daily life (eating, playing...); (ii) moderate ARI: 
persistence o f the symptoms previously described and productive cough with abnormal 
pulmonary auscultation; (iii) severe ARI: respiratory rate > 60/min, presence of one or 
more signs o f severity: chest indrawing, alar flare, cyanosis.
Diarrhoea: more than 3 loose stools per day (or increased number of stools in a 
breastfed infant), with/without fever and/or cramps. There are no routine laboratory 
diagnoses in the camps. Diarrhoeal episodes are classified as watery, or bloody. They 
are considered as moderate when oral rehydration salt are sufficient, or severe when the 
degree of dehydration requires intravenous treatment.
Infantile Beri-Beri: sudden onset o f respiratory distress in a young (around 6 weeks-4 
months), previously healthy, breastfed infant: respiratory rate > 60/min, enlarged liver, 
normal pulmonary auscultation, with sometimes cyanosis, moderate fever, hoarse voice 
and rapid improvement (within few hours) o f  these signs after a single intramuscular 
injection o f vitamin Bl. In Shoklo and Maela camps, the diagnosis was always assessed 
by one SMRU physician or the trained medical assistant in-charge o f the Infant Clinic. 
In the other camps, the frequency was usually overestimated, as the health workers have 
been encouraged to prevent this serious event by an injection of vitamin Bl if they have 
any doubt. SMRU physicians subsequently interviewed the mother and classified the 
case as probable, unlikely or unknown.
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l ow Birthweight (LBWt: birthweight, as weight recorded in the first 3 days of life, 
under 2500g. Children with a birthweight of 2500g or m ore were classified as “Normal” 
Birthweight (NBW). This classification is independent from the gestational age. In both 
groups o f children, there could be some newborn with appropriate weight-for-age and 
others small-for-age.
Premature birth: birth before 37 weeks of gestation. Gestational age was estimated by 
using Dubowitz score, which combines external (superficial) and neurological criteria. 
The method is reliable when applied from 6 hours to 5 days after birth and provides an 
estimate o f gestational age with 95% confidence limits of ± 2 weeks (Dubowitz & 
Dubowitz, 1977).
Anaemia during pregnancy: a woman was considered anaemic when her HCT was 
lower than 30%. This cut-off corresponded to 2 standard deviations (SD) below the 
mean HCT level in pregnant women in this population. Severe anaemia was defined by 
a HCT < 25%. There are physiological variations o f  HCT during the course o f 
pregnancy. HCT levels decrease at the end of the first trimester, and then remain in 
plateau until 30-34 weeks of gestation. The levels raise again during the last weeks 
before delivery (Nosten et al., in press). Moreover, there is a certain degree of haemo- 
dilution during pregnancy that may lead to an overestimation o f the prevalence of 
anaemia. Using different definitions of anaemia at various stage o f pregnancy rendered 
the analysis too complex. We therefore used only one cut-off to determine if a woman 
had been anaemic (HCT<30%) or severely anaemic at any time during the pregnancy, 
and if she remained so at the time of delivery.
Infant anaemia: normal values of HCT in infants living in developing countries are not 
well defined. Reference values have been calculated for developed countries (Saarinen 
& Siimes, 1978; Lubin, 1987) and take in account the physiological anaemia that 
develops by two-three months of age (O’Brien & Pearson, 1971). In the study, infant 
anaemia was defined using lower values, in order to harmonize the definition with that 
of maternal anaemia (e.g. infant anaemia was defined as HCT < 30% from 6 months 
onwards whereas the reference values is 33%). Anaemia at birth was defined as 
HCT<45%, and at two and three months: HCT<28%.
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I Jnderweight/stunted/wasted infant: Underweight was defined as a weight-for-age Z 
score (WAZ) below 2 SD of the mean of the National Center for Health Statistics/ 
World Health Organization (NCHS/WHO) reference population. Stunting and wasting 
were defined respectively as a height-for-age Z score (HAZ) and a weight-for-height Z 
score (WHZ) below 2 SD of the NHCS/WHO reference population.
4.3.5. Treatment
Children with vivax malaria were given 25 mg base/kg of chloroquine phosphate 
over three days. Infants who developed uncomplicated falciparum malaria were 
administered a three day combination o f oral artesunate (4 mg/kg per day) and 
mefloquine (15 mg/kg on the second day of treatment followed by 10 mg/kg on the 
third day (Nosten et al., 1994b). In case of recrudescence (i.e. presence of asexual forms 
of P.falciparum on the blood film, with fever or not, within 63 days after the treatment), 
a further supervised seven day course o f oral artesunate was given to the patients. 
Children with severe malaria received different treatments according to their clinical 
features and the health structures in which they were admitted. Oral artesunate (7 days) 
combined with mefloquine was given if they presented with hyperparasitaemia but no 
signs of vital organ dysfunction (Luxemburger et al., 1995). Whenever they had any 
other signs of severe malaria (as defined previously), they received parenteral treatment: 
intramuscular injection of artemether in the SMRU hospitals or intravenous quinine 
when they were hospitalized in MSF structures. In both hospitals, ancillary treatments 
were similar: paracetamol as antipyretic, intrarectal diazepam for the treatment of 
convulsions, followed by phenobarbitone for the prevention o f further convulsions, 
intravenous glucose for hypoglycaemia, transfusion o f  whole blood when required. 
Other conditions than malaria, especially ARI and diarrhoea, were prescribed treatments 
in accordance with the MSF guidelines, using essential drugs (WHO lists).
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4.3.6. Laboratory procedures for malaria diagnosis:
Blood smears were stained with Giemsa and read by microscopic examination 
(objective X1000). The result was declared negative after examination of 200 fields. 
The parasite count for positive smears was expressed as the number o f parasites per 500 
white blood cells or per 1000 red blood cells in cases of high parasitaemia (>2% of 
parasitised red blood cells). A white blood cell count and HCT (QBC haematology 
Becton Dickinson) was performed on any positive case. When the smears were read in 
the MSF laboratory and could not be double-checked by the SMRU staff, parasite 
counts were classified using a semi-quantitative method (rare; + to ++++). Previous 
comparisons of the two methods have shown little correlation between this 
classification and parasite density. But parasite densities that were classified as (++++) 
using the semi-quantitative method were indeed hyperparasitaemia in a small 
comparative study. Forty smears classified as (++++) by the Karen MSF laboratory 
technicians were double-checked and counted. Median parasitaemia on these smears 
was 7.5% of infected red blood cells, with a lower limit o f 3.5% (Proux & 
Luxemburger; unpublished data). Thus in the study, parasite density was considered as 
missing when only MSF results were available, but (++++) results were classified as 
hyperparasitaemia (i.e. severe malaria cases).
4.4. Quality control
At random, physical measurements and examination (temperature, spleen 
palpation, weight) were performed on the same children by health workers and 
investigators and differences were discussed in order to underline the errors in the 
method (the most common being to weigh children with clothes in winter). Laboratory 
quality control was part of routine checking of SMRU study procedures. Sampled 
smears were double-checked and inter and intra-laboratory technician variations in 
reading HCT were evaluated.
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4.5 Ethical approval
The study was approved by the Ethical Committees o f the Karen Refugee 
Committee and Mahidol University, Thailand; and the London School of Hygiene and 
Tropical Medicine, London, UK.
4.6. Data entry
All forms were checked for missing values and coded prior computer-entry by 
trained data entry clerks using Dbase IV software. Database structures were created 
with internal checks for impossible values (e.g.: sex male = 1 or female = 2; the value 3 
cannot be entered). A print out of the database spreadsheets was then compared against 
paper notes by teams of home-visitors and the corrections were entered in the computer 
files. A third data check was performed by the main investigator. Outliers were detected 
and either corrected or considered as missing values (e.g. height at one visit much 
shorter than at the previous and further visits). Illogical entries were also corrected. 
Most in them were dates (e.g. December 94, followed by January 94 instead of 95).
4.7. Sample size
An initial sample size was calculated by using Epitable in Epi-Info software. For 
the detection o f a 50% difference (from 15 to 7.5%) in infant mortality in children bom 
to anaemic mothers when compared to those bom to non-anaemic mothers, with 5% of 
significance level and 80% of power, and assuming from previous studies that the 
prevalence of maternal anaemia at delivery would be 25% and the proportion lost to 
follow-up 20%, the recruitment o f 1018 children was necessary. After two years of 
study, 2 major components changed. The IMR was apparently decreasing over time and 
the estimated proportion of children lost to follow-up was likely to increase after the 
important population movements that happened in 1995. The sample was therefore re- 
estimated by using a reduction o f infant mortality from 12 to 6% and a drop out of 30%. 
The final sample size required was 1414 children.
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4.8. Analysis
Analysis was performed using SPSS software for basic statistics, logistic 
regression and survival analysis. Poisson regression was performed using STAT A 
software. The Z scores for growth analysis were calculated using the ANTHRO 
programme (WHO, 1990).
4.8.1. Morbidity during pregnancy and pregnancy outcomes
All variables on mother’s characteristics, mother’s morbidity and newbom’s 
weight and gestational age were summarized at birth (i.e. admission to the study). 
Mother’s characteristics and their morbidity during pregnancy were described in order 
to identify potential confounders for the two main exposures (i.e. malaria and anaemia 
during pregnancy) for further analysis in the study. Proportions were compared using 
the Chi-squared test and continuous variables were compared using /-tests and anova or 
Mann-Whitney U and Kruskal-Wallis tests, as appropriate. Risk factors for malaria 
during pregnancy (at any time; presence of one or more malaria episodes or no malaria 
episodes detected); for anaemia during pregnancy and/or at delivery; and the 
determinants of LBW or prematurity were identified in univariate analysis using 
methods for unmatched case-control studies. All factors associated with the outcome in 
univariate analysis (p<0.10) were included in a logistic regression model by forward 
step addition. Population attributable fractions (PAF) were calculated assuming that the 
exposure had a causal effect on the outcome. The formula was: PAF= pc (Adjusted 
OR-1)/Adjusted OR, where pc is the prevalence of the factor among the cases (Bruzzi el 
al., 1985; Rothman & Greenland, 1998).
4.8.2. Infant mortality
The main outcome of the study was the comparison of IMR in the presence or 
absence of the exposure factors, mainly maternal anaemia and malaria. Various 
classifications were used to describe anaemia during pregnancy (HCT<30%): anaemia 
at any time during the follow-up, the duration o f anaemia, development of severe
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anaemia (HCT<25%) at any time during pregnancy, persistence of moderate or severe 
anaemia at delivery. Similarly, some variables were created to describe malaria during 
pregnancy in order to include the available information on the infected species, on the 
number o f attacks and on the timing o f first exposure to a Plasmodium species during 
pregnancy. These variables were created for malaria of any species, and for falciparum 
and malaria species separately. A variable was created in order to summarize malaria 
history during pregnancy. There were four groups o f pregnant women: those who never 
had malaria during pregnancy, those who had only falciparum malaria, a third group 
with only vivax malaria and women who were infected at the same time or successively 
by the two species.
Apart from malaria and anaemia during pregnancy, the effects of other 
morbidity during pregnancy (ARI, UTI, hypertension, paresthesia) on infant mortality 
were analysed and potential confounders such as mother’s education, birth order and 
camp, were identified whenever possible. Unfortunately, information on smoking 
during pregnancy was missing. Smoking was identified as an important determinant o f 
LBW in another study (McGready et al., 1998), but this was unknown when the follow­
up of the cohort started.
There were numerous potential confounding factors and a hierarchy between 
them which made the issue of how to fit confounders more complex. Each level o f the 
hierarchy could affect those further down, either directly and/or indirectly through an 
intermediate and some of the potential confounders were secondary outcomes (infant 
morbidity and growth) (Fig. 4.1). Multivariate analysis was therefore performed by 
step, including at each level an intermediate explanatory variable. Using that method, 
the first step (i.e. model without intermediate explanatory variable) allowed to identify 
an effect that could have been underestimated if the intermediate explanatory variable 
was contained in the model. In the second step, that included the intermediate variable, 
the effect o f that intermediate variable was estimated, as well as the effect from the first 
exposure factors not mediated by the intermediate variable. Further steps were analysed 
when appropriate (Victora et al., 1997).
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Fig. 4.1: Exposure factors and counfounders in the analysis of infant mortality.
Analysis o f infant mortality was done using survival methods. Prior to use 
survival analysis, another method, Poisson regression showed that rate ratios varied 
with the infant age. Analysis of survival was therefore done for three different periods: 
neonatal (1-28 days), 1-3 months (29-92 days), 3-12 months (93-365 days). Kaplan- 
Meyer plots and log rank tests were performed for each potential factor that could 
influence infant mortality. A summary of the univariate analysis was done and Hazard 
Ratios (HR) were presented to see the direction o f  the effects. All factors identified by 
this method (p<0.10) were included in Cox regression as well as the determinants of 
LBW and/or prematurity. Nevertheless, variables that were not independent from each 
others were not included together in final models (e.g. presence or absence of 
falciparum malaria is contained in presence or absence of malaria from any species; 
when both were significant in univariate analysis, they were tested one after the other in 
multivariate analysis and only the best was retained).
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Anaemia and malaria during pregnancy could have a direct effect on infant 
deaths, but they were likely to act via low birthweight. Malaria could also act though 
anaemia at delivery. Three models were therefore fitted, the first without anaemia at 
delivery, nor LBW and prematurity. Anaemia at delivery was added in the second 
model, and LBW and prematurity in the third.
4.8.3. Infant morbidity
Poisson regression was used to identify risk factors for infant morbidity. The 
outcomes were morbidity from all causes, malaria, ARI and diarrhoeal episodes. 
Incidence Rates (IR) were calculated for each of these diseases and Incidence Rate 
Ratios (IRR) were compared in the presence or absence of each factor. Incidence Rates 
of each disease varied widely between camp and year, but the risk factors identified in 
Poisson regression were similar in models including camp and year or study and in 
models not including them. Although this is not shown in summarised results, site and 
year of study were always taken in account.
4.8.4. Anaemia and growth
Anaemia in infancy was not detected prospectively, but at the time o f each 
monthly visit. Anaemia could develop between 2 visits and remained undetected. It was 
therefore not possible to calculate the incidence rate of anaemia in infancy. Case-control 
study methods were used to identify the risk factors of infant anaemia at a given age (1 
month, 3 months, 6 months and 12 months). Similarly, impaired growth (stunted, 
underweight or wasted infants) was analysed at 6 and 12 months. Logistic regression 
and Odds Ratio (OR) were used for this part o f the analysis.
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CHAPTER 5
MOTHERS AND LIVE NEWBORN
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5.1. Registration and inclusion into the cohort
From June 1993 to August 1996, 1,624 live bom children were registered in the 
study. Eight per cent (129/1624) were excluded from the analysis. Fifty-seven were 
twins (the number is odd, because 1 twin was stillborn) and 72 singletons did not meet 
inclusion criteria. Twenty of them were bom to mothers not followed in ANC. The 
other 52 mothers were followed in ANC, but 45 were not residents of the camps and left 
after delivery, 4 ANC cards were lost, 2 mothers with psychiatric problems were unable 
to bring their children for follow-up, and 1 mother gave her baby to a foster mother not 
living in the camps.
Thus, 1,495 children bom to 1,448 mothers were included in the cohort. Forty- 
seven (3%) women delivered twice during the study time. Although the socio-economic 
environment o f  the siblings was similar, the exposure factors referring to morbid events 
during pregnancy was different for each child. Thus the unit of analysis was the 
pregnancy and not the woman. The second child o f these 47 mothers was therefore 
included into the cohort. Seven (0.5%) babies were adopted (5 within the first week, one 
at 2 and one at 3 months of age). For these children exposure factors were morbidity 
during pregnancy of their biological mother and socio-economic level o f their foster 
parents.
5.2. Description of mothers population
5.2.1. Demographic and obstetrical characteristics
Demographic and obstetrical characteristics differed greatly between camps 
(table 5.1). Differences in mothers mean age was partly due to the distribution of ethnic 
groups in the camps. Black Karen women, who are Muslims, tend to have their first 
child at a younger age than women from the other ethnic groups (Karen, Burmese, Pa- 
Oh, Mon), who are Buddhist or Christian. Means (SD) age at first pregnancy were 18.5 
(2.9) years for Black Karen and 20.1 (3.2) for the other ethnic groups (p<0.01). But the 
numbers of pregnancies were similar in all ethnic groups. Differences between camps
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remained after adjusting by ethnic groups. There were obviously various environmental 
and socio-economic factors influencing reproductive life o f  the women.
Women living in well-established camps (Shoklo, Bonoklo, Maesalit) attended 
ANC earlier in pregnancy than did women from Klaymuta and Maela where the 
programme was implemented recently, although this improved with time in the latter 
camp. In all camps, multigravidae came earlier to ANC than primigravidae: 15.6 (8.4) 
vs 17.8 (9.1) weeks of pregnancy (p<0.01). Overall nearly half of the women were 
registered during the first trimester of pregnancy and were seen regularly until delivery 
(at 91% of the planned visits. The expected number o f ANC attendance was defined as 
the number of weeks between registration to ANC and delivery).
5.2.2. History of refugee situation and SES
Questionnaires on background and current SES were applied to 81% 
(1210/1495) of the women. This proportion was lower in Maesalit and Klaymuta where 
many women moved before the interview. There was also a problem in reaching 
mothers whose children had died in early life because most of them left the camp 
immediately after the death in order to find work. Thus women whose child died within 
the first three months o f life were interviewed less often than those for whom the child 
survived: 48% (32/67) vs 83% (1178/1428); p<0.01. Overall, information on SES could 
be used in the analysis o f risk factors o f morbidity during pregnancy, and infant deaths 
from 3 to 12 months and infant morbidity. But the lack o f information on SES factors 
for half of early infant deaths, probably introduced a bias in the analysis of events at 
birth and in the first three months of life. Two models, with and without SES factors, 
were therefore applied for the analysis of determinants o f  LBW and that of risk factors 
for infant deaths in the first three months. The results of the questionnaires are 
summarized in table 5.2. The majority of the women (93%; 1121/1205) were living in 
the camps for more than 2 years and a quarter of them (26%; 308) arrived in Thailand 
during their childhood. Most of those who arrived only after 15 years old were farmers 
when living in Burma (82%; 689/842). Education of both parents was similar in the 
camps, but economic scores were different. There were various reasons for that. 
Bonoklo was a well-established camp with a good access to trade between the two
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countries. Klaymuta was located on Burma soil, thus the refugees had still access to 
their farms. On contrary, people from Maela, who were located there when the security 
situation worsened, could not go easily out of the camps and many had lost their garden 
and poultry while moving. Education and economic scores were similar between ethnic 
groups.
5.2.3. History of previous children
Multiparae (N=1066) had a mean (range) 3 (1-12) children bom before the index 
child. There were no difference between camps and ethnic groups. However, there were 
more deaths among the previous children bom to Karen than to Muslims women: mean 
(range) 0.8 (0-8) and 0.4 (0-3) respectively (p<0.01). Within ethnic groups, mean 
numbers of dead or live previous children were similar between camps. Among the last 
bom children for whom information was known, 14% (104/741) had died before one 
year o f age.
Interval between births was similar between camps and ethnic groups: median 
(range) 31 (9-151) months. Only 11% of the women (75/696) delivered within 18 
months after the last bom child, and 26% (181/696) within 2 years.
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Table 5.1: Demographic and obstetrical characteristics of the mothers in the five study sites.
Stndy site Sohklo Bonoklo Maesalit Klaymuta Maela All camps P
(n=523) (n=214) (n=101) (n=56) (n=601) (n=1495)
Ethnic group: n (%) Karen 462 (88) 176(82) 101 (100) 55 (98) 498(83) 1292(86)
Black Karen 50 (10) 32 (15) 0(0) 1(2) 92(15) 175(12)
Others 11(2) 6(3) 0(0) 0(0) 11(2) 28 (2) <0.01
Mean (SD) age in years: 24.9 (5.9) 25.3 (6.1) 27.0 (6.7) 27.5 (5.7) 25.4 (6.3) 25.4(6.1) <0.01
Age distribution : n (%): < 20 y 100(19) 42 (20) 12(12) 3(5) 118(20) 275 (18)
>20 y 423 (81) 172(80) 89(88) 53 (95) 483 (80) 1220 (82) 0.04
Mean (SD) No of gravida 3.2 (2.3) 3.5 (2.3) 4.2 (3.2) 4.1 (2.3) 3.5 (2.5) 3.5 (2.5) <0.01
Primigravidae: n (%) 146 (28) 49 (23) 24 (24) 5(9) 158 (26) 382 (26) 0.03
Mean (SD) gestational age in 
weeks on admission to ANC 14.6(8.2) 16.5 (8.6) 16.3 (9.2) 23.5 (8.1) 17.4(8.7) 16.4(8.7) <0.01
Trimester of pregnancy on 
admission to ANC: n(%): Is1 295 (56) 104(49) 51 (51) 7(13) 249 (42) 706 (47)
2nd 172 (33) 72(34) 33 (33) 27(48) 247(41) 551 (37)
3rd 56(11) 37(17) 17(17) 22 (39) 102(17) 234(16) <0.01
Attendance to ANC: no weeks seen 11,273/ 4,371/ 2,048/ 749/ 11,663/ 30,104/
at ANC /n of weeks between 
registration and delivery (%)
12,452 (91) 4,647 (94) 2,259(91) 844 (89) 12,755 (91) 32,957(91) <0.01
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Table 5.2: History of refugee situation and current SES of the parents
Study site Sohklo Bonoklo Maesalit Klaymuta Maela All camps P
(n=523) (n=214) (n=101) (n=56) (n=601) (n=1495)
No (Vo) women interviewed: 430(82) 150(70) 46(46) 29 (52) 555 (92) 1210(81) <0.01
Time in refugee camps: n (%)
<2 years 26(6) 4(3) 2(4) 7(4) 45(8) 84(7)
2-5 years 168 (39) 43 (29) 16 (35) 14(48) 190 (34) 431 (36)
6-10 years 162 (38) 37 (25) 15 (33) 6(21) 176 (32) 396 (33)
> 10 years 71 (17) 65 (43) 13 (28) 2(7) 143 (26) 294 (24) <0.01
No (%) arrived during childhood 95 (22) 52(35) 9(20) 2(7) 150 (27) 308 (26) <0.01
No (%) farmers in Burma 249/324(77) 76/96 (79) 31/32 (97) 20/24 (83) 313/366(86) 689/842 (82) <0.01
No (%) literate mothers 235 (55) 91 (61) 25(54) 12(41) 292 (53) 655 (54) 0.29
No (%) literate fathers 323 (75) 115(77) 30(65) 19(66) 408 (74) 895 (74) 0.43
Means (SD) score of family’s 
education 10.2 (4.6) 10.4(4.6) 9.6 (5.2) 8.8 (4.4) 9.7 (4.3) 10.0(4.5) 0.21
Means (SD) score of family’s 
income and quality of life 7.0 (2.4) 8.1 (3.3) 6.7 (2.2) 7.8 (3.1) 6.5 (2.1) 6.9 (2.4) <0.01
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5.3. Malaria during pregnancy
5.3.1. Timing of detection and symptoms
Thirty-seven per cent (555/1495) of the women developed malaria during 
pregnancy. In 128 women (23%), the first slide-confirmed malaria episode was 
diagnosed during the period between conception and first attendance to ANC (i.e. they 
were diagnosed and treated in another health structure). In the other 427 women (77%), 
malaria was detected during the follow-up period in ANC, either at the weekly visit 
(active detection) or in between two visits, if the women presented to the clinic with 
fever (passive detection). Overall, 31% (170) of the first detected malaria infection 
occurred during the first trimester, 40% (222) during the second and 29% (162) during 
the third part of pregnancy. This distribution was similar for both major plasmodium 
species P.falciparum and P.vivux. Five per cent (72) of the women had malaria during 
the week prior delivery (31 P.falciparum, 39 P.vivax and 2 mixed with P.falciparum 
and P.vivax).
There were 1,096 parasitacmic episodes [1-8 per woman] in the 555 malaria- 
infected women (491 P.falciparum; 570 P.vivax; 34 mixed infection with P.falciparum 
and P.vivax-, 1 malaria from unrecorded species). Thirty-eight per cent (210/555) of the 
women infected with malaria had only had falciparum malaria episodes [1-5 
parasitaemic episodes] during their whole pregnancy, 40% (225) only vivax infections 
[1-6] and 22% (120) had experienced malaria from each of the two species [1-8].
Symptoms were present in 59% (566/960) of the episodes for which this 
information was available (136 missing values: 12%). Nearly all malaria episodes 
detected prior to admission in ANC were symptomatic (96% ; 135/140) whereas only 
53% (431/820) of the episodes detected during ANC w ere associated with fever 
(p<0.001). Symptoms were more often present in falciparum than in vivax malaria 
episodes: 72% (309/433) vs 47% (233/498) (p<0.001). Primary episodes o f  falciparum 
malaria (i.c. first detected P.falciparum parasitacmia) were also more often associated 
with symptoms than subsequent episodes: 77% (210/274) vs 62% (99/159) (p=0.002), 
whereas the risk to develop symptoms did not change from one vivax episode to the 
next one (p-1.0).
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Out of 525 falciparum (or mixed) malaria episodes, 13 (2%) were severe. As 
only live births were admitted into the study, it is not surprising that none of the mothers 
died, but during the same period only 1 pregnant woman died with severe malaria.
Table 5.3 summarises the relationships between timing and type of detection in 
the first P.falciparum parasitaemic episodes diagnosed during pregnancy. The presence 
of symptoms and the co-existence with vivax malaria are also described. The proportion 
of episodes detected during the period o f ANC follow-up (as opposed to history recall) 
increased with the gestational age at first falciparum malaria (following the increasing 
chance to be registered in ANC). Similarly, the number of women who had suffered 
from vivax malaria earlier in pregnancy, and the proportion o f those who developed 
their first episode o f falciparum malaria as a mixed infection (P.falciparum and 
P. vivax), increased with the stage of pregnancy at which falciparum malaria was 
diagnosed. Nevertheless, the proportion of first falciparum malaria infections associated 
with symptoms and signs o f severity were the same throughout pregnancy. And overall, 
the proportion o f women who also had P. vivax malaria during pregnancy did not change 
with the stage at which falciparum malaria was first detected.
Table 5.3: Description o f detection, symptoms, and co-existence with P.vivax 
according to the stage of pregnancy at which first falciparum malaria episodes 
occurred.
Stage o f pregnancy
trimester
2nd trimester 3rd trimester P
No (%) detected during ANC 45/93 (48) 113/132(86) 98/105 (93) <0.001*
No (%) symptomatic 70/85 (82) 87/118(74) 71/92 (77) 0.35
No (%) severe 3/85 (4) 3/118 (3) 5/92 (5) 0.54
No (%) mixed infection 3/93 (3) 8/132 (6) 12/105(11) 0.01*
No (%) with P.vivax malaria 
detected earlier in pregnancy 6/93 (7) 16/132(12) 21/105 (20) 0.005*
No (%) with P.vivax at any time 
during pregnancy 36/93 (39) 52/132 (39) 32/105 (31) 0.31
*: %2 for trend.
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5.3.2. Risk factors for malaria during pregnancy
Twenty-two per cent (330/1495) of the women had at least one P.falcipurum 
malaria episode during pregnancy. Falciparum malaria occurred more often in 
primigravidae than in multigravidae: 28% (107/382) vs 20% (223/1113) (OR: 1.6; 
95%CI: 1.2-2.1) (fig 5.1). The infection was also more common in recent refugees (< 5 
years in the camps) than in those who were living in Thailand for more than 5 years: 
26% (133/515) and 18% (125/690) respectively (OR: 1.6;95%CI: 1.2-2.1). Malaria was 
less common when the education of the husband was high than when he had a low or 
average score: 18% (91/497) vs 24% (160/676) (OR: 0.7; 95%CI: 0.5-1.0; p=0.03). The 
proportion of women with P.falciparum (Pf) during pregnancy also varied from one 
camp to the other and was seasonal, but the general tendency was to  decrease over time 
(fig 5.2). In a multivariate analysis, only first gravida (Adjusted OR: 1.7; 95%CI: 1.3-
2.3) and low-average father education (Adjusted OR: 1.4; 95%C1: 1.1-1.9) remained 
independently associated with infection with falciparum malaria during pregnancy. 
These two risk factors were identified in the model that included cam p and year in order 
to take in account the differences in transmission level, and in the other model that did 
not adjust for these variables.
The proportion of women who suffered from P.vivax malaria during pregnancy 
was 23% (345/1495), with important variations from one camp to another and over time 
and season. Infection with vivax malaria increased in Shoklo and Macsalit, whereas it 
decreased slightly in the other camps (fig 5.3). Overall, the proportion o f women 
infected with P.vivax during pregnancy tended to become more important than that with 
P.falciparum (fig 5.4). The risk to have vivax malaria was similar in all gravidac (fig 
5.1). Past history o f slide-confirmed malaria (OR: 1.4; 95%CI: 1.1-1.8), Karen group 
(OR: 1.5; 95%CI: 1.0-2.3) and number of consultations in ANC (OR per unit o f 1 visit: 
1.02; 95%CI: 1.00-1.03) were associated with vivax malaria during pregnancy in 
univariate analysis. On the contrary the risk of having vivax infection decreased as the 
time spent in the camps increased (OR per unit of 1 year: 0.89; 95%CI: 0.87-0.93). In 
multivariate analysis, a past history of malaria (Adjusted OR: 1.5; 95%CI: 1.1-2.0), and 
the number of ANC consultations (Adjusted OR per unit of 1 visit: 1.02; 95%CI: 1.00-
1.04) remained independently associated with the risk of having vivax malaria during 
pregnancy, whereas the time spent in the camp (Adjusted OR per unit of 1 year: 0.90;
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95%CI: 0.87-0.93) protected against P.vivax (Pv) infection. The past history of malaria 
may reflect previous vivax infection and therefore a higher risk of relapses. It could also 
be related to behaviour. The association between the number of ANC consultations and 
P.vivax infection was not surprising. As infection with this species sometimes remains 
asymptomatic, it is likely that a higher number o f consultations, and therefore of active 
detection, increased the chance to diagnose it.
Fig 5.1: Proportion of malaria-infected pregnant women according to gravidity.
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flg 5.2: Falciparum malaria prevalence during pregnancy 
per site and year
S h o k lo  B onoklo M aesalit K iaym uta Macia
■  1993 Q 1994 0 1 9 9 5  IQ I996
fig 5.3: Vivax malaria prevalence during pregnancy 
per site and year
Shoklo Bonoklo M aeullt Kiaymuta M aela
■  1993 01994  D I995 0 1 9 9 6
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fig 5.4: Time-trend malaria prevalence rate 
during pregnancy
5.4. Anaemia during pregnancy
Unlike malaria that could be detected throughout pregnancy because reported 
history of malaria is reliable in this area, there was no way to know the hacmatological 
status of the women prior to their registration to ANC. Thus the data collected in this 
study focused on anaemia during the second and third trimester of pregnancy. The 
duration of anaemia was defined as the number of weeks between the first HCT level 
below 30% and the first HCT level that reached again 30% or more. In women who 
were anaemic on admission, the duration o f  anaemia was underestimated (from 
admission to the first HCT level above 30%, as the number of weeks with anaemia 
before the first ANC consultation could not be defined). During the follow-up period in 
ANC, anaemia (HCT < 30%) was extremely common. A quarter (25%; 373/1466) of 
women were anaemic on admission and 69% (759/1093) o f the women not anaemic 
when they registered for ANC developed anaemia later in pregnancy. Thus overall 77% 
(1 132/1466) o f  the women developed anaemia at some stage of pregnancy, for a mean
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(SD) duration of 7.7 (5.9) weeks. When a woman started haematinic treatment, it was 
given until delivery and thus the mean (SD) duration of iron and folic treatment was
11.2 (8.7) weeks. At delivery 24% (353/1444) of the women remained anaemic. Severe 
anaemia (HCT < 25%) developed in 17% (247/1445) of the pregnant women and 1% 
(21/1494) needed transfusion (haematocrit < 20% or clinical signs of severe anaemia).
Risk factors for anaemia during pregnancy are summarized in tables 5.4 and
5.5. Camp, year and number of ANC consultations were added as covariates in the final 
models of multivariate analysis. Falciparum malaria during pregnancy was the strongest 
risk factor for moderate and/or severe anaemia. A quarter (26%) of anaemic women had 
falciparum malaria. Thus the PAF of anaemia due to P.falciparum malaria was 18% 
(95%CI: 13-21). Ethnic group and education were also independently associated with 
anaemia during pregnancy. Multigravidae were more often anaemic than primigravidae, 
but the risk to develop severe anaemia was not associated with gravidity. In the model 
without “camp” and “year”, vivax malaria during pregnancy was associated with 
anaemia (Adjusted OR: 1.58; 95%CI: 1.05-2.36), but not with severe anaemia.
Table 5.4: Risk factors for anaemia (HCT< 30%) during pregnancy.
Risk factors Prevalence
N (%)
Univariate 
analysis 
OR (95%CI)
Multivariate 
analysis 
OR (95%CI)
Mother’s age: < 20 years 
2: 20 years
185/268 (69) 
949/1200(79)
1.00
1.70(1.25-2.30) NS
Gravidity: Multigravidae 
Primigravidae
883/1093 (81) 
251/375 (67)
2.08(1.58-2.72)
1.00
1.76(1.24-2.50)
Ethnic group: Karen
Black Karen
1018/1296(79) 
116/172 (67)
1.77(1.23-2.53)
1.00
1.65(1.07-2.53)
Woman’s education: Low
Average-high
438/534 (82) 
498/656 (76)
1.45(1.08-1.94)
1.00
NS
Husband’s education: Low-average 
High
543/668(81) 
365/487 (75)
1.45(1.08-1.95)
1.00
1.64(1.20-2.56)
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Family’s economic level: Low
Average
High
273/333 (82) 
519/663 (78) 
54/83 (65)
2.19(1.22-3.91)
1.94(1.15-3.24)
1.00
NS
P.falciparum malaria during 
pregnancy: Yes 
No
296/329 (90) 
838/1139 (74)
3.22 (2.20-4.73) 
1.00
3.10(1.93-5.00)
P.vivax malaria during pregnancy: 
Yes 
No
292/341 (86) 
842/1127 (75)
2.02(1.45-2.81)
1.00
NS
ARI during pregnancy: Yes 
No
335/410(82) 
799/1058 (76)
1.45 (1.09-1.93) 
1.00
NS
Table 5.5: Risk factors for severe anaemia (HCT< 25%) during pregnancy.
Risk factors Prevalence
N (% )
Univariate 
analysis 
OR (95%CI)
Multivariate 
analysis 
OR (95%CI)
Ethnic group: Karen
Black Karen
230/1277(18)
17/168(10)
1.95(1.13-3.41)
1.00
1.82(1.01-3.29)
Woman’s education: Low
Average-High
109/528 (21) 
91/646(14)
1.59(1.17-2.15)
1.00
1.54(1.11-2.14)
Husband’s education: Low
Aver.-High
69/317(22)
124/822(15)
1.57(1.13-2.17)
1.00
1.44(1.02-2.04)
P.falciparum malaria during 
pregnancy: Yes 
No
113/322 (35) 
134/1123(12)
3.99 (2.98-5.34) 
1.00
3.63 (2.60-5.08)
P.vivax during pregnancy: Yes 
No
69/333 (21) 
178/1112(16)
1.37(1.01-1.87)
1.00
NS
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At the time of delivery, falciparum malaria during pregnancy and low education 
remained risk factors for moderate and/or severe anaemia. As the prevalence of 
falciparum malaria was 26% in women anaemic at delivery, the PAF of anaemia due to 
P.falciparum malaria was 12% (95%CI: 5-17). Multigravidae were more often anaemic 
at delivery but not severely (Table 5.6). UTI during pregnancy was associated with 
severe anaemia at delivery (Table 5.7)
Table 5.6: Risk factors for anaemia (HCT< 30%) at delivery.
Risk factors Prevalence
N (%)
Univariate 
analysis 
OR (95%CI)
Multivariate 
analysis 
OR (95%CI)
Gravidity: Multigravidae 
Primigravidae
289/1078 (27) 
64/366(18)
1.73(1.27-2.36)
1.00
1.75 (1.21-2.52)
Ethnic group: Karen
Black Karen
321/1274 (25) 
32/170(19)
1.45 (0.95-2.22) 
1.00
NS
Woman’s education: Low
Average-High
152/526 (29) 
130/646 (20)
1.61 (1.22-2.13) 
1.00
1.59(1.19-2.12)
Husband’s education: Low
Aver.-High
94/317(30) 
185/821 (23)
1.45(1.07-1.96)
1.00
NS
Family’s economic level: 
Low
Average-High
94/330 (29) 
167/732 (23)
1.35(0.99-1.83)
1.00
NS
P.falciparum malaria during 
pregnancy: Yes 
No
105/319(33) 
248/1125 (22)
1.74(1.32-2.28)
1.00
1.67(1.19-2.34)
ARI during pregnancy: Yes 
No
114/405 (28) 
239/1039 (23)
1.31 (1.01-1.70) 
1.00
NS
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Table 5.7: Risk factors for severe anaemia (HCT< 25%) at delivery.
Risk factors Prevalence
N (% )
Univariate 
analysis 
OR (95%CI)
Multivariate 
analysis 
OR (95%CI)
Woman’s education: Low
Average-High
22/526 (4) 
12/645 (2)
2.30(1.13-4.70)
1.00
NS
Husband’s education: Low
Aver.-High
16/317(5) 
18/820 (2)
2.37(1.19-4.71)
1.00
2.37(1.17-4.80)
P. falciparum malaria during 
pregnancy: Yes 
No
19/319(6) 
24/1123 (2)
2.90(1.57-5.37)
1.00
2.55 (1.25-5.22)
UTI during pregnancy: Yes 
No
7/103 (7) 
36/1339(3)
2.64(1.14-6.09)
1.00
4.12(1.58-10.79)
5.5. Other morbidity during pregnancy
Non-malarious morbid events were recorded only during the ANC period and 
there were no means to detect episodes that could have occurred before mother’s 
follow-up.
5.5.1. Febrile episodes with negative malaria smear
Nearly ha lf (42%; 620/1495) of the women had at least one febrile episode with 
a negative malaria smear during ANC. Prevalence rates of ARI and UTI, the two most 
common diseases, were 28% (414) and 7% (104) respectively. Fifty-two women (3.5%) 
presented with a febrile non-malaria infection within the week preceding delivery (37 
ARI; 5 urinary tract infections UTI; 5 diarrhoea! diseases; 2 self-limited fever; 1 otitis).
Overall, there were 1,037 morbid events in 620 women: 651 ARI; 126 UTI; 115 
self-limited undiagnosed fever; 85 diarrhoeal episodes; 28 infected skin diseases or
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abscesses; 16 upper respiratory tract infection and 14 other infections. One woman was 
diagnosed with tuberculosis and one with paragonimus.
5.5.2. Hypertension
Three per cent (38/1495) of the women were treated for hypertension. Three 
women remained with hypertension during the post-partum period.
5.5.3. Thiamin deficiency
Half of the mothers (54%; 804/1495) had paresthesia and were treated with 
vitamin B1 for a mean (SD) duration of 11.2 (8.7) weeks. Two women presented with 
severe dry Beri-Beri and one developed cardiac failure.
5.6. Live newborn
5.6.1. Description
Half (51%; 761/1495) of the babies were bom in hospital, including 690 in 
SMRU’s obstetrical department and 71 in Thai hospitals. But most (91%; 1355) were 
seen within the first 3 days of life; 90% (1346) were weighed and Dubowitz score was 
performed in 84% (1263). Mean (SD) birthweight was 2872 (490) g; mean (SD) height 
48 (3) cm; mean (SD) head circumference 33 (2) cm; and mean (SD) gestational age
38.5 (1.6) weeks.
Eighty per cent (1201) of the newborn were weighed and tested by using 
Dubowitz score within the first three days of life. Sixteen per cent (190) of them were 
LBW and 11% (135) were premature. Distribution of birthweight and gestational age is 
given in table 5.8. Nearly all (94%; 43/46) the children weighing less than 2000 g were 
premature. On contrary, among the infants weighing between 2000 and 2499 g, the 
majority (68%; 98/144) were bom at term and 32% (46/144) were premature. Five per
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cent (47/1011) o f children with a birthweight of 2500g or more were reported as 
premature, but all were bom after 34 weeks of gestation.
Partial information was also available for another 229 children. Either they had 
birthweight or Dubowitz score alone, or they had been weighed within the first week of 
life and a reliable mother’s history of last menstruation had been collected together with 
fundal height at previous ANC consultations. Overall 1430 (96%) were could be 
categorised. Nine per cent (125) were pre-term LBW (<2500g and <37weeks); 8% 
(121) were full-term LBW (<2500g and >37weeks) and 83% (1184) were regarded as 
“normal” or appropriate birthweight (NBW) (2: 2500 g, regardless of gestational age).
Table 5.8: Distribution of birthweight and gestational age in 1201 children seen at 
birth; n (%).
Gestational age
Birthweight <34w 34-36.9w >=37w Total
<2000g 17(37) 26 (57) 3(6) 46(100)
(74) (23) (3 ) (4)
2000-2499g 6(4) 40 (28) 98 (68) 144(100)
(26) (35) (9) (12)
2500-2999g 0 37 (8) 433(92) 470(100)
(33) (41) (39)
3000-3499g 0 10(2) 408 (98) 418(100)
(9) (38) (35)
>=3500g 0 0 123(100) 123 (100)
(12) (10)
Total 23 (2) 113(9) 1065 (89) 1201 (100)
(100) (100) (100) (100)
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5.6.2. Determinants of LBW
Several factors were associated with LBW in univariate analysis (table 5.8). 
Malaria during pregnancy was associated with LBW, but also with anaemia at delivery. 
Thus anaemia at delivery could be on the pathway of the association between malaria 
(especially falciparum malaria) and LBW. Similarly, recent arrival and education were 
previously shown to be associated with falciparum malaria and anaemia during 
pregnancy. But, as seen previously, this information was biased toward children who 
survived the first three months of life, and should be used with caution. Multivariate 
analysis was therefore performed in three steps. A first model was applied, without 
“anaemia” and “SES factors”. A second model contained “maternal anaemia” (as 
anaemia at delivery or severe anaemia during pregnancy or severe anaemia at delivery) 
and the third model included SES factors (recent arrival, camp, husband’s education). 
Results were identical in the three models. First gravida, premature birth and malaria 
during pregnancy were risk factors for LBW (Table 5.10). Half (49%) o f the women 
who delivered a LBW infant had falciparum malaria during pregnancy, giving an 
estimated PAF of LBW due to malaria: 23% (95%CI: 14-30).When the analysis was 
repeated using “falciparum malaria” and “vivax malaria” separately rather than 
“malaria”, each species were associated with LBW.
Table 5.9. Factors associated with LBW in univariate analysis
Prevalence 
LBW N (%)
OR (95%CI)
Camp: Shoklo 88/445 (20) 1.34 (0.95-1.88)
Bonoklo 22/203 (11) 0.66 (0.39-1.11)
Maesalit 9/90(10) 0.60 (0.27-1.30)
Klaymuta 19/55 (35) 2.87 (1.50-5.43)
Maela 86/553(16) 1.00
Year of birth: 1993 20/98 (20) 1.35 (0.75-2.44)
1994 68/427 (16) 0.91 (0.63-1.32)
1995 77/447(17) 1.11 (0.75-1.64)
1996 59/374(16) 1.00
Gravidity: Primigravidae 90/346 (26) 2.27 (1.66-3.10)
Multigravidae 134/1000(13) 1.00
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Ethnic group: Karen
Black Karen
34/169 (20) 
190/1177(16)
1.31 (0.87-1.97) 
1.00
Age: < 20 years 
> 20 years
61/250 (24) 
163/1096(15)
1.85 (1.31-2.61) 
1.00
Trimester o f  pregnancy at registration to ANC: 
1 “  trimester 
2 nd 
3 rd
81/641 (14) 
98/493 (20) 
34/210(16)
1.00
1.50(1.08-2.08)
1.18(0.75-1.85)
Infant sex: Male 
Female
106/685 (16) 
118/661(18)
0.84 (0.63-1.12) 
1.00
Premature infant: Yes 
No
88/135(65)
102/1066(10)
17.70(11.53-27.21)
1.00
Malaria during pregnancy: Yes 
No
109/496 (22) 
115/850(14)
1.80(1.35-2.41)
1.00
P.falciparum malaria during pregnancy: Yes
No
68/293 (23) 
156/1053 (15)
1.74(1.25-2.42)
1.00
P.vivax malaria during pregnancy: Yes
No
65/310(21)
159/1036(15)
1.46(1.05-2.04)
1.00
Anaemia (HCT<30%) during pregnancy: Yes
No
176/1021 (17) 
45/304(15)
1.20 (0.84-1.71) 
1.00
Severe a r  aemia (HCT<25%) during 
pregnancy: Yes 
No
47/221 (21) 
171/1086(16)
1.45(1.01-2.07)
1.00
Anaemia (HCT<30%) at delivery: Yes
No
67/319(21)
151/990(15)
1.48(1.06-2.06)
1.00
Severe anaemia (HCT<25%) at delivery: Yes
No
14/39 (36) 
204/1268(16)
2.92(1.49-5.72)
1.00
Hypertension during pregnancy: Yes
No
10/33 (30) 
214/1313(16)
2.23 (0.98-5.00) 
1.00
ARI during pregnancy: Yes 
No
65/378(17)
159/968(16)
1.06(0.77-1.45)
1.00
UTI during pregnancy: Yes 
No
21/93 (23) 
203/1253(16)
1.51 (0.91-2.51) 
1.00
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Time spent in the camp: < 5 years 94/473 (20) 1.82(1.29-2.57)
S 5 years 74/617(12) 1.00
Woman’s education: Low 86/497 (17) 1.47 (0.96-2.27)
Average 44/291 (15) 1.25 (0.76-2.05)
High 38/305 (13) 1.00
Husband’s education: Low 56/295 (19) 1.67(1.09-2.56)
Average 53/318(17) 1.43 (0.93-2.19)
High 55/448 (12) 1.00
Family’s economic level: Low 58/305 (19) 2.05 (0.89-4.90)
Average 82/606(14) 1.37 (0.61-3.20)
High 8/78(10) 1.00
Table 5.10. Factors associated with LBW in multivariate analysis
Models Adjusted OR (95%CI)
First sten: without “maternal anaemia” and “SES factors”
2.27(1.53-3.37) 
0.36 (0.31-0.42) 
1.97(1.34-2.90)
Primigravidae
Gestational age (continuous variable) 
Malaria during pregnancy
Second sten: with “maternal anaemia” but no “SES factors”
2.29(1.53-3.41) 
0.36 (0.31-0.43) 
1.94(1.31-2.87)
Primigravidae
Gestational age (continuous variable) 
Malaria during pregnancy
Third step: with “maternal anaemia” and “SES factors”
2.37(1.52-3.70) 
0.38 (0.32-0.45) 
1.67(1.08-2.58)
Primigravidae
Gestational age (continuous variable) 
Malaria during pregnancy
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5.6.3. Determinants of prematurity
Malaria from P.falciparum or P.vivax and anaemia during pregnancy did not 
reduce the duration of gestation. The mean (SD) number o f weeks of gestation was 38.5 
(1.7) in malaria-infected women and 38.5 (1.4) in women without malaria during 
pregnancy (p=0.33). The duration of gestation were also similar in anaemic and non- 
anaemic women: 38.5 (1.6) and 38.5 (1.6) weeks respectively (p=0.40).
Premature labour was more common in primi- (17%; 57/335) and secondi- 
(13%; 32/238) than in third or higher gravidae (8%; 57/690) [OR (95%CI) primi- vs 
gravidae 3+: 2.28 (1.51-3.44); OR (95%CI) secondi- vs gravidae 3+: 1.73 (1.06-2.80)]. 
The risk o f  delivering prematurely was higher in young mothers (<20 years) than in 
older ones: 20% (47/236) vs 10% (99/1027) (OR: 2.33; 95%CI: 1.56-3.47), and varies 
between camp and year. In univariate analysis, P.falciparum malaria during pregnancy 
was associated with a risk of delivering prematurely: 15% (41/267) vs 11% (105/996) in 
women without falciparum malaria during pregnancy (OR: 1.54; 95%CI: 1.02-2.31). 
Premature birth was also associated with febrile disease within the week preceding 
delivery: 28% (22/78) vs 10% (123/1183) in non-febrile women (OR: 3.39; 95%CI: 
1.93-5.90). Diagnosis o f the 78 febrile diseases in the week preceding delivery were: 
symptomatic falciparum (23), vivax (17) and mixed (1) malaria, ARI (33) and UTI (4). 
The risk o f  premature delivery was present for each condition, probably reflecting an 
effect o f  fever. Asymptomatic malaria infection was not associated with premature 
delivery. A multivariate analysis was done that included the factors identified in 
univariate analysis and adjusted for the number of ANC consultations. Only febrile 
episodes preceding delivery (Adjusted OR: 3.00; 95%CI: 1.72-5.25) and mothers under 
20 years old (Adjusted OR: 2.19; 95%CI: 1.48-3.26) remained independently associated 
with the risk of delivering prematurely. Fifteen percent o f the women who delivered 
prematurely had an infection within the previous week. The PAF of premature birth due 
to infection close to term was: 10% (95%CI: 6-12).
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5.6.4. Effects of malaria during pregnancy on anthropometric markers of the 
newborn.
All anthropometric markers were affected in children bom to mothers with 
malaria, indicating a chronic symetric growth retardation, (table 5.11).
Table 5.11: Anthropometric markers of the newborn according to maternal 
malaria during pregnancy.
Malaria during 
pregnancy
Mean (SD) 
height in cm
P Mean (SD) 
head
circumference 
in cm
P Mean (SD) 
birthweight 
in g
P
No malaria 
Falciparum malaria 
Vivax malaria
48.4 (2.8)
47.7 (2.3)
47.7 (3.3)
0.01
<0.01
33.0(1.6) 
32.6 (2.0) 
32.5(1.9)
0.02
<0.01
2940 (455) 
2755 (502) 
2813 (515)
<0.01
<0.01
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5.7. Summary o f  the results contained in this chapter
Figure 5.5 summarises the results contained in this chapter. Both vivax and 
falciparum malaria during pregnancy reduced birthweight, and the effect was 
independent of socio-economic factors. Twenty-three per cent of LBW were attributable 
to malaria during pregnancy. Malaria did not affect the duration of gestation and the 
reduction of all anthropometric markers was compatible with a prolonged foetal growth 
retardation. Nevertheless, symptomatic malaria episodes that occurred close to term 
were risk factors for premature birth, as well as ARI and UTI during that period. 
Infections close to term were responsible for 10% o f premature deliveries. Maternal 
anaemia did not have an independent effect on birthweight.
Fig 5.5: Effects of malaria and anaemia during pregnancy on live newborn
Pregnancy Delivery Live newborn
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6.1. Follow-up of the infants
Eighteen months after the beginning of the study, the situation in the Karen 
Refugee camps gradually deteriorated. During the 1995 dry season, dissident Karen 
groups supported by the Burmese army attacked the camps in order to destabilize the 
situation and to pressure the refugees to go back to Burma. Bonoklo was burnt (April 
1995) and insecurity increased in Maesalit and Klaymuta. The inhabitants of these 3 
camps were relocated to Maela in May and July 1995. Some refugees from Shoklo 
camp arrived in Maela in January 1996 after an attack, but Shoklo camp was not burnt 
and most people stayed in the site. Another attack occurred in Maela at the end of 
January 1997 and the camp was evacuated for one week. As a result, there were 
important population movements. Overall, 24% (366/1495) of the infants in the cohort 
were affected by these migrations. Some of them (212; 14%) went back to Burma or 
were lost during the crisis periods (152 between January and April 1995; 34 in July 
1995; 16 in January 1996 and 10 in February 1997). Another 10% (154) of children 
moved from their birth place to Maela during infancy, but were still followed in the 
study.
Overall 368 (25%) of the infants were lost to follow-up. More than half of them 
(58%; 212/368) left during periods o f insecurity, the others moved, or followed their 
mothers working outside the camps; only 1 mother refused to pursue the follow-up after 
the older brother o f the index child died in the Research Unit's hospital. Children were 
lost regularly over infancy (fig 6.1). Table 6.1 summarises the study compliance in each 
camp.
Table 6.1: Admission, movements and lost to follow-up in the 5 camps: n (%)
period o f  registration No admitted No moved 
to another camp
No lost to 
follow-up
Shoklo June 93-December 95 523 31(6) 118(23)
Bonoklo January 94- April 95 214 79 (37) 92 (43)
Maesalit January 94- July 95 101 13(13) 47 (47)
Klaymuta September 94-July 95 56 30(54) 25 (45)
Maela May 95-August 96 601 3 (0.5) 86(14)
Total June 93-August 96 1495 154(10) 368 (25)
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Fig 6.1: Proportion of children remaining in the study per age
0- 1- I -  3- 4- 5- 6- 7- 8- 9- 10- 11-
months
Malaria during pregnancy was similar in mothers whose children were lost 
and in those who completed follow-up. But pregnant women whose children were lost 
during follow-up were less likely to be anaemic during pregnancy (73%; 262/360) than 
those whose children were followed (79%; 872/1108) (p=0.02). Similarly mothers o f 
lost children had less ARI during pregnancy (22%; 82/368) than mothers of children 
who were followed (30%; 333/1127) (p<0.01). But the former were seen later in 
pregnancy: 22% (82/368) registered to ANC during the third trimester of pregnancy 
whereas only 14% (152/1123) did so in the group of successively followed children 
(p<0.001). Recent refugees (<2 years) were also more often lost than those who were 
living in Thailand for a longer time: 12% (21/183) vs 6% (63/1022) (p=0.02). In a 
logistic regression in which all these factors were included, as well as camp and year o f 
study, the only risks to be lost during follow-up were a history o f recent arrival to 
Thailand (Adjusted OR: 2.43; 95%CI: 1.36-4.33) and attendance to ANC late in 
pregnancy (Adjusted OR: 1.92; 95%CI: 1.14-3.22).
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6.2. Crude Infant Mortality
Out of 1,127 children who completed the follow-up, 88 died before 1 year of 
age, giving a crude infant mortality rate o f 78.1 per 1,000 live births. Forty-nine (56%) 
died during the neonatal period and 39 (44%) during the post-neonatal period. Seventy- 
six per cent (67) o f  deaths occurred during the first 3 months of life. Fig 6.2, represents 
the age distribution at the time of death.
fig 6.2. Age distribution of infant deaths
months
6.3. Causes of infant deaths
Fifty-nine per cent (58/88) of the infants who died were hospitalised or seen at 
the dispensaries during their final illness. Among children who died at home, 21 
mothers reported a history that permitted a classification of the cause of deaths. Thus 
overall, 90% (79/88) of the deaths could enter in a broad classification. The causes of 
deaths are listed in table 6.2. Among infectious diseases, ARI was the leading cause of 
deaths (12), followed by diarrhoea (7) and sepsis (7), malaria (2), neonatal tetanus (1) 
and congenital herpes (1).
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Table 6.2: main causes of infant deaths
Causes n (%)
Infectious diseases 32 (36.4)
Premature 23 (26.1)
Impaired growth 7 (8.0)
Abnormalities 6 (6.8)
Infantile Beri-Beri 6 (6.8)
Complication o f difficult labour 3 (3.4)
Others 2 (2.3)
Unknown 9(10.2)
6.3.1. Neonatal deaths
The majority (63%; 31/49) of the children who died in the neonatal period did 
not survive the first week of life. The leading cause o f death in the neonatal period was 
“prematurity” (23), but a quarter (12) o f the children died from infectious diseases (6 
sepsis, 2 diarrhoeal diseases, 1 congenital herpes, 1 tetanus, 1 congenital malaria and 1 
ARI). Six infants were grossly abnormal, 3 died from consequences of complicated 
labour, 1 child presented with severe hemolytic disease, 1 whose mother suffered from 
hypertensive disease prior to the pregnancy was grossly growth-retarded and died 
within 24 hours. Causes o f deaths were unknown for 3 other children (fig 6.3).
6.3.2. Post-neonatal deaths
In the post-neonatal period, half of the children (52%; 20/39) died from 
infectious diseases. Among them, 11 infants died from ARI, 5 from diarrhoea, 2 from 
meningitis, 1 from sepsis and 1 from malaria. Six infants died from suspected thiamin 
deficiency. Five presented with impaired growth from birth and eventually died from 
undefined cause. One adopted child suffered from lactose intolerance and could not be 
breast-fed by a wet mother. Another one fell down a well. The causes of death were 
unknown for the 6 remaining infants (fig 6.4).
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Fig 6.3; Causes of neonatal deaths
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Fig 6.4: Causes of post-neonatal deaths
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6.4. Risk factors for infant deaths
6.4.1. Birthweight and gestational age
Analysis was restricted to the 1201 newborn with known birthweight and 
gestational age, and for each period, to the children who completed follow-up. In the 
first 3 months of life, premature infants were more likely to die than full-term infants. 
Out of 1179 babies for whom survival at 1 month of age was known 31 had died (26 per 
1,000). The risk o f neonatal deaths was 19.1 (95%CI: 9.0-40.5) times higher in 
premature (164 per 1,000%; 22/134) than in infants bom at term (9 per 1,000; 9/1045). 
Among children who had survived the neonatal period, those premature remained at 
higher risk of deaths from 1 to 3 months of age (37 per 1,000; 4/107) than term infants 
(11 per 1,000; 11/979): Relative Risk (RR): 3.3 (95%CI: 1.1-10.3). In the period from 3 
to 12 months of age, mortality rates were similar in premature infants who had survived 
the first 3 months (12 per 1,000; 1/83) and in term children (20 per 1,000; 15/785), but 
numbers were small (RR=0.6; 95%CI: 0.1-4.7).
Similarly LBW infants were at higher risk to die in the neonatal period (112 per
I, 000; 21/187) than children weighing more than 2500g (10 per 1,000; 10/992) (RR=
I I .  1; 95%CI: 5.3-23.3). The risk remained at 3.0 (1.0-8.6) from 1 to 3 months of age: 
mortality 32 (5/156) and 11 (10/930) per 1,000 respectively. From 3 to 12 months of 
age, mortality was 24 per 1,000 (3/126) in LBW infants and 18 per 1,000 (13/742) in 
children weighing more than 2500g at birth (RR=1.4; 95%CI: 0.4-4.7).
When looking at both factors, weight in itself seemed a less important risk factor 
for deaths in infancy than did prematurity. Fig 6.5 shows neonatal mortality rates in 
different groups of children classified by their birthweight and gestational age. Within 
each class of gestational age, mortality rates were similar in children weighing less than 
2000g and those weighing 2000 to 2499g. Thus the 2 groups were combined. Similarly, 
all children weighing more than 2500g within a gestational age class were combined. 
Children moderately premature (34-36.9 weeks) were more likely to die than full term 
infants within the same weight group. Among LBW children, mortality rates were 123 
per 1000 (8/65) in moderately premature and 10 per 1000 (1/100) in full-term infants: 
RR=12.3 (95%CI: 1.6-96.1). When newborn were considered to be bom with a
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“normal” birthweight (i.e £ 2500g), those premature remained more likely to die during 
the neonatal period than did full-term infants: 43 (2/47) vs 8 per 1,000 (8/945) (RR=5.1; 
95%CI: 1.1-23.2). On the contrary, within children bom between 34 and 36.9 weeks, 
LBW infants had a higher (but not significantly so) neonatal mortality than NBW 
newborn: 123 (8/65) and 43 (2/47) per 1,000 respectively (RR=2.9; 95%CI: 0.6-13.0). 
Among children bom at term, mortality rates were similar in LBW and NBW infants: 
10 (1/100) and 8 (8/945) per 1,000 (RR=1.2; 95%CI: 0.2-9.4). In the post-neonatal 
period, all infants bom at term had the same chance o f  survival, irrespective of their 
birthweight.
Overall, infant mortality rate was 362 per 1,000 (25/69) in premature LBW 
infants, 50 per 1,000 (2/40) in premature NBW infants, 48/1000 (4/83) in LBW infants 
bom at term, and 43 per 1,000 (31/722) in NBW infants bom at term.
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6.4.2. Study site and period
Infant mortality differed from 1 camp to the other and over time (fig 6.6). These 
differences occurred mainly in the post-neonatal period. Neonatal mortality rates did not 
differ between camps and did not change over time. There were no deaths in Maesalit, 
or among the children bom in Klaymuta in 1995. In Shoklo, the reduction in infant 
mortality was due to a marked decrease in post-neonatal deaths. From 1993 to 1995, 
neonatal mortality rates remained stable (36 to 33 per 1,000) whereas post-neonatal 
deaths decreased from 84 to 23 per 1,000. On the contrary, in Maela, the apparent 
increase in infant mortality was due to a higher, but not significant, neonatal mortality 
rate (15 to 48 per 1,000). Post-neonatal mortality rate was stable (23 and 28 per 1,000) 
in this camp.
fig 6.6: Infant mortality rates per camp and year
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6.4.3. Risk factors for neonatal deaths.
Potential risk factors for neonatal deaths are listed in Table 6.3 in which HR are 
indicated in order to indicate the direction and the magnitude of the effect. P. falciparum 
malaria during pregnancy was associated with neonatal death, but the number of 
episodes or the gestational age at first detection o f P.falciparum did not influence 
neonatal infant survival. When symptomatic falciparum malaria occurred close to term, 
the risk o f neonatal death was important, but children whose mothers were infected 
earlier in pregnancy or remained asymptomatic were not more likely to die than those 
bom to non-infected mothers. Similarly vivax malaria was associated with increased 
risk o f neonatal death if it occurred within the week of delivery and was associated with 
symptoms. The risk o f neonatal death was also higher in children whose mothers 
presented with non-malarious infection within the week prior delivery than in babies 
bom to non-infected mothers. Maternal anaemia at delivery and complicated labour 
were also identified as potential risk factors of neonatal death in univariate analysis. 
Confounding factors were mother’s age, gravidity, number of ANC consultations and 
birth in winter. There were no SES factors associated with neonatal deaths, but only 24 
(49%) of the mothers those newborn died in the neonatal period, were interviewed.
Table 6.3. Potential risk factors for neonatal deaths; univariate analysis.
Hazard Ratio (95%CI)
P.falciparum malaria during pregnancy: Yes
No
2.07(1.16-3.70)
1.00
P.falciparum malaria during pregnancy:
- yes, including 1 symptomatic episode during the week 
prior delivery
- at least 1 episode, but not within 1 week prior delivery
- no
6.39 (2.25-18.10)
1.74 (0.92-3.27) 
1.00
Number o f P.falciparum episodes during pregnancy:1 1.14(0.85-1.53)
Gestational age at first P.falciparum malaria during pregnancy: 
- 1" trimester 
-2 nd 
-3 rd
1.00
1.43 (0.43-4.76) 
1.34 (0.38-4.75)
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P.vivax malaria during pregnancy: Yes
No
1.21 (0.64-2.29) 
1.00
P.vivax malaria during pregnancy:
- yes, including 1 episode during the week prior delivery
- at least 1 episode, but not within 1 week prior delivery
- no
6.88 (2.45-19.32)
0.90(0.43-1.87)
1.00
Number of P.vivax episodes during pregnancy 1.26 (1.01-1.56)
Gestational age at first P.vivax malaria during pregnancy:
- 1st trimester
2nd
- 3 rd
1.00
0.65 (0.16-2.60) 
0.87 (0.23-3.25)
Non-malarious infection (ARI or UTI) within 1 week prior 
delivery: Yes
No
3.00 (0.93-9.73)*
1.00
Infection (malaria or ARI or UTI) within 1 week prior delivery:
Yes
No
5.30 (2.71-10.38)
1.00
Infection within 1 week prior delivery:
- Falciparum malaria (or mixed)
- Vivax malaria
- ARI or UTI
2.09 (0.47-9.36) 
3.01 (0.67-13.44) 
1.00
Maternal anaemia during pregnancy: Yes
No
1.18(0.33-4.18)
1.00
Severe maternal anaemia during pregnancy: Yes
No
0.75 (0.17-3.31) 
1.00
Maternal anaemia at delivery: Yes
No
1.81 (1.01-3.24)
1.00
Severe maternal anaemia at delivery: Yes
No
2.33 (0.31-17.72) 
1.00
Duration of anaemia during pregnancy: none
< 6 weeks 
^  6 weeks
1.00
0.78 (0.35-1.74) 
1.28 (0.63-2.60)
ARI during pregnancy (except last week): Yes
No
1.50 (0.83-2.71) 
1.00
Hypertension during pregnancy: Yes
No
0.80 (0.11-5.79) 
1.00
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Complicated delivery: Yes 2.63 (1.34-5.14)
No 1.00
Mother’s age: < 20 years 2.19(1.21-3.99)
£ 20 years 1.00
Gravidity: Primigravidae 2.04 (1.15-3.60)
Multigravidae 1.00
Number of ANC consultations:11 0.96 (0.93-0.99)
Ethnic group: Karen 3.16(0.77-13.03)
Black Karen 1.00
Infant’s sex: Male 1.37(0.78-2.43)
Female 1.00
Birth in winter: Yes 1.91 (1.08-3.39)
No 1.00
Recent arrival (< 2years) in Thailand: -Yes 3.34 (0.37-29.85)
-N o 1.00
Composite score o f mother’s education: - low 1.23 (0.11-13.58)
- average 2.03 (0.18-22.39)
- high 1.00
Composite score of father’s education: - low 0.51 (0.05-4.89)
- average 0.47 (0.05-4.55)
- high 1.00
Bold: p<0.05 
*: p£ 0.05 and <0.10 
continuous variable: HR per unit.
Multivariate analysis was performed in three steps. The first model included the 
factors identified in univariate analysis and the determinants of LBW and prematurity 
(Table 7.4), but not anaemia at delivery, LBW and prematurity. When some factors 
were closely related, they were entered in the model separately and only one was 
retained. A similar method was employed when one factor was included in another one. 
(e.g. the variable “P.falciparum overall” was not retained, nor “P.falciparum 
classification separating the episode within last week of pregnancy”, because
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information was contained in “infection last week”). In the second model, “anaemia at 
delivery”, that could be on the causal pathway between malaria and neonatal death, was 
included. LBW and prematurity, combined in four categories, were added in the third 
step. The children were classified as preterm-LBW, pretem-NBW, term-LBW and term- 
NBW.
Table 6.4: Potential risk factors and confounders included in multivariate analysis
Factors identified in univariate analysis
P.falciparum malaria during pregnancy
- P. falciparum malaria during pregnancy (last week separated)
- P.vivax malaria during pregnancy (last week separated)
- Number of P. vivax episodes during pregnancy
- Infection (malaria or ARI or UTI) within 1 week prior delivery 
Maternal anaemia at delivery
Complicated delivery 
Mother’s age
- Gravidity
- Number of ANC consultations
- Birth in winter
Determinants of LBW
- P. falciparum malaria during pregnancy
- P.vivax malaria during pregnancy
- Gravidity
Determinant of prematurity
- Mother’s age
- Infection (malaria or ARI or UTI) within 1 week prior delivery
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In the multivariate analysis, malaria during pregnancy was not associated with 
neonatal death. Febrile episode (due to malaria, ARI or UTI) within the week prior 
delivery was the most important risk factor for neonatal death and remained in the 
model when premature birth and LBW were accounted for (table 6.5). Thus the effect 
of malaria on neonatal mortality was all mediated through LBW, whereas fever in the 
week prior birth had additional independent effect as well as inducing premature birth.
Table 6.5: Risk factors for neonatal deaths; multivariate analysis
Risk factor Adjusted HR (95%CI) PAF (95%CI)
Model not including maternal anaemia at
1.98 (1.08-3.61) 
2.25 (1.14-4.44) 
4.82 (2.46-9.48)
16 % (2-24) 
12% (3-17) 
18% (13-20)
delivery. LBW and orematuritv
Mother under 20 years old
Complicated delivery
Infection within the week prior delivery
Model including maternal anaemia at
1.94(1.06-3.54) 
2.25 (1.14-4.45) 
4.01 (2.00-8.05) 
0.97 (0.94-1.00)
16% (2-23) 
12% (3-17) 
17% (11-20) 
NA
delivery, but not LBW and Drematuritv
Mother under 20 years old 
Complicated delivery 
Infection within the week prior delivery 
Number of ANC consultations (continuous)
Model including maternal anaemia at
4.27 (1.98-9.24) 
9.79 (3.80-25.22) 
2.91 (1.15-7.33)
17% (11-20) 
65% (53-69) 
46% (9-60)
deliverv. LBW and nrematuritv
Infection within the week prior delivery
Premature birth
LBW
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6.4.4. Risk factors for deaths from 1 to 3 months o f age.
The number o f deaths occurring from 1 to 3 months of age was lower than in the 
neonatal period. Thus analysis that compared various exposure levels (such as 
gestational age at first malaria episode divided in 3 groups corresponding to trimester) 
could not be done. Numbers in each group would have been too small. Infection within 
the week prior delivery was the only risk factor for infant death from 1 to 3 months of 
age identified in univariate analysis, and in a multivariate model including LBW, 
prematurity and their determinants (i.e. malaria during pregnancy, mother’s age and 
gravidity) (AHR: 3.98; 95%CI: 1.15-13.74). PAF for this factor was 13% (95%CI: 2- 
15).
6.4.5. Risk factors for deaths from 3 to 12 months o f  age.
In univariate analysis, malaria and anaemia during pregnancy were not 
associated with infant deaths from 3 to 12 months o f  age. LBW and prematurity did not 
influence late infant survival either. Infant who were anaemic (HCT<28%) at 3 months 
of age were more likely to die later in infancy than non-anaemic children. Recent arrival 
(<2 years) in Thailand was also a risk factor of dying between 3 to 12 months o f age 
(Table 6.6). As LBW was associated with infant anaemia (see chapter 8.4.2), and that 
infant anaemia might be on the causal pathway o f the effect o f LBW, two models of 
multivariate analysis were used. One model included “recent arrival”, “infant anaemia”, 
“camp” and “year”. The other model also contained “LBW”. None o f these factors 
remained independently associated with late infant deaths in multivariate analysis.
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Table 6.6: Potential risk factors for infant deaths from 3 to 12 months of age;
univariate analysis.
Hazard Ratio (95%CI)
P.falciparum malaria during pregnancy: Yes
No
0.91 (0.31-2.72) 
1.00
P.vivax malaria during pregnancy: Yes
No
1.35 (0.53-3.49) 
1.00
Infection (malaria or ARI or UTI) within 1 week prior delivery:
Yes
No
1.11 (0.15-8.26) 
1.00
Maternal anaemia during pregnancy: Yes
No
2.54 (0.59-10.94) 
1.00
Maternal anaemia at delivery: Yes
No
0.84 (0.28-2.52) 
1.00
Mother’s age: < 20 years 
ä  20 years
0.76 (0.23-2.59) 
1.00
Gravidity: Primigravidae 
Multigravidae
0.96 (0.35-2.61) 
1.00
Ethnic group: Karen
Black Karen
1.28 (0.30-5.50) 
1.00
Infant’s sex: Male 
Female
1.03 (0.44-2.43) 
1.00
Premature infant: Yes 
No
0.56 (0.07-4.21) 
1.00
LBW: Yes 
No
1.29 (0.37-4.49) 
1.00
Infant anaemia (HCT<28%) at 3 months o f age: Yes
No
5.62 (1.59-19.93)
1.00
Recent arrival (< 2years) in Thailand: -Yes
-N o
4.11 (1.15-14.72)
1.00
Composite score of mother’s education: - low/ average
- high
5.00 (0.65-38.25)
1.00
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Composite score of father’s education: - low/ average 1.32 (0.44-3.92)
-high 1.00
composite score of economic level: - low/ average 0.93 (0.12-7.19)
- high 1.00
6.5. Deaths from birth to three months of age in children born to malaria-infected 
mothers
In the cohort, 4 neonatal deaths (at 1, 2, 6 and 12 days of age) occurred in 
premature newborns whose mothers suffered from symptomatic malaria (2 P.falciparum 
and 2 P.vivax) during the week preceding delivery. One child, bom at term, but who 
weighed less than 2500g died at day 14 (his mother suffered from vivax malaria near 
delivery). Three other children, bom at term and weighing more than 2500g, but whose 
mothers had symptomatic malaria within the last week o f pregnancy died within the 
neonatal period: 1 from congenital malaria (8 days) and 1 from sepsis (15 days) (both 
bom to a mother infected with P.falciparum). The third child was abnormal and thus the 
direct relationship with maternal malaria is unlikely. Two children whose mothers had 
falciparum malaria within the week preceding delivery, died between 1 and 3 months. 
One was bom prematurely and never put on weight (1840g at birth; 1850g at 1 month 
age; he died at 58 days o f age from a final episode o f  diarrhoea). The second infant was 
bom at term and died at 84 days o f life after a 2-3 days history of fever and jaundice. 
Thus 13% (9/67) of the deaths in the first three months o f age may have been the direct 
consequence of symptomatic malaria infection in the third trimester of pregnancy. 
Among the other neonatal deaths, there were 13 LBW newborn whose mothers had 
suffered from falciparum or vivax malaria during pregnancy. Although this is probably 
a gross over-estimation, these children may have died from the effect o f malaria during 
pregnancy. Assuming a causal effect of malaria on neonatal mortality through LBW, 
27% (13/49) of the neonatal deaths could be attributed to malaria during pregnancy. 
Overall, malaria could be responsible for 41% (20/49) o f the neonatal deaths and of 
11% (2/18) of the deaths that occurred between one and three months o f life.
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6.6. Summary of the results contained in this chapter
Infectious diseases (mainly ARI, diarrhoea and sepsis) and prematurity were the 
leading causes of infant deaths. Maternal infection within the week prior delivery (PAF: 
17%), premature birth (PAF: 65%) and LBW (PAF: 46%) were identified as risk factors 
for neonatal deaths. These three factors accounted for 80% (39/49) of the neonatal 
deaths in the cohort. The effect of malaria during pregnancy was mediated through 
LBW, whereas maternal infection in the week prior birth had additional independent 
effect as well as inducing premature birth. Thirteen per cent of the deaths that occurred 
between one and three months of age were attributable to maternal infection within the 
week prior birth. There were no independent exposure factors association with infant 
deaths that occurred between three and twelve months o f age. Maternal anaemia was not 
associated with infant death, at any period of infancy.
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7.1. Morbidity from all causes
7.1.1. Description
During their first year of life, the infants presented to the dispensary or hospital 
on average 5.5 times (6776 consultations / 1228 child-year) (95%CI: 5.3-5.6). The main 
diagnoses are summarized in table 7.1. Some children presented with two diagnoses at 
the same consultation (such as ARI and diarrhoea), but only the most important cause 
(complaints from the mother or decision of the medic) was used for this classification. 
Malaria was always counted as the main diagnosis. More than half of the consultations 
(53%; 3580/6776) were due to respiratory infections (53% mild viral upper respiratory 
tract infections and 47% moderate or severe ARI). The second leading cause of 
consultation was diarrhoea. Malaria represented only 3% o f  the consultations.
Table 7.1: Main diagnoses in children seen at the health structures
Diagnoses N %
Mild ARI (common cold) 1896 28.0
ARI (bronchitis, pneumonia...) 1684 24.9
Diarrhoeal episodes 1286 19.0
Eyes Nose Throat (ENT) 511 7.5
Self-limited undiagnosed fever 451 6.7
Malaria all species 205 3.0
Skin diseases (mainly scabies, impetigo...) 139 2 . 1
Suspicion o f thiamin deficiency 82 1 . 2
Chicken pox 24 0.4
Measles 2 1 0.3
Others 454 6.7
Unknown 23 0.3
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The prevalence of morbid events increased with age in the first 3 months o f life 
and then remained in plateau (fig 7.1). The seasonal and annual variations were more 
difficult to assess. There were not enough children in each camp at each time point to be 
able to analyze monthly incidence by camp.
fig 7.1: Age-specific prevalence of dispensary attendance. 
Morbidity from all causes
month
Hospitalization was required in 3% (174/6776) of the morbid episodes. 
Diagnoses of severe events included 54 ARI, 47 diarrhoea, 19 falciparum malaria, 17 
suspicion of thiamin deficiency, 7 meningitis, 6  sepsis, 4 undiagnosed fever, 4 
abscesses, 2 measles, 2 malnutrition, 1 severe anaemia, 1 vivax malaria and 9 other 
conditions.
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7.1.2. Risk factors for morbidity from all causes during infancy
Poisson regression was used to identify morbid events during pregnancy that 
could be related to morbidity from all causes during infancy. Potential risk factors and 
confounders identified in univariate analysis are summarized in table 7.2. Falciparum 
malaria during pregnancy was associated with infant morbidity, only when the first 
episode occurred during the first trimester. Maternal anaemia was also associated with 
infant morbidity, and the association was stronger when the duration of anaemia 
increased. ARI and numbness during pregnancy were also associated with infant 
morbidity.
Table 7.2. Potential risk factors for morbidity from all causes during infancy 
(univariate analysis).
OPD consultations during infancy 
(0-12 months)
Factors Incidence Rate 
(episodes/child-year)
IRR (95%CI)
Maternal and birth characteristics
Mother age: <20
ä  2 0  years
5.8(1267/220) 
5.5 (5509/1007)
1.05 (0.99-1.12) 
1 . 0 0
Mother primigravidae 
Multigravidae
5.4(1640/304) 
5.6 (5136/924)
0.97 (0.92-1.03) 
1 . 0 0
Attendance to ANC in
1 "  trimester o f pregnancy
2 ”d
3rd
5.6 (3371/598) 
5.5 (2469/452) 
5.3(912/173)
1 . 0 0
0.97 (0.92-1.02) 
0.93 (0.87-1.01)*
Birth order: first bom 
Second 
Third
fourth or above
5.5(1869/339) 
5.3(1319/249) 
4.9 (998/205) 
6.0 (2586/433)
1 . 0 0
0.96 (0.90-1.03) 
0.88 (0.82-0.96) 
1.08(1.02-1.15)
Ethnic group: Karen
Black Karen
5.5(5954/1081) 
5.6 (822/146)
1 . 0 0
1.02(0.95-1.10)
Sex: male 
Female
5.7 (3599/633) 
5.3 (3177/594)
1.06(1.01-1.12)
1 . 0 0
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Complicated delivery: Yes 
No
6.1 (756/124) 
5.5(6020/1103)
1.12(1.03-1.21)
1 . 0 0
Weight/ gestational age: 
preterm-LBW 
term-LBW 
NBW
4.8 (372/78) 
6.0 (583/98) 
5.6 (5519/993)
0.86 (0.77-0.95)
1.08 (0.99-1.17)* 
1 . 0 0
Season o f birth: winter
dry season 
rainy season 
post-rainy season
5.6(1617/288)
5.3(1550/294)
5.6 (2660/475)
5.6 (949/170)
1 . 0 0
0.94(0.88-1.01)*
1.00(0.94-1.06)
1.00(0.92-1.08)
Malaria during pregnancy
Malaria during pregnancy: Yes 
(any species) No
5.6 (2457/437) 
5.5 (4319/791)
1.03 (0.98-1.08) 
1 . 0 0
Detection of 1st or only malaria 
infection during:
1  st trimester of pregnancy
2 nd
3rd
absence of malaria
6.1 (855/140) 
5.4 (961/177) 
5.3 (635/119) 
5.5(4319/791)
1.12(1.04-1.21)
0.99(0.92-1.07) 
0.97 (0.90-1.06) 
1 . 0 0
Malaria species during pregnancy 
absence of malaria 
only P.falciparum 
only P.vivax 
both species
5.5(4319/791) 
5.5 (861/157) 
5.6(1014/182) 
6.0 (582/97)
1 . 0 0
1.00(0.93-1.08)* 
1.02 (0.95-1.09) 
1.09(1.00-1.19)
P.falciparum malaria during 
pregnancy: Yes 
No
5.7(1443/255) 
5.5 (5333/973)
1.03 (0.97-1.09) 
1 . 0 0
Detection of 1 st or only P.falciparum 
malaria during:
1  st trimester o f pregnancy
2 nd
3rd
no falciparum malaria
6 . 6  (509/77) 
5.5(554/101) 
5.0 (380/76) 
5.5 (5333/973)
1.20(1.10-1.31)
1.00 (0.92-1.09) 
0.91 (0.82-1.01)*
1 . 0 0
Number of P.falciparum malaria 
episodes during pregnancy: 
none 
one
two or more
5.5 (5333/973) 
5.8 (920/160)
5.5 (523/95)
1 . 0 0
1.05 (0.98-1.13) 
1.0 (0.92-1.10)
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P.vivax malaria during pregnancy: 
Yes 
No
5.7 (1596/280) 
5.5(5180/948)
1.04(0.99-1.10)
1 . 0 0
Detection o f 1st or only P.vivax 
malaria during:
1 st trimester of pregnancy
2 nd
3rd
no vivax malaria
5.5 (385/70) 
5.6(623/111) 
5.9 (582/98) 
5.5(5180/948)
1.00(0.91-1.11) 
1.03 (0.95-1.12) 
1.09 (1.00-1.19)* 
1 . 0 0
Number o f P.vivax malaria episodes 
during pregnancy: none 
one
two or more
5.5 (5180/948)
5.6 (991/177) 
5.9 (605/102)
1 . 0 0
1.02 (0.96-1.10) 
1.08 (0.99-1.18)*
Anaemia during pregnancy
Anaemia at any time: Yes 
No
5.6 (5267/938) 
5.2 (1376/267)
1.09 (1.03-1.16)
1 . 0 0
Anaemia at delivery: Yes 
No
5.4(1534/286) 
5.6 (5001/900)
0.97 (0.91-1.02) 
1 . 0 0
Lengh o f anaemia during pregnancy 
None 
< 6  weeks 
2  6  weeks
5.1 (1415/275) 
5.5(2312/419) 
5.7 (2916/512)
1 . 0 0
1.07 (1.00-1.15) 
1.11 (1.04-1.18)
Non-malarious maternal morbidity
Hypertension during pregnancy: Yes
No
6.2(192/31)
5.5 (6584/1197)
1.13(0.97-1.30)
1 . 0 0
ARI during pregnancy: Yes 
No
6.5 (2243/345) 
5.1 (4533/882)
1.27 (1.20-1.33)
1 . 0 0
UTI during pregnancy: Yes 
No
5.5 (455/83)
5.5 (6321/1145)
0.99 (0.91-1.09) 
1 . 0 0
Numbness during pregnancy: Yes
No
5.8 (3821/661) 
5.2 (2942/564)
1.11 (1.06-1.16)
1 . 0 0
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Socio-economic markers:
Mother’s age at arrival in Thailand: 
<15 years 
^ 15 years
5.0(1371/273) 
6.0 (4859/813)
1 . 0 0
1.19(1.12-1.26)
Time elapsed since mother’s 
arrival in Thailand: < 2 years 
2-5 years 
5-10 years 
> 1 0  years
6 . 6  (455/69) 
6.0 (2300/384)
5.7 (2100/366) 
5.2(1375/267)
1.28(1.15-1.42) 
1.16(1.08-1.24) 
1.11 (1.04-1.19)
1 . 0 0
Composite score of mother’s 
education: low
average
high
6.1 (2966/487) 
5.7(1714/299) 
5.2(1564/303)
1.18(1.11-1.25) 
1.11 (1.04-1.19)
1 . 0 0
Composite score of father’s 
education: low
average
high
6.4(1875/293) 
5.8(1820/316) 
5.3 (2382/447)
1.20 (1.13-1.28) 
1.08(1.02-1.15)
1 . 0 0
Composite score of economic level 
low
average
high
6.6(1976/300) 
5.7 (3469/610) 
4.1 (315/77)
1.60(1.42-1.80)
1.38(1.23-1.55)
1 . 0 0
Site of birth: Shoklo 
Bonoklo 
Maesalit 
Klaymuta 
Maela
4.8 (2094/434) 
3.4 (525/154) 
5.1 (411/80) 
3.8(137/36)
6.9 (3609/523)
1 . 0 0
0.71 (0.64-0.78) 
1.06 (0.95-1.18) 
0.79 (0.66-0.94) 
1.43 (1.36-1.51)
Year of birth: 1993
1994
1995
1996
6 . 6  (638/97) 
4.0(1559/390)
6.2 (2455/397)
6.2 (2124/343)
1 . 0 0
0.61 (0.56-0.67)
0.94 (0.86-1.03) 
0.95 (0.87-1.03)
bold: p<0.05 
*: p^O.05 and p<0 . 1 0
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In multivariate analysis, falciparum malaria detected in the first trimester of 
pregnancy, ARI and numbness during pregnancy remained associated with infant 
morbidity. Male and full-term LBW infants were also associated with higher morbidity, 
whereas premature LBW children presented with less morbid events. Morbidity 
decreased in the third child of a family and increased again for higher birth order. Low 
father’s education, low or average economic level and mother recently arrived in 
Thailand (as she was adult) were also associated with morbidity during the first year of 
life (Table 7.3).
Table 7.3: Risk factors for morbidity from all causes during infancy; multivariate 
analysis.
Adjusted IRR (95% Cl)
Detection of 1 st or only P.falciparum during the first 
trimester of pregnancy 1.14(1.03 -1.26)
ARI during pregnancy 1.14(1.07-1.21)
Numbness during pregnancy 1.06(1.00- 1.13)
Third child 0.88 (0.80 - 0.96)
Male gender 1.06(1.00- 1 . 1 2 )
Term LBW 1.09(1.00-1.20)
Premature LBW 0.87 (0.77 -  0.99)
Mother arriving in Thailand in adulthood (>15 years old) 1.16(1.08- 1.25)
Low father’s education: 1.09(1.02- 1.17)
Low economical level: 1.31 (1.15-1.49)
Average economical level 1.21 (1.07- 1.37)
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7.2. Malaria during infancy
7.2.1. Morbidity and mortality from malaria.
There were 205 malaria cases in 132 infants. The majority (70%; 143) of the 
malaria cases were due to P.vivax, 26% (53) to P.falciparum and 4% (9) were mixed 
infections with P.vivax and P.falciparum. Fifty-five P.vivax malaria cases were possibly 
relapses and 2 falciparum malaria episodes were considered as treatment failures. Thus 
only 148 cases were “new” infections ( 8 8  P.vivax, 51 P.falciparum and 9 mixed), 
giving a malaria incidence rate during infancy of 121 (148/1228) per 1,000 child-year 
(95%CI: 103-142). Falciparum malaria incidence rate was 49 per 1,000 child-year (51 
Pfalciparum plus 9 mixed infections/1228 child-years) (95%CI: 38-63). Vivax malaria 
incidence rate was 76 per 1,000 child-year ( 8 8  P.vivax plus 5 mixed infections in which 
P.vivax was encountered for the first time/1228 child-years) (95%C1: 62-93).
Out of the 132 children who developed malaria during infancy, 74 (56%) had 
only vivax malaria during infancy, and 2 2  of them had subsequent relapses during the 
follow-up (1 to 5 times) (total 110 vivax malaria cases). Thirty-nine infants (29% of 
those with malaria) suffered from Pfalciparum malaria only during infancy. Four 
infants (3%) had uncomplicated mixed infections, 2 of them followed by vivax relapses. 
The remaining 15 children (12%) had alternatively P.vivax and Pfalciparum during 
infancy. P.vivax was the first infecting species in 12 infants, P.falciparum in 2 and the 
remaining child had 1 mixed infection followed by 1 falciparum malaria infection.
Out of the 143 pure vivax malaria cases, 1 required hospitalization for severe 
anaemia (HCT=15%) but the child was already anaemic (HCT=25%) at his previous 
routine visit three weeks before.
The risk of developing severe malaria was 31% (19/62 cases o f  Pfalciparum 
malaria alone or mixed with P.vivax) (95%CI: 19-42%) and the CFR was 32 per 1,000 
(2/62) (95%CI: 9-112). Thus malaria-attributable mortality was 1.6 (2/1228) per 1,000 
child-year (95%CI: 0.4-6.5). One child developed severe falciparum malaria at 8  days 
of life and died. The mother was infected with falciparum malaria at delivery and the 
child was likely to have congenital malaria. The second child died at 8  months. He
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presented to the hospital with acute severe anaemia (HCT= 3%). He had been living in 
the forest with the mother during the 2 previous weeks and was febrile and unwell for 3 
days when he arrived at the hospital. Twelve o f  the 17 other patients with severe malaria 
were hospitalized in the SMRU structures where clinical and laboratory features were 
recorded. All but one had hyperparasitaemia (median (range): 6.4 (4.0-20.4) %  infected 
red blood cells), two of them combined with severe anaemia (HCT= 13 and 17.5%). 
One infant presented with severe malaria-attributable anaemia (no HCT available, but 
clinical signs of cardiac failure). None o f the patients with severe malaria were 
comatose. The risk of developing severe malaria was similar in children for whom it 
was the first malaria episode (34%; 14/41), in those with mixed infection first (20%; 
1/5) and in those who had vivax malaria prior their falciparum infection (33%; 4/12) 
(p=0.89).
7.2.2. Acquisition of malaria during infancy
Children with congenital malaria (N=3; 1 severe case and 2 asymptomatic 
infections) were excluded from this analysis. Malaria was rare in the first three months 
of life and then increased regularly. Overall the incidence of malaria from 3 to 12 
months of age was 13 per 1,000 child-month (137/10,529) whereas it was 3 per 1,000 
child-month (10/4,163) in the first 3 months o f life (IRR: 4.9; 95%CI: 2.7-9.1). Vivax 
malaria was acquired earlier in life than P.falciparum. Cumulative incidence rates for 
each species are represented in fig 7.2. The median age (range) at first P.vivax malaria 
was 6.3 (0.9-11.9) months and that of first P.falciparum malaria was 7.9 (2.3-11.5) 
months, but this was not significant (p=0.29). As reported previously, most (80%; 
12/15) of the children who had both species during infancy first developed P.vivax 
malaria. Malaria during pregnancy did not influence the age of the first malaria attack 
during infancy. Children bom to mothers with malaria during pregnancy acquired their 
first malaria at a median (range) age of 6 . 8  (1.5-11.6) months and those whose mothers 
had no malaria during pregnancy developed their first malaria attack at 7.0 (0.9-11.9) 
months of age (p=0.87). There were also no differences in the age at first malaria during 
infancy, when the timing or the species o f malaria during pregnancy were taken in 
account.
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Fig 7.2: Cumulative malaria incidence rates in the first year of life
months
P.falciparum ^ ^ P .v iv a x
7.2.3. Relationships between malaria during pregnancy and malaria during 
infancy
In univariate analysis (table 7.4), falciparum malaria during pregnancy was 
weakly associated with increased malaria during infancy. But the stage at which the first 
P.falciparum malaria occurred during pregnancy seemed essential in this association. 
Only the infections detected in the first trimester of pregnancy were associated with 
increased malaria in infancy. Children whose mothers had a last o r only falciparum 
malaria at the end of their pregnancy (within the last 2  months) were not protected 
against malaria in infancy. Prolonged maternal anaemia was also associated with 
increased malaria in infancy. Surprisingly children bom to mothers who had non- 
malarious morbidity during pregnancy had less malaria in infancy than infants whose 
mothers did not present with numbness, ARI or UTI. Karen infants were more likely to
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acquire malaria during infancy than Black Karen. Camp and year of study were 
important confounding factors. Overall, malaria morbidity decreased over time. In 
Maela, transmission was reduced and malaria incidence in this camp was much lower 
than in the other sites.
In multivariate analysis, a first episode o f P.falciparum malaria during the first 
trimester of pregnancy remained strongly associated with malaria in infancy. Karen 
ethnicity and low father’s education were other independent risk factors for malaria in 
infancy (Table 7.5).
Table 7.4. Potential risk factors for malaria (all species) during infancy (univariate 
analysis).
Malaria incidence rate during infancy 
(per 1,000 child-year)
Incidence rate 
(episodes/child-year)
Rate ratio 
(95%C1)
Maternal and birth characteristics
Mother age: <20
2  2 0  years
105 (23/220) 
123 (124/1007)
0.85 (0.54-1.32) 
1 . 0 0
Mother primigravidae 
Multigravidae
99 (30/304) 
127(117/924)
0.78 (0.52-1.16) 
1 . 0 0
Attendance to ANC in
1 st trimester o f  pregnancy
2 nd
3 rd
110(66/598) 
124 (56/452) 
144(25/173)
1 . 0 0
1.12(0.79-1.60) 
1.31 (0.83-2.07)
Birth order: First bom 
Second 
Third
Fourth or above
115(39/339) 
125 (31/249) 
146(30/205) 
109(47/433)
1 . 0 0
1.08 (0.68-1.73) 
1.27 (0.79-2.05) 
0.94 (0.62-1.44)
Ethnic group: Karen
Black Karen
120(141/1081) 
41 (6/146)
3.17(1.40-7.18)
1 . 0 0
Sex: Male 
Female
122 (77/633) 
118(70/594)
1.03 (0.75-1.43) 
1 . 0 0
weight/ gestational age: preterm-LBW 
term-LBW 
normal BW
64 (5/78) 
113(11/98) 
121 (120/993)
0.53 (0.22-1.30) 
0.93 (0.50-1.72) 
1 . 0 0
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season o f birth: winter
dry season 
rainy season 
post-rainy season
121 (35/288) 
102(30/294) 
128 (61/475) 
123 (21/170)
1 . 0 0
0.84 (0.52-1.37) 
1.04(0.63-1.71) 
1.02(0.59-1.75)
Malaria during pregnancy
Malaria species during pregnancy 
absence o f malaria 
only P.falciparum 
only P.vivax 
both species
106(84/791) 
172 (27/157) 
126 (23/182) 
133(13/97)
1 . 0 0
1.62(1.05-2.50)
1.19(0.75-1.89) 
1.26 (0.70-2.25)
P.falciparum malaria during pregnancy: 
Yes 
No
157 (40/255) 
110(107/973)
1.43 (0.99-2.05)* 
1 . 0 0
Detection of 1 st or only P.falciparum 
malaria during:
1 st trimester of pregnancy
2 nd
3rd
no falciparum malaria
208 (16/77) 
119(12/101) 
158(12/76) 
110(107/973)
1.89 (1.12-3.20)
1.08 (0.59-1.96) 
1.43 (0.79-2.60) 
1 . 0 0
Last or only Pfalciparum  malaria during 
the last 2 months of pregnancy: Yes
No
167(12/72)
117(135/1156)
1.43 (0.72-2.58) 
1 . 0 0
Number of Pfalciparum  malaria episodes 
during pregnancy: none 
one
two or more
110 (107/973) 
150 (24/160) 
168(16/95)
1 . 0 0
1.37(0.88-2.13) 
1.53 (0.91-2.59)
P.vivax malaria during pregnancy: 
Yes 
No
129 (36/280) 
117(111/948)
1.10(0.75-1.60)
1 . 0 0
Detection of 1st or only P.vivax malaria 
during: 1 st trimester of pregnancy 
2 nd
3rd
no vivax malaria
43 (3/70) 
135(15/111) 
184(18/98) 
117(111/948)
0.37 (0.12-1.15)* 
1.15(0.67-1.98) 
1.57 (0.95-2.58) 
1 . 0 0
Number of P.vivax malaria episodes 
during pregnancy: none 
one
two or more
117(111/948) 
141 (25/177) 
108(11/102)
1 . 0 0
1.21 (0.78-1.86) 
0.92 (0.50-1.71)
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Anaemia during pregnancy
Anaemia at any time Yes 
No
131 (123/938) 
8 6  (23/267)
1.52 (0.98-2.38)* 
1 . 0 0
Anaemia at delivery: Yes 
No
143 (41/286) 
111 (100/900)
1.29 (0.90-1.86) 
1 . 0 0
Lengh o f anaemia during pregnancy 
none
< 6  weeks 
> 6  weeks
84 (23/275) 
124 (52/419) 
139 (71/512)
1 . 0 0
1.48 (0.91-2.42) 
1.66 (1.04-2.65)
Non-malarious maternal morbidity
Hypertension during pregnancy: Yes
No
97 (3/31) 
120(144/1197)
0.80 (0.26-2.52) 
1 . 0 0
ARI during pregnancy: Yes 
No
93 (32/345) 
130(115/882)
0.71 (0.48-1.05)* 
1 . 0 0
UTI during pregnancy: Yes 
No
48 (4/83) 
125(143/1145)
0.39 (0.14-1.04)* 
1 . 0 0
Numbness during pregnancy: Yes
No
98 (65/661) 
144(81/564)
0.68 (0.49-0.95)
1 . 0 0
Socio-economic markers:
Mother’s age at arrival in Thailand: 
<15 years 
S 15 years
92 (25/273) 
126(102/813)
1 . 0 0
1.37 (0.88-2.12)
Time elapsed since mother’s arrival in 
Thailand: < 2 years 
2-5 years 
5-10 years 
> 1 0  years
145 (10/69) 
128 (49/384) 
120 (44/366) 
90 (24/267)
1.61 (0.77-3.37) 
1.42 (0.87-2.31) 
1.34 (0.81-2.20) 
1 . 0 0
Composite score of mother’s education: 
low
average
high
119(58/487) 
100(30/299) 
129 (39/303)
0.93 (0.62-1.39) 
0.78 (0.48-1.25) 
1 . 0 0
Composite score of father’s education: 
low
average
high
164(48/293) 
114(36/316) 
94 (42/447)
1.74(1.15-2.64)
1.21 (0.78-1.89) 
1 . 0 0
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Composite score of economic level 
low
average
high
137(41/300) 
112(68/610) 
65 (5/77)
2.09 (0.83-5.29) 
1.72 (0.69-4.26) 
1 . 0 0
Site of birth: Shoklo 177 (77/434) 1 . 0 0
Bonoklo 182 (28/154) 1.03 (0.67-1.58)
Maesalit 249 (20/80) 1.40 (0.86-2.29)
Klaymuta 305(11/36) 1.72 (0.91-3.23)*
Maela 21 (11/523) 0.12(0.06-0.22)
Year of birth: 1993 402 (39/97) 1 . 0 0
1994 169 (66/390) 0.42 (0.28-0.63)
1995 91 (36/397) 0.23 (0.14-0.35)
1996 18(6/343) 0.04 (0.02-0.10)
Bold: p<0.05
*: p> 0.05 and <0.10
Table 7.5. Risk factors for malaria during infancy (multivariate analysis).
Adjusted incidence rate ratio 
(95% Cl)
- P.falciparum during first trimester of pregnancy
- Karen ethnic group
- Low father’s education:
2.75(1.48-5.10)
2.93(1.18-7.25)
1.60(1.04-2.47)
Following these results, further analysis was performed in order to identify the 
risk factors for developing falciparum malaria during the first trimester o f  gestation 
rather than later in pregnancy. Pregnant women were more likely to be infected with 
P.falciparum during the first trimester when they delivered in winter than in other 
seasons (p=0.08), but this was not significant. Birth in winter corresponded to 
conception between February and April, immediately before the malaria peak (May- 
July). But the main risk factor o f having a first falciparum malaria episode during the 
first trimester rather than later in pregnancy was a maternal history of slide-confirmed 
malaria before the pregnancy (Mantel-Haenszel OR after adjusting for season: 2.35;
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95%CI: 1.17-4.73). Nevertheless, a history of maternal malaria before pregnancy was 
not associated with infant malaria. Malaria incidence rates during infancy were 167 per 
1,000 child-year (12/72) in children bom to mothers with a pre-pregnancy history of 
malaria compared to 117 (135/1156) per 1,000 in infants whose mothers did not declare 
malaria before pregnancy (IRR: 1.43; 95%CI: 0.72-2.58). When history of maternal 
malaria was accounted for in the Poisson regression, P.falciparum during the first 
trimester o f pregnancy was an even stronger risk factor for malaria during infancy 
(Adjusted IRR: 3.24; 95%CI: 1.67-6.30). The higher risk for the Karen ethnic group 
remained unchanged (Adjusted IRR: 2.80; 95%CI: 1.01-7.73).
In order to avoid potential interactions between P.vivax and P.falciparum, the 
analysis was repeated in the sub-group of infants those mothers had only P.falciparum 
malaria or did not suffer from malaria during pregnancy. Results were identical. 
Children bom to mothers who had their first or unique falciparum malaria during the 
first trimester o f pregnancy were 2.71 (1.46-5.04) times more likely to develop malaria 
during infancy than those whose mothers had no malaria or were infected later in 
pregnancy. The Karen group remained at higher risk o f malaria than Black Karen 
(Adjusted IRR: 2.44; 95%CI: 0.98-6.08; p=0.056), although it was not significant 
anymore.
When looking at the acquisition o f different species during infancy, first 
falciparum malaria during the first trimester o f pregnancy remained a risk factor for 
P.vivax malaria (Adjusted IRR: 2.46; 95%CI: 1.17-5.16), whereas it did not reach 
significance for P.falciparum malaria (Adjusted IRR: 2.92; 95%CI: 0.96-8.87; 
p=0.059). Infants bom to multigravidae (Adjusted IRR: 2.92; 95%CI: 1.12-7.61) and 
those whose mothers attended ANC only during the third trimester of pregnancy 
(Adjusted IRR: 2.96; 95%CI: 1.34-6.54) were also at risk of having P.falciparum 
malaria during infancy.
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7.3. Morbidity from respiratory infections and diarrhoea 
7.3.1 Respiratory infections (excluding mild diseases)
Children had an average of 1.37 (95%CI: 1.30-1.43) episodes of AR1 per child- 
year (1677/1228). Three per cent (54/1677) of the patients with ARI were referred to 
hospital and 12 died, giving a CFR of 7.2 per 1,000 (95%CI: 3.1-11.2) and mortality 
attributable to ARI of9.8 per 1,000 child-year (95%CI: 5.5-17.2).
ARI during pregnancy, male gender, arrival o f the mother in Thailand at age 15 
or more, low education and low economic level were identified as risk factors o f having 
ARI during infancy (Table 7.6).
Table 7.6: Risk factors for ARI during infancy
Incidence rate 
(No/child-year)
IRR (95%C1) Adjusted IRR 
(95%CI)
ARI during pregnancy: Yes 
No
1.76 (608/345) 
1.21 (1069/882)
1.45(1.31-1.61)
1 . 0 0
1.30(1.14-1.49)
Numbness during pregnancy: 
Yes 
No
1.44 (949/661) 
1.28(723/564)
1.12(1.02-1.24)
1 . 0 0
NS
Birth order: first bom 
Second 
Third
fourth or above
1.21 (412/339) 
1.28 (320/249) 
1.24(253/205) 
1.60(692/433)
1 . 0 0
1.06 (0.91-1.22) 
1.02(0.87-1.19) 
1.32(1.16-1.49) NS
Sex: Male 
Female
1.49 (941/633) 
1.24(736/594)
1.20(1.09-1.32)
1 . 0 0
1.21 (1.08-1.35)
Mother’s age at arrival in 
Thailand: < 15 years 
it 15 years
1.12(306/273)
1.46(1184/813)
1 . 0 0
1.30(1.14-1.48) 1.34 (1.16-1.53)
Mother’s education: low
Average
high
1.53 (744/487) 
1.40 (418/299) 
1.09 (330/303)
1.40(1.23-1.60)
1.28(1.11-1.48)
1 . 0 0
1.18 (1.02-1.37)
1.16 (0.99-1.36)
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Father’s education: low 1.51 (443/293) 1.21 (1.07-1.37) NS
Average 1.41 (447/316) 1.13 (1.00-1.28)* NS
high 1.25 (561/447) 1 . 0 0
Economic level: low 1.57(471/300) 1.69(1.32-2.17) 1.33 (1.03-1.71)
Average 1.38(842/610) 1.49(1.17-1.90) 1.31 (1.00-1.71)
high 0.93 (71/77) 1 . 0 0
Bold: p<0.05
*: p> 0.05 and <0.10
7.3.2. Diarrhoeal diseases
There were 1271 episodes o f diarrhoea: 1.04 per child-year (95%CI: 0.98-1.09). 
Forty-seven (4%) children were hospitalized and 7 died: CFR: 5.5 per 1,000 (95%CI: 
1.4-9.6); mortality attributable to diarrhoea: 5.7 per 1,000 child-year (95%CI: 2.7-12.0). 
LBW infants, premature as well as term-LBW ones, were at higher risk of diarrhoea 
during infancy than NBW. ARI and UTI during pregnancy were also identified as risk 
factors for diarrhoea in infancy (Table 7.7).
Table 7.7: Risk factors for diarrhoea during infancy
Incidence rate 
(No/child-year)
IRR (95%CI) Adjusted IRR 
(95%CI)
Weight/gestational age:
- preterm LBW
- term LBW 
-NBW
0.72 (56/78)
1.24(121/98)
1.04(1037/993)
0.69 (0.53-0.90)
1.19(0.98-1.43)*
1 . 0 0
1.34 (1.01-1.78) 
1.58 (1.14-2.20)
ARI during pregnancy: Yes 
No
1.30 (449/345) 
0.93 (822/882)
1.40(1.24-1.57)
1 . 0 0
1.24(1.09-1.41)
UTI during pregnancy: Yes 
No
1.31 (109/83) 
1.01 (1162/1145)
1.29 (1.05-1.58)
1 . 0 0
1.27(1.03-1.56)
Bold: p<0.05
*: p£ 0.05 and <0.10
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7.4. Anaemia during infancy
7.4.1. Monthly visits
Between 74 and 83% of the children who were still followed (i.e. alive and who 
did not withdrawn from the study) were seen at monthly visits. At each visit, some 
results were lost, or rejected as unreliable, and some HCT tubes were broken. Thus the 
numbers o f measurements effectively done were lower than the number of children 
seen. Nevertheless, 72-81% of the infants were weighed and measured at each point, 
and 63-77% had an HCT level done. Attendance was higher at 6  months and 1 year of 
age because a special effort was made to see a maximum of children at these ages 
(Table 7.8). Children who were absent at one point were seen at a following visit. 1,318 
children were followed at least 3 months (i.e. they should have attended a minimum of 2 
visits). Ninety-five per cent of them were weighed (N=1253) and measured (N=1254) 
more than twice (median: 8  times; range: 0-11) during infancy and 98% (N=1292) had 
at least two HCT measurements (median: 9 times; range: 0-11).
Table 7.8. Attendance for monthly visits and proportion of anthropometric and 
haematocrit measurements effectively done.
Age in 
months
No children 
remaining in 
study
No visits (%) No weight 
(%)
No height 
(%)
No hct (%)
1 1410 1135(80) 1046 (74) 1039(74) 882 (63)
2 1364 1106(81) 1029(75) 1023 (75) 949 (70)
3 1318 1060(80) 995 (75) 994 (75) 940 (71)
4 1273 1018(80) 955 (75) 954 (75) 915(72)
5 1243 992 (80) 926 (74) 929 (75) 8 8 8  (71)
6 1208 998(83) 942 (78) 941(78) 883 (73)
7 1179 894 (76) 853 (72) 853(72) 798 (6 8 )
8 1151 900(78) 853 (74) 853(74) 820 (71)
9 1119 854 (76) 813 (73) 811 (72) 782 (70)
1 0 1084 810(75) 782 (72) 779(72) 751 (69)
1 1 1061 784 (74) 767 (72) 766(72) 716(67)
1 2 1039 855(82) 841 (81) 838(81) 796 (77)
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7.4.2. HCT profile and anaemia during infancy
When the study started, samples for HCT level were not taken routinely at birth 
and later on, most mothers refused that blood was drawn from their newborn. It was 
therefore not possible to use the HCT levels obtained at birth. The HCT profile of Karen 
infants from 1 to  12 months o f age is shown in fig 7.3 (line without markers) together 
with that of a reference population (line with circle markers) of infants from developed 
countries (Saarinen et al., 1978). Karen infants did not recover from physiological 
anaemia at 2-3 months of age. Whereas a plateau was reached at 6  months at around 36- 
37% HCT in the reference population, HCT in the infants from the cohort continued to 
decrease from 6  to 12 months (33.3 to 32.0%). As a consequence, the prevalence of 
anaemia increased with age (fig 7.4).
Fig 7.3: haematocrit levels in Karen infants and in a reference 
population of infants from developed countries.
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Fig 7.4: Prevalence of anaemia in Karen infants
age in months
7.4.3. Risk factors for anaemia in infancy
7.4.3.1. Risk factors for anaemia at one month o f age
Only 2.7% (24/882) of the children were anaemic at 1 month of age. Malaria 
during pregnancy was not associated with anaemia in I month-old infants. Babies bom 
during the rainy season were more likely to be anaemic at one month (4.4%; 16/367) 
than children bom during other periods of the year (1.6%; 8/515) (OR=2.89; 95%CI: 
1.15-7.45). Children bom to mothers who were anaemic during pregnancy were less 
likely to have anaemia at 1 month o f age than those whose mothers were not anaemic: 
2.1% (14/662) vs 4.9 (10/206) (OR: 0.42: 95%CI: 0.18-0.97). The risk of infant 
anaemia decreased as the duration o f maternal anaemia increased: 2.6% (8/304) and 1.7 
(6/351) for less and more than 6  weeks of anaemia (x2 for trend: 4.19; p=0.04). In a 
multivariate analysis in which the duration of iron supplementation and the number of 
consultations at ANC were added as covariates, to be bom in rainy season remained the 
only risk factor for anaemia at 1 month of age (Adjusted OR: 2.83; 95%CI: 1.19-6.72).
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7.4.3.2. Risk factors for anaemia at three months of age
Malaria and anaemia during pregnancy were not associated with anaemia in 3 
month old infants. Similarly, infant anaemia at this age, was not influenced by morbid 
events and hospitalisation during the first three months o f life. Only LBW and 
prematurity were associated with anaemia at 3 months of age. LBW remained the only 
identified risk factor for anaemia at 3 months of age after adjustment for gestational age 
(Table 7.9). The proportion o f  anaemic infants bom with LBW was 32% (11/34), 
giving the PAF of anaemia due to LBW: 20% (95%CI: 2-27).
Table 7.9: Risk factors for anaemia in 3 month old infants
Prevalence 
of anaemia
%(n)
OR (95%CI) Adjusted OR 
(95%CI)
Maternal and newborn 
characteristics
Mother primigravidae 
Multigravidae
6(14/237) 
4 (26/703)
1.64(0.84-3.19)
1 . 0 0
Not in model
Attendance to ANC in
1 " trimester o f  pregnancy
2n<J
3rd
4(19/462)
4(13/355)
7(8/120)
1 . 0 0
0.89 (0.41-1.91) 
1.67 (0.65-4.15)
Not in model
Ethnic group: Karen
Black Karen
5 (37/825) 
3(3/115)
1.75 (0.54-9.03) 
1.00
Not in model
Infant sex: Male 
Female
4 (20/470) 
4 (20/470)
1.00(0.53-1.88)
1 . 0 0
Not in model
LBW: Yes 
No
10(11/116) 
3 (23/738)
3.26(1.54-6.88)
1 . 0 0
2.58(1.07-6.21)
Premature infant: Yes 
No
10(7/73)
4 (28/749)
2.73(1.15-6.49)
1 . 0 0
NS
Maternal morbidity during 
pregnancy
Malaria: Yes 
No
5(15/328)
4(25/612)
1.13(0.59-2.17)
1 . 0 0
Not in model
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Anaemia at any time: Yes 
No
5 (34/716) 
2 (5/205)
1.99 (0.77-5.17) 
1 . 0 0
Not in model
Anaemia at delivery: Yes 
No
6(13/210) 
3 (23/695)
1.93 (0.96-3.88)* 
1 . 0 0
NS
Severe anaemia at any time: Yes
No
6  (9/146) 
4(28/761)
1.72 (0.79-3.73) 
1 . 0 0
Not in model
Infection within the week prior to 
delivery: Yes 
No
5 (2/43)
4 (38/894)
1.10(0.26-4.71)
1 . 0 0
Not in model
ARI: Yes 
No
4(12/273) 
4 (28/667)
1.05 (0.53-2.10) 
1 . 0 0
Not in model
UTI: Yes 
No
3 (2/63)
4 (38/877)
0.72 (0.17-3.07) 
1 . 0 0
Not in model
Numbness: Yes 
No
5(25/518)
4(15/421)
1.37 (0.71-2.64) 
1 . 0 0
Not in model
Hypertension: Yes 
No
8  (2/25) 
4(38/915)
2.01 (0.46-8.82) 
1 . 0 0
Not in model
Infant morbidity during the 
first three months of life
At least one attendance to 
dispensary: Yes 
No
4(17/388) 
4 (23/552)
1.05 (0.53-2.09) 
1 . 0 0
Not in model
Malaria: Yes 
No
0 (0/3)
4 (40/937)
0.00 (0.00-57.82) 
1 . 0 0
Not in model
ARI: Yes 
No
4(7/162) 
4 (33/778)
1.02(0.37-2.40)
1 . 0 0
Not in model
Diarrhoea: Yes 
No
5(6/117)
4 (34/823)
1.25 (0.42-3.12) 
1 . 0 0
Not in model
Hospitalised: Yes 
No
4(1/28)
4(39/912)
0.83 (0.02-5.31) 
1 . 0 0
Not in model
Socio-economic and 
environmental factors
Birth in rainy season: Yes 
No
4(14/385) 
5 (26/555)
0.77 (0.40-1.49) 
1 . 0 0
Not in model
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Time spend in Thailand (mother): 
< 1 0  years 
£ 1 0  years
5 (29/620) 
3 (7/210)
1.42 (0.61-3.30) 
1 . 0 0
Not in model
Mother’s education: Low
Average/high
4(16/378) 
4 (20/455)
0.96 (0.47-1.97) 
1 . 0 0
Not in model
Father’s education: Low
Average/high
4 (9/226)
4 (26/582)
0.89 (0.38-2.02) 
1 . 0 0
Not in model
Economic level: Low/ Average 
High
4 (29/655) 
8  (5/60)
1 . 0 0
2.05 (0.60-5.66)
Not in model
Bold: p<0.05
*: p> 0.05 and <0.10
7.4.3.3. Risk factors for anaemia at six months of age
Malaria in the first 6  months o f life was associated with infant anaemia at 6  
months o f age. LBW  remained another important risk factors for infant anemia. At this 
age, socio-economic and environmental factors (time spent in Thailand by the mother, 
low father’s education, birth outside the rainy season) were also associated with infant 
anaemia. Infant nutrition was not associated with infant anaemia. Nearly all (98%; 
840/856) infants were still breast-fed, but 26% (207/794) received complementary food 
(usually rice) before 6  months of age. Exclusively breast-fed infants and those for whom 
weaning food had been introduced had similar prevalence of anaemia (Table 7.10). 
Environmental factors were more prevalent in anaemic infants than LBW and malaria. 
Thus PAF of anaemia due to SES and environmental factors were more important than 
PAF due to LBW or infant malaria (Table 7.11).
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Table 7.10: Risk factors for anaemia in 6 month old infants
Prevalence 
o f anaemia 
% (n)
OR (95%CI) Adjusted OR 
(95%CI)
Maternal and newborn 
characteristics
Mother primigravidae 
Multigravidae
15 (33/219) 
9 (60/664)
1.79(1.13-2.82)
1 . 0 0
NS
Ethnic group: Karen
Black Karen
11(82/781) 
1 1  ( 1 1 / 1 0 2 )
0.97 (0.48-2.00) 
1 . 0 0
Not in the model
Infant sex: Male 
Female
12(55/461) 
9 (38/422)
1.37(0.89-2.11)
1 . 0 0
Not in the model
LBW: Yes 
No
17(19/109) 
9 (63/690)
2.10(1.20-3.67)
1 . 0 0
2.09(1.16-3.77)
Premature infant: Yes 
No
16(13/84)
10(66/683)
1.71 (0.90-3.26) 
1 . 0 0
Not in the model
Maternal morbidity during 
pregnancy
Malaria: Yes 
No
13(39/313)
10(54/570)
1.36 (0.88-2.11) 
1 . 0 0
Not in the model
Anaemia at any time: Yes 
No
10(67/679)
13(25/190)
0.72 (0.84-1.18) 
1 . 0 0
Not in the model
Anaemia at delivery: Yes 
No
10(21/205) 
11 (69/648)
0.96 (0.57-1.60) 
1 . 0 0
Not in the model
ARI: Yes 
No
8  (22/268) 
12(71/615)
0.69 (0.42-1.13) 
1 . 0 0
Not in the model
UTI: Yes 
No
11 (6/55)
11 (87/828)
1.04 (0.43-2.51) 
1 . 0 0
Not in the model
Infant morbidity during the 
first six months of life
Number o f morbid events: none 
1 to 3 
¿ 4
8(13/157)
10(46/461)
13(34/265)
1 . 0 0
1.23 (0.62-2.47) 
1.63 (0.80-3.38)
Not in the model
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Malaria: Yes 
No
29(10/36)
10(83/847)
3.54 (1.65-7.60)
1 . 0 0
2.74 (1.08-6.98)
ARI: Yes 
No
11 (40/353) 
10(53/530)
1.15(0.73-1.81)
1 . 0 0
Not in the model
Diarrhoea: Yes 
No
11 (12/107) 
10(81/776)
1.08 (0.54-2.14) 
1 . 0 0
Not in the model
Hospitalised: Yes 
No
16(8/51)
10(85/832)
1.64(0.69-3.76)
1 . 0 0
Not in the model
Socio-economic and 
environmental factors
Exclusive breast-feeding during 
the first 6  months: Yes 
No
12(22/188) 
1 1 (58/534)
1.09(0.65-1.83)
1 . 0 0
Not in the model
Birth in rainy season: Yes 
No
7 (26/364) 
13 (67/519)
1 . 0 0
1.93(1.17-3.19) 1.88(1.10-3.21)
Time spend in Thailand (mother): 
< 1 0  years 
i  1 0  years
13 (77/603) 
5 (10/201)
2.80(1.42-5.52)
1 . 0 0
2.32 (1.12-4.83)
Mother’s education: Low/Aver.
High
12(68/575) 
9 (20/230)
1.41 (0.81-2.46) 
1 . 0 0
Not in the model
Father’s education: Low
Average/high
16(35/213) 
9 (50/568)
2.04(1.28-3.24)
1 . 0 0
1.95(1.18-3.21)
Economic level: Low
Average
High
12(27/233) 
11 (46/436) 
10(6/58)
1.14(0.43-3.54) 
1.02 (0.41-3.07) 
1 . 0 0
Not in the model
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Table 7.11. Risk factors and PAF for anaemia at 6 months of age.
Exposure factors Adjusted OR 
(95%CI)
Prevalence of 
exposure factors 
among anaemic 
infants: % (n)
PAF
(95%CI)
LBW 2.09(1.16-3.77) 23% (19/82) 12% (3-17)
Infant malaria in the 
previous 6  months o f life 2.74(1.08-6.98) 11% (10/93) 7% (1-9)
Bom in winter, dry or post- 
rainy season 1.88(1.10-3.21) 72% (67/93) 34% (7-50)
<10 years in Thailand 2.32(1.12-4.83) 89% (77/87) 50% (9-70)
Low father’s education 1.95(1.18-3.21) 41% (35/85) 2 0 % (6-28)
7.4.3.4. Risk factors for anaemia at one year of age
Nineteen per cent (153/796) o f the children for whom the HCT level was known 
were anaemic at one year of age. Table 7.12 summarizes the results of the univariate 
analysis performed in order to identify the risk factors for anaemia at 1 year. Maternal 
anaemia at delivery was associated with infant anaemia. The risk of being anaemic at 
one year tended to increase with the number of morbid events during infancy: 1 2 % in 
children who were not ill, or had only one episode; 2 0 % in children with 2 - 1 2  episodes 
(i.e. less than once a month); 25% in those who had on average more than one episode 
per month (x2 for trend=3.80; p=0.05). Children bom to primigravidae, LBW, male 
gender, recent arrival in Thailand, low parental education were also identified in 
univariate analysis.
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Table 7.12: Risk factors for anaemia at 1 year of age (univariate analysis).
Prevalence of 
anaemia: % (n)
OR (95%CI)
Maternal and newborn characteristics
Gravidity: Primigravidae 
Multigravidae
27 (51/187) 
17(102/609)
1.86 (1.27-2.74)
1 . 0 0
Ethnic group: Karen
Black Karen
20 (143/705) 
11 (10/91)
2.06 (1.01-4.34)
1 . 0 0
Infant sex: Male
Female
24 (95/404) 
15(58/392)
1.77 (1.23-2.54)
1 . 0 0
LBW: Yes 
No
34 (34/100) 
16(100/618)
2.67 (1.68-4.25)
1 . 0 0
Premature infant: Yes 
No
27 (18/66) 
19(117/631)
1.65 (0.93-2.94) 
1 . 0 0
Maternal morbidity during pregnancy
Malaria: Yes 
No
19(50/270)
20(103/526)
0.93 (0.64-1.36) 
1 . 0 0
Anaemia at any time: Yes 
No
20(125/617)
16(26/165)
1.36 (0.86-2.16) 
1 . 0 0
Anaemia at delivery: Yes 
No
25 (47/188) 
17(99/582)
1.63(1.10-2.41)
1 . 0 0
Lengh of anaemia during pregnancy 
None 
< 6  weeks 
i  6  weeks
17(28/170) 
16(43/271) 
24 (80/341)
1 . 0 0
0.96 (0.55-1.66) 
1.55 (0.94-2.58)*
ARI during pregnancy: Yes 
No
15(39/257) 
21 (114/539)
0.67 (0.45-0.99)* 
1 . 0 0
UTI during pregnancy: Yes 
No
11 (6/55) 
20(147/741)
0.50 (0.21-1.18) 
1 . 0 0
Infant morbidity since birth:
Number of morbid events: 0-1 
2 - 6  
7-12 
2: 13
12(11/89) 
20 (75/374) 
19(52/272) 
25(15/61)
1 . 0 0
1.78 (0.87-3.73) 
1.68 (0.80-3.60) 
2.31 (0.91-5.95)*
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Nu of malaria attacks: none 
1 - 2
S 3
19(135/725) 
23 (14/61)
40 (4/10)
1 . 0 0
1.30 (0.66-2.52) 
1.75 (0.39-6.17)
Nu of ARI: none 
1
2 - 6
S 7
2 2  (6 6 /2 0 2 ) 
15 (29/199) 
20 (54/272) 
17(4/23)
1 . 0 0
0.61 (0.37-1.01)* 
0.89 (0.58-1.35) 
0.75 (0.18-2.38)
Nu of diarrhoeal episodes: 0-1 
2-3 
S 4
18(99/551) 
20 (38/186) 
27(16/59)
1 . 0 0
1.17(0.76-1.81) 
1.70 (0.88-3.26)
Nu of hospitalisations: none 
1
2-3
19(134/723)
24(16/66)
43 (3/7)
1 . 0 0
1.41 (0.74-2.63) 
3.30 (0.48-19.69)
Socio-economic and environmental factors
Exclusive breast-feeding during the first 6  
months: Yes 
No
21 (31/151) 
19(87/453)
1.09 (0.69-1.72) 
1 . 0 0
Birth in rainy season: Yes 
No
19(60/317)
19(93/479)
0.97 (0.68-1.39) 
1 . 0 0
Recent arrival (< 2 years): Yes 
No
39(17/44)
18(130/720)
2.86 (1.44-5.63)
1 . 0 0
Mother’s education: Low
Average
High
23 (75/333) 
19(40/209) 
15 (34/225)
1.63 (1.02-2.62)
1.33(0.78-2.26)
1 . 0 0
Father’s education: Low
Average/high
24 (50/205) 
18(94/537)
1.52(1.03-2.24)
1 . 0 0
Economic level: Low/Average 
High
21(135/650) 
12(6/52)
2.01 (0.83-5.88) 
1 . 0 0
Bold: p<0.05
*: pS 0.05 and <0.10
In multivariate analysis, LBW remained an independent risk factor for infant 
anaemia, together with ethnic group, gender, being first bom and recent arrival (Table 
7.13). Maternal anaemia at delivery and infant morbidity had no independent effect on 
infant anaemia.
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Table 7.13. Risk factors and PAF for anaemia at one year of age.
Exposure factors Adjusted OR 
(95%CI)
Prevalence of 
exposure factors 
among anaemic 
infants: % (n)
PAF
(95%CI)
LBW 3.19(1.91-5.36) 25% (34/134) 17% (12-21)
Primigravidae 1.97(1.26-3.08) 33% (51/153) 16% (7-22)
Karen 2.39(1.55-3.69) 94% (143/153) 54% (6-76)
Male infant 2.39(1.55-3.69) 62% (95/153) 36% (22-45)
Recent (<2 years) arrival 3.73 (1.85-7.53) 12% (17/147) 8 % (5-10)
7.4.3.5. Anaemia in LBW  infants
From 3 months onwards LBW was an important risk factor for infant anaemia. 
HCT profiles of LBW (diamond markers) and NBW infants (no markers) are 
represented in fig 7.5. HCT levels were comparable at 1-2 months o f age. Physiological 
anaemia at 3 months o f  age dipped more in LBW infants than in NBW, and from 5 
months onwards, HCT decreased more markedly in the former than the latter.
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fig 7.5: haematocrit levels during infancy in LBW and NBW children
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7.5. Summary of the results contained in this chapter
Morbidity during pregnancy influenced infant morbidity, but a number of SES 
and environmental factors were also important. Falciparum malaria during the first 
trimester of pregnancy was associated with an increased risk of acquiring malaria during 
infancy. Apart from this direct effect, malaria during pregnancy influenced infant 
morbidity through LBW which was associated with an increased overall morbidity and 
diarrhoeal episodes during infancy (Fig 7.6).
Figure 7.6: Effects of malaria during pregnancy on infant morbidity.
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The effects of malaria during pregnancy on infant anaemia were all mediated 
through LBW which was responsible for 12-20% of anaemia throughout infancy. 
Falciparum malaria in early pregnancy was also indirectly associated with anaemia at 6 
months of age, through an increased risk of infant malaria that was responsible for 7% 
of anaemia at that age (fig 7.7).
Figure 7.7.: Effects of malaria during pregnancy on infant anaemia
Infant anaemia
Malaria during 
pregnancy At 3 months of age
At 6 months of age
At 12 months of age
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8.1 Description
Attendance for monthly visits was described in paragraph 7.4.1. Mean WAZ 
and HAZ scores were constantly under the mean of the NCHS/WHO reference 
population. Weight increased rapidly during the first 3 months o f  life and, as a result the 
infants nearly catch-up with the reference population. But then weight increase 
flattened, which is a common feature of infant growth pattern. There was less tendency 
to catch-up for height than for weight in the first 3 months. HAZ remained lower than 
that of the reference population and regularly decreased (fig 8.1; WAZ solid line; HAZ 
dotted line). Mean WHZ remained close to that of reference population: -0.7 in boys 
and -0.6 in girls at 1 year of age.
Acute malnutrition was not a common problem in this population and the 
prevalence of wasted (WHZ<-2 SD) children remained under 5% (range: 0.5-5.3%) 
throughout infancy. Age-specific prevalence rates o f stunted and underweight infants 
followed the same profile. Prevalences of stunted and underweight infants were 
comparable at birth and at one year of age. Nevertheless, as a result of faster increase in 
weight than height during the first 3 months of life, there were only 2% (24/995) of 
infants with (WAZ<-2 SD) at 3 months of age, whereas 12% (119/992) were stunted 
(fig 8.2).
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Fig 8.1: Mean (SEM) WAZ and HAZ during infancy
♦ WAZ (solid line)
■ HAZ (dotted line)
163
Chapter 8: Infant growth
Fig 8.2: Prevalence of malnourished infants
■  stunted □  underweight IDD wasted
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8.2. Risk factors for infant malnutrition
8.2.1. Risk factors for impaired growth at 6 months of age.
Only 3 (0.3%) of the 939 infants who were weighed and measured at 6 months 
of age were wasted. Numbers were too small to be able to identify risk factors for 
wasting.
Seven per cent (63/942) of the 6-months old infants were underweight. LBW 
and prematurity were strongly associated with being underweight in univariate analysis. 
Black Karen children were also more likely to be underweight than Karen infants. 
Hospitalisation during the first 6 months o f life was more common in underweight 
infants than in those who had an appropriate weight for age, but this was not significant. 
Exclusive breast feeding protected children from being underweight, when compared to 
feeding combining breast milk with complementary food (usually rice), but again this 
was not significant. In multivariate analysis, LBW and premature birth were the only 
independent risk factors associated with being underweight at the age of 6 months 
(Table 8.1). The PAF of being underweight due to LBW was 36% (95%CI: 21-43), and 
that of premature birth was 29% (95%CI: 15-35).
Table 8.1: Risk factors of being underweight at 6 months of age.
Prevalence of 
underweight 
infants: %(n)
OR (95%CI) Adjusted OR 
(95%CI)
Maternal and newborn 
characteristics
Mother primigravidae 
Multigravidae
6 (14/233)
7 (49/709)
0.86 (0.47-1.59) 
1.00
Not in the model
Ethnic group: Karen
Black Karen
6(51/845)
12(12/97)
1.00
2.20 (1.13-4.28) NS
Infant sex: Male 
Female
7 (34/489) 
6 (29/453)
1.09(0.65-1.82)
1.00
Not in the model
LBW: Yes 
No
25 (29/118) 
4 (30/726)
7.56 (4.34-13.18)
1.00
3.77 (1.77-8.07)
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Premature infant: Yes 24 (21/86) 7.26 (3.95-13.36) 3.61 (1.62-8.07)
No 4(31/728) 1.00
Maternal morbidity during
pregnancy
Malaria: Yes 6 (21/344) 0.86 (0.50-1.48) Not in the model
No 7 (42/598) 1.00
Anaemia at any time: Yes 7(49/741) 1.25 (0.62-2.52) Not in the model
No 5 (10/187) 1.00
Anaemia at delivery: Yes 8 (18/215) 1.46 (0.82-2.60) Not in the model
No 6 (41/696) 1.00
ARI: Yes 5 (14/275) 0.68 (0.37-1.25) Not in the model
No 7 (49/667) 1.00
UTI: Yes 8 (5/60) 1.29(0.50-3.35) Not in the model
No 7 (58/882) 1.00
Infant morbidity during the
first six months of life
Number of morbid events: none 6(7/122) 1.00 Not in the model
1 to 3 6 (34/533) 1.12(0.47-3.07)
£ 4 8 (22/287) 1.36 (0.54-3.89)
Malaria: Yes 4 (2/49) 0.58(0.07-2.31) Not in the model
No 7 (61/893) 1.00
ARI: Yes 8 (32/394) 1.47 (0.86-2.53) Not in the model
No 6(31/548) 1.00
Diarrhoea: Yes 7 (23/309) 1.18(0.67-2.06) Not in the model
No 6 (40/633) 1.00
Hospitalised: Yes 13(8/60) 2.31 (0.96-5.36)* NS
No 6 (55/882) 1.00
Socio-economic and
environmental factors
Camp: Shoklo 7 (24/333) 1.00 Not in the model
Bonoklo 14(9/65) 2.07 (0.84-4.98)
Maesalit 7(5/71) 0.98 (0.28-2.74)
Klaymuta 14(2/14) 2.15 (0.22-10.50)
Maela 5 (23/459) 0.68 (0.36-1.27)
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Year of birth: 1993
1994
1995
1996
8 (7/89) 
9(21/248) 
7 (20/304) 
5(15/301)
1.00
1.08 (0.42-2.92) 
0.82 (0.32-2.23) 
0.61 (0.23-1.73)
Not in the model
Exclusive breast-feeding during 
the first 6 months: Yes 
No
4 (8/207)
8 (44/587)
0.50 (0.23-1.07)* 
1.00
NS
Birth in rainy season: Yes 
No
5(19/380) 
8 (44/562)
0.62 (0.34-1.11) 
1.00
Not in the model
Time spend in Thailand (mother): 
< 10 years 
2 10 years
7 (44/645) 
5(11/206)
1.56 (0.76-3.27) 
1.00
Not in the model
Mother’s education: Low
Average
High
8 (29/372) 
6(15/234) 
4(11/248)
1.82 (0.85-3.96) 
1.48 (0.62-3.52) 
1.00
Not in the model
Father’s education: Low
Average
High
8(19/231)
6(14/240)
5(19/360)
1.61 (0.79-3.26) 
1.11 (0.52-2.38) 
1.00
Not in the model
Economic level: Low
Average
High
8(21/249) 
5 (25/482) 
8(4/51)
1.08 (0.34-4.53) 
0.64(0.21-2.65) 
1.00
Not in the model
Bold: p<0.05 
*: p£ 0.05 and <0.10
The prevalence of stunted 6-months old infants was 21% (196/940). LBW and 
prematurity were again identified as risk factors, but stunting was also associated with 
low parental education, and was more common in children bom in 1996 (i.e. after 
relocation of the refugees and sudden changes in their food ration). Morbidity during 
pregnancy or during the first 6 months o f  life was not associated with stunting, nor was 
the type o f  infant food. In multivariate analysis LBW, prematurity and birth in 1996, 
were independent risk factors for stunting (Table 8.2), but 31% (95%CI: 15-38) of 
stunting was due to being bom in 1996, whereas LBW accounted for 28% (95%CI: 24- 
30), and premature birth for 12% (95%C1: 4-16) of stunted infants.
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Table 8.2: Risk factors for stunting at 6 months of age
Prevalence of 
stunted 
infants: % (n)
OR (95%CI) Adjusted OR 
(95%CI)
Maternal and newborn 
characteristics
Mother primigravidae 
Multigravidae
23 (54/234) 
20(142/706)
1.19(0.84-1.70)
1.00
Not in the model
Ethnic group: Karen
Black Karen
21 (175/843)
22 (21/97)
0.95 (0.55-1.63) 
1.00
Not in the model
Infant sex: Male 
Female
23 (110/486) 
19(86/454)
1.25 (0.91-1.72) Not in the model
LBW: Yes 
No
51 (60/117) 
16(117/725)
5.47 (3.62-8.27)
1.00
5.52 (3.30-9.24)
Premature infant: Yes 
No
42 (36/85) 
19(137/726)
3.16(1.98-5.05)
1.00
2.34 (1.25-4.40)
Maternal morbidity during 
pregnancy
Malaria: Yes 
No
22 (75/344) 
20(121/596)
1.10(0.79-1.51)
1.00
Not in the model
Anaemia at any time: Yes 
No
20(150/738) 
22 (41/188)
0.92 (0.62-1.35) 
1.00
Not in the model
Anaemia at delivery: Yes 
No
19(41/214) 
21 (149/695)
0.87 (0.59-1.28) 
1.00
Not in the model
ARI: Yes 
No
21 (57/274) 
21 (139/666)
1.00 (0.70-1.41)
1.00
Not in the model
UTI: Yes 
No
25 (15/60)
21 (181/880)
1.29 (0.70-2.36) 
1.00
Not in the model
Infant morbidity during the 
first six months of life
Number of morbid events: none 
1 to 3 
2 4
21 (25/122) 
20(104/531) 
23 (67/287)
1.00
0.95 (0.57-1.59) 
1.18(0.68-2.05)
Not in the model
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Malaria: Yes 
No
16(8/49)
21 (188/891)
0.73 (0.31-1.65) 
1.00
Not in the model
ARI: Yes 
No
23 (90/393) 
19(106/547)
1.24 (0.89-1.72) 
1.00
Not in the model
Diarrhoea: Yes 
No
20(128/631) 
20 (68/332)
0.99(0.70-1.39)
1.00
Not in the model
Hospitalised: Yes 
No
30(18/60)
20(178/88)
1.69 (0.91-3.11) 
1.00
Not in the model
Socio-economic and 
environmental factors
Birth in rainy season: Yes 
No
22 (46/207) 
22(130/586)
1.00 (0.69-1.47)
1.00
Not in the model
Camp: Shoklo 
Bonoklo 
Maesalit 
Klaymuta 
Maela
19(64/331)
12(8/65)
13(9/71)
13(2/15)
25(113/458)
1.00
0.59 (0.24-1.35) 
0.61 (0.27-1.34) 
0.64 (0.07-2.95) 
1.37 (0.95-1.96)*
NS
Year of birth: 1993
1994
1995
1996
15(13/89) 
17(42/248) 
19(56/302) 
28 (85/301)
1.00
1.19(0.58-2.48) 
1.33 (0.66-2.71) 
2.30(1.17-4.60) 3.61 (1.55-8.43)
Exclusive breast-feeding during 
the first 6 months: Yes 
No
21(79/379) 
21(117/561)
1.00 (0.72-1.39)
1.00
Not in the model
Time spend in Thailand (mother): 
< 10 years 
2 10 years
22(142/644) 
20 (40/205)
1.17(0.77-1.76)
1.00
Not in the model
Mother’s education: Low
Average
High
26(95/371) 
19(45/233) 
17(42/238)
1.69(1.10-2.59)
1.17(0.72-1.92)
1.00
NS
Father’s education: Low
Average
High
26(59/231) 
21(50/239) 
18(66/359)
1.52(1.00-2.31)
1.17(0.76-1.81) 
1.00
NS
Economic level: Low
Average
High
25(62/249) 
19(92/480) 
22(11/51)
1.21 (0.56-2.67) 
0.86 (0.41-1.86) 
1.00
Not in the model
Bold: p<0.05 
*: p£ 0.05 and <0.10
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8.2.2. Risk factors for impaired growth at one year of age.
At one year of age, only 44% (368/834) of the infants had reached an 
appropriate weight and height, and had a WHZ score above -2SD. Five per cent (44) of 
the infants were wasted (including 12 who were also stunted), 28% (231) were 
underweight and stunted, 13% (108) stunted but not underweight, and 10% (83) 
underweight but not stunted.
Black Karen infants were more likely to be wasted at 1 year of age than Karen 
children: 11% (10/93) vs 5% (34/741) (OR: 2.51; 95%CI: 1.19-5.26). Ten per cent 
(7/70) o f the premature infants were wasted compared to 4% (29/665) o f the children 
bom at term (OR: 2.44; 95%CI: 1.03-5.79). Wasting was also associated with infant 
morbidity (OR: 1.07; 95%CI: 1.00-1.14 per morbid event). These 3 risk factors, Black 
Karen (Adjusted OR: 2.87; 1.29-6.41), premature birth (Adjusted OR: 2.77; 95%CI: 
1.14-6.70) and number of morbid episodes (Adjusted OR: 1.07; 95%CI: 1.00-1.15), 
remained associated with wasting in the multivariate model. The prevalence of 
premature births among wasted infants was 19% (7/36), giving a PAF of wasting due to 
premature birth: 12% (95%CI: 2-17).
Univariate analysis was performed in order to identify which of the exposure 
factors already tested for anaemia (see chapter 7.4.2.4) were associated with 
underweight and/or stunting at one year of age. The results are summarised in tables 8.3 
and 8.4. In multivariate analysis, LBW and low father’s education remained associated 
with both underweight and stunting. Male infants and children bom in 1995 and 1996 
were also at risk o f being stunted at 1 year. Twenty-three per cent of underweight 
(72/320) and/or stunted (72/318) infants were bom with LBW. The PAF of underweight 
due to LBW was 14% (95%CI: 8-17), and PAF of stunting due to LBW was: 16% 
(95%CI: 12-19).
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Table 8.3: Risk factors of being underweight at 1 year of age.
Prevalence of 
underweight 
infants % (n)
OR (95%CI) Adjusted OR 
(95%CI)
Severe maternal anaemia 
(HCT<25%) at delivery: Yes 
No
67(14/21)
42 (334/793)
2.75 (1.10-6.88)
1.00
NS
Birth order: First
Second
Third or above
35 (71/203) 
39 (62/160) 
47 (224/478)
1.00
1.18 (0.75-1.85) 
1.64(1.15-2.34) NS
LBW: Yes 
No
66(72/110) 
38 (248/649)
3.06 (2.01-4.68)
1.00
2.57(1.51-4.38)
Premature: Yes 
No
61 (43/70)
40 (270/670)
2.36 (1.42-3.91)
1.00
NS
Sex: Male 
Female
47(199/427)
38(158/414)
1.41 (1.07-1.86)
1.00
NS
Nu o f diarrhoeal episodes: 0-1 
>2
40 (230/581) 
49(127/260)
1.00
1.46 (1.07-1.98) NS
Exclusive breast-feeding during 
the first 6 months: Yes 
No
36 (58/160) 
45 (218/490)
0.71 (0.49-1.03)* 
1.00
NS
Father’s education: Low
Average/High
50(110/220) 
39 (219/563)
1.57 (1.13-2.18)
1.00
1.80 (1.14-2.83)
Mother’s education: Low
Average
High
48(170/357) 
43 (94/221) 
33 (77/231)
1.82 (1.27-2.60)
1.48 (0.99-2.21)* 
1.00
NS
Bold: p<0.05 
*: 0.05 and <0.10
171
Chapter 8: Infant growth
Table 8.4: Risk factors of being stunted at 1 year of age.
Prevalence of 
stunted 
infants % (n)
OR (95%CI) Adjusted OR 
(95%CI)
LBW: Yes 66 (72/200) 3.15 (2.10-4.94) 3.54 (2.21-5.67)
No 38 (246/644) 1.00
Premature: Yes 59 (42/71) 2.13(1.26-3.61) NS
No 41 (269/665) 1.00
Sex: Male 52(112/217) 1.72(1.24-2.38) 1.63(1.17-2.26)
Female 38 (215/561) 1.00
Mother’s gravidity: Primigravidae 36 (72/200) 1.00
Multigravidae 44 (279/635) 1.39 (0.99-1.50) NS
Father’s education: Low 47 (200/427) 1.50 (1.13-2.00) 1.70 (1.15-2.53)
Average/High 37(151/408) 1.00
Bom in: 1993 35 (24/68) 1.00
1994 36(62/174) 1.01 (0.54-1.90) NS
1995 44(135/304) 1.46(0.82-2.62) 1.97 (1.02-3.82)
1996 45(130/285) 1.50 (0.84-2.69) 2.12 (1.10-4.09)
8.2.3. Growth of LBW infants
Fig 8.3 and 8.4. represent the growth curves of LBW compared to that of NBW infants. 
LBW infants never catch up weight nor height during infancy.
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fig 8.3: Weight growth curves of NBW and L B W  infants
age (months)
—• —LBW —»-NBW
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Fig 8.4: Height growth curves o f NBW an d  LBW infants
— hLBW ----- h NBW
8.3. Summary of the results contained in this chapter
Malaria during pregnancy had an indirect effect on infant growth through LBW 
that was responsible for 14% to 36% o f impaired growth during infancy (underweight 
and/or stunted). Premature birth was more responsible for being underweight (29%) 
than stunting (12%) at 6 months of age, and was not independently associated any more 
with impaired growth at one year of age. Nevertheless, prematurity was responsible for 
12% of wasting at one year of age.
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9.1. Study population
The epidemiological study described in this thesis encountered some problems 
in its realisation. The first was the important population movements that occurred in the 
middle o f the study and that led to a much higher proportion o f infants lost to follow-up 
than expected. Nevertheless, the reasons for leaving the cohort were not associated with 
the exposure factors that were tested or with the outcomes. Withdrawal from the study 
was mainly due to security reasons and occurred in periods o f crisis. In each period, 
infants from all ages were lost. Maternal characteristics identified as risk factors of 
being lost during infancy were: recent arrival in Thailand and registration for ANC late 
in pregnancy. Refugees who had just arrived in Thailand, were probably more inclined 
to leave and go back to Burma when problems occurred in the camps. Late attendance 
to ANC was probably also a marker of unstable population. Women who attend ANC at 
the end of their pregnancy are often working outside and moving readily. These groups 
of refugees who are not living permanently and for long time in the camps may also 
differ in their risk of developing malaria. But this was not evident in the cohort.
Although a quarter o f the infants admitted in the cohort, were affected by the 
population movements, outcomes were reliably collected. Karen midwives and home- 
visitors were living within the community. They were therefore displaced at the same 
time and were able to locate the children easily. Thus they reported immediately on 
children’s departure to Burma. When the populations from 3 camps were displaced to 
Maela, the Karen home-visitors from these sites were able to call the children to the 
SMRU’s clinic in Maela, as soon as they arrived. They were given a new code and 
follow-up was pursued. Thus overall, the proportion of infants lost to follow-up was 
high (25%) but the quality o f the follow-up was good. This is demonstrated by the high 
proportion (80%) of children that was seen each month at the clinics and the reality of 
longitudinal follow-up (95% of them seen at least twice between 1 and 12 months of 
age and a median number o f 8 visits in the year).
The second major issue was the dramatic decrease o f the two main outcomes, 
infant mortality and malaria during infancy that occurred during the data collection. 
There is no doubt that this fact may have reduced the power o f  the study. An attempt 
was done to recalculate the sample size needed for infant mortality and a sufficient
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number of newborns was recruited. There was no solution for the reduction in malaria 
incidence during infancy. At the end of the study, only Maela camp was stable but 
malaria incidence there was extremely low. The situation would not have been modified 
if  more children had been recruited there. Thus it was not possible to study in detail the 
relationships between malaria during pregnancy and malaria in infancy, in particular 
numbers became too small when infant malaria incidence rates were calculated by age 
and by Plasmodium species.
In order to have reliable information on morbidity during pregnancy, only 
children bom to mothers who attended ANC were recruited. This may have introduced a 
selection bias, as the women who were not coming to the clinics may well be a different 
group. Nevertheless, 90% of the pregnant women in the camps attend ANC and this 
proportion remained fairly constant over the years. The inconvenience o f missing 10% 
o f the pregnant women was greatly compensated by the quality of information collected 
on women who were followed prospectively during pregnancy, half o f  them from the 
first trimester of gestation. Moreover in this area, all patients with P.falciparum malaria 
and most with P.vivax malaria develop symptoms (Luxemburger et al., 1996). Thus a 
history of slide-confirmed malaria episode is a good proxy for malaria infection. This 
might differ in pregnant women who sequester the parasites in the placenta and may 
have some undetectable malaria infections. But the extent of the phenomenon in this 
population is unknown. Malaria during pregnancy was detected by recall of slide- 
confirmed episodes until registration for ANC and presence of asexual parasites in 
peripheral blood throughout the follow-up. Thus this study was the first reported cohort 
o f mothers and infants for whom malaria history was known from conception to the first 
year of life.
Pregnant women in this study were a sub-group of 11,000 pregnancies followed 
in all camps in the area. They were remarkably similar in age, gravidity, malaria and 
anaemia history to the entire population. Malaria and anaemia during pregnancy had the 
same consequences on the newborn in both this cohort and the larger database (Nosten 
et al., 1991; Nosten et al., in press). Thus the infants in the cohort could be considered 
as a good representative sub-group of the children bom to all pregnant women in the 
area.
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9.2. Consequences of maternal malaria and anaemia on the newborn infant.
The proportion o f LBW (16%) in the cohort was comparable to that of 
neighbouring Thai and Burmese populations (de Onis et al., 1998). Nearly all (91%) of 
the children weighing less than 2000 g were premature, whereas the majority (68%) of 
those weighing between 2000 and 2499g were bom at term and therefore growth- 
retarded. Some premature babies were probably also growth-retarded but this was more 
difficult to assess. Overall, around 10% o f the newborns were premature (including 
some weighing more than 2500 g) and 8% were term-LBW. This situation was in 
accordance with the general assumption that the excess o f LBW in developing countries 
is mainly due to IUGR, whereas the proportion of premature births is fairly stable 
worldwide (Villar & Beiizan, 1982). Thus in developing countries the aim of prenatal 
care is to reduce the excess of moderate LBW (2000-2499g) due to infections and/or 
nutritional deficiencies during pregnancy.
Malaria during pregnancy was associated with LBW. Numerous studies have 
already shown this association. Most were conducted in areas of high malaria 
transmission (reviewed by Brabin, 1991; Menendez, 1995). But the association had also 
been demonstrated at the study site, an area o f low malaria transmission (Nosten et al., 
1991), and with vivax malaria as well as P.falciparum infection (Nosten et al., in press). 
In this cohort, information on SES was collected and did not modify the results. Malaria 
during pregnancy was an independent determinant of LBW and accounted for 23% of 
them. Adjustment for SES had not been done in previous published reports, and this 
was mentioned as a possible confounding factor in the association between malaria 
during pregnancy and LBW (Kramer, 1987). In this study, both malaria species were 
determinant o f LBW, after adjusting for SES and environmental factors. All 
anthropometric markers were reduced in children bom to malaria-infected mothers, 
suggesting that the infants suffered from chronic and symétrie growth retardation 
(Meuris et al., 1993).
Malaria during pregnancy did not reduce the duration o f  gestation, unless a 
symptomatic or severe episode occurred during the last trimester o f  pregnancy. These 
findings were similar to that of the few studies in which gestational age was assessed. 
Most reported that malaria during pregnancy was mainly related to IUGR (Reinhardt et
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al., 1978b; Watkinson et al., 1983; Dolan et al., 1993; Meuris et al., 1993; Nosten et al., 
1994a; Nosten et al., in press). Taha et al.( 1993a) and D’Allessandro et al (1996) 
reported an association between malaria and premature delivery, but both were probably 
describing the effects of symptomatic malaria. Symptomatic and severe malaria has 
been known for long time to be associated with high rate of prematurity 
(Wickramasuriya, 1937; Le Van Hung, 1951; Endeshaw, 1991; Nair & Nair, 1993). In 
this study, symptomatic malaria from both species, led to premature deliveries, but to a 
similar extent to other febrile infections (ARI and UTI). This event (i.e. malaria close to 
term) was rare, and only an estimated 5% of the premature birth could be attributable to 
symptomatic malaria.
Maternal anaemia during pregnancy was associated with LBW in univariate 
analysis, and the risk was more important when maternal anaemia was severe. But 
maternal anaemia had no independent effect on birthweight in multivariate analysis. In a 
malaria-endemic area of Papua New Guinea, Brabin & Piper (1997) demonstrated that 
malaria was a more important risk factor than anaemia for LBW. Moreover, in their 
study, only severe anaemia had an independent effect on LBW. In the current work, 
maternal anaemia was relatively moderate. Only 17% of the women developed severe 
anaemia, and most o f them (91%; 226/247) had an HCT between 20 and 25%. Thus the 
lack of association between maternal anaemia and LBW in this study, was possibly due 
to the moderate level of anaemia.
In summary, malaria during pregnancy was responsible for a substantial number 
of growth-retarded newborn and for a small proportion o f premature births. Maternal 
anaemia had no independent effect on the newborn.
179
Chapter 9: Discussion
9.3. Infant mortality
Infant mortality remained higher than in surveys conducted in Thailand 
(Lumbiganon et al., 1990) and Vietnam (Swenson et al., 1995), but was similar to Java, 
Indonesia (Handayani et al., 1983) and lower than Bangladesh (Chen et al., 1980; Islam 
et al., 1982; Bhatia et al., 1989). But the more important fact was that IMR was halved 
since the last studies conducted in this population (Dolan et al., 1993; Nosten et al., 
1994a). This was mainly due to a decrease of post-neonatal mortality and an important 
factor was the reduction of deaths due to thiamin deficiency (from 38 to 7%). Apart 
from this local specificity o f deaths from thiamin deficiency, the causes were very 
similar to that o f  most developing countries. The majority of deaths were due to 
infectious diseases and “prematurity” (Murray & Lopez, 1997). ARI and diarrhoea were 
the leading causes of infant deaths from infectious diseases, as in most studies 
summarized in table 2.2. Malaria was responsible for only 2% of the infant deaths, 
reflecting the low transmission in this area. Tetanus was rare and severe measles absent 
in this well-vaccinated cohort.
Premature birth was the strongest risk factor for neonatal death. LBW and 
maternal infection within the week preceding delivery were the others main risk factors 
that could be identified. The latter remained an important risk factor for deaths in the 
first 3 months o f  life. There were no risk factors identified for infant deaths that 
occurred after three months o f age, but numbers were small.
Thus malaria itself (i.e. except symptomatic attack close to term) during 
pregnancy was not directly associated with neonatal deaths. This was similar to 
previous studies in which malaria during pregnancy did not increase the risk for 
neonatal deaths (Bruce-Chwatt, 1952; Cannon, 1958; Spitz, 1959; Jilly, 1969; 
McGregor et al., 1983; Taha & Gray, 1993b; McDermott et al., 1996). Nevertheless, 
there was obviously an indirect effect of malaria during pregnancy on neonatal 
mortality, all mediated through LBW. Malaria during pregnancy was responsible for a 
quarter of LBW newborn, who were more likely to die during the neonatal period. But 
malaria was mainly associated with LBW due to IUGR, and this group had less risk to 
die than pre-term infants. Thus the effects of malaria during pregnancy on neonatal 
mortality are likely to be smaller than expected. This aspect should be integrated into
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the estimation of the impact of prevention against malaria during pregnancy on neonatal 
survival (i.e. sample sizes of further studies should be increased if the outcome is the 
survival o f neonates).
Maternal infections close to term had an additional effect on neonatal deaths, as 
well as inducing premature birth. This was possibly the effect of a septic environment at 
birth. Premature delivery is a well-known consequence of symptomatic and/or severe 
malaria during pregnancy in areas low malaria endemicity or during epidemics 
(Wickramasuriya, 1937; Le Van Hung, 1951; Endeshaw, 1991; Nair & Nair, 1993; 
Luxemburger et al., 1997). The risk of premature delivery and/or neonatal deaths was 
similar for ARI or UTI, reflecting an effect of fever rather than malaria per se. 
Nevertheless, as malaria is a major cause o f  morbidity in this area, the infant deaths 
occurring after symptomatic maternal malaria could be prevented by a reduction of this 
disease during pregnancy.
When adjusted for covariates maternal anaemia was not independently 
associated with neonatal nor post-neonatal deaths. This result was in contradiction with 
other studies. Maternal anaemia in malarious areas has been shown to be related with 
perinatal deaths in several studies (Tasker, 1958; Llewellyn-Jones, 1965; Macgregor, 
1963; Brabin et al., 1990a). But women in these studies were severely anaemic whereas 
most pregnant women in this cohort were moderately anaemic (only 3%  had an 
HCT<25% at delivery; median: 22%; range: 19 to 24.5%) and all anaemic women were 
receiving iron and folic acid treatments. The association between maternal anaemia and 
infant death that was also reported in the previous studies conducted in this area (Dolan 
et al., 1993; Nosten et al., 1994a) and the current work did not confirm this findings. 
Various hypotheses can be proposed. The number of post-neonatal deaths was very 
small in the current cohort and thus the study may have lacked of power to detect any 
impact o f maternal morbidity on late infant mortality. The reduction in deaths between 
the 2 previous studies and the current one was mainly contained in the post-neonatal 
period and the proportion of deaths from thiamin deficiency decreased considerably. 
Thus in the previous studies, maternal anaemia may have been a marker o f  a broader 
nutritional deficiency. If anaemic mothers were also more often thiamin deficient, their 
offspring would have had more risk to die later from infantile Beri-Beri. But data on the 
relationships between thiamin deficiency and anaemia in pregnant women and in infants
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are lacking to confirm this hypothesis. Another possibility was that SES factors were 
confounders in the previous studies, but this type of data was not always collected. 
Some women were interviewed after the completion of the impregnated bed nets study 
and there was no association between SES factors and infant deaths. In conclusion, this 
study did not confirm that maternal anaemia was a risk for infant deaths, but IMR had 
been halved since the previous studies. Moreover, this association was recently found in 
an area of intense malaria transmission in Malawi (Verhoeff & Brabin, personal 
communication).
9.4. Infant morbidity
9.4.1. Overall impact of morbidity during pregnancy on morbidity in infancy.
ARI and diarrhoea were the leading causes of morbidity during the first year of 
life, whereas malaria was not frequent. Several morbid events during pregnancy (ARI, 
UTI, paresthesia, malaria in early pregnancy) were associated with an increased infant 
morbidity. Malaria during pregnancy had also an indirect effect mediated through LBW. 
Term-LBW infants were at higher risk of morbidity from all causes than NBW children, 
mainly through an increased number of diarrhoea! episodes. This findings was expected 
from the results of previous studies (Victora el al., 1990; Bukenya el al., 1991; 
Ittiravivongs et al., 1991; Barros et al., 1992; Lira el al., 1996). Surprisingly, preterm- 
LBW infants seemed to have lower morbidity than NBW children, except for dirrhoeal 
episodes. One explanation could be that only healthier premature infants survived.
Several SES factors were also associated with infant morbidity. A recent arrival 
in Thailand, a low father’s education, a low economic level, and a large family (3 
children or more) were risk factors for infant morbidity. It was slightly surprising that 
father’s education appeared as a more important factor that mother’s education (except 
for ARI) to prevent morbidity throughout pregnancy and infancy. Mother’s education is 
usually recognized as an important element in public health (Ware, 1984). In this study, 
a low mother’s education was often a risk factor for morbidity in univariate analysis, but 
did not remain in model including father’s education. This was observed by other 
authors who pointed out that the association between mother’s education and infant
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health might be confounded by other aspects of SES (Desai & Alva, 1998). Male infants 
had a higher morbidity during infancy than female. In this community, there are no 
obvious gender-related behaviours towards infant health. The birth of a girl is 
welcomed, and female children are encouraged to attend school. Adult women have 
important roles and may become community leaders. It is therefore unlikely that male 
infants would have been taken more easily to health facilities. Moreover, morbid events 
were actively reported by home-visitors.
The mechanisms through which maternal ARI or UTI could be a risk factor for 
infant ARI or diarrhoea remained unexplained. They could be related to some 
environmental factors of the household (tobacco, hygiene) that the current work was 
unable to detect. Malaria during infancy was influenced by the stage at which the first 
malaria episode occurred during pregnancy and this finding will be discussed below.
9.4.2. Malaria during infancy and its relationships with maternal malaria during 
pregnancy.
Morbidity and mortality from malaria during infancy were low, as expected in 
this hypo-endemic malaria area. As a result, malaria was only marginally associated 
with anaemia and did not influence growth. This is a very different picture from that of 
areas with high malaria transmission, where malaria is the single most important risk for 
infant anaemia (Renaudin & Lombart, 1994; Achidi et al., 1996b; Kitua et al., 1997) 
and seems to influence growth (ShifT et al., 1996; Snow et al., 1997b). This could be 
explained by the high proportion of P.vivax malaria which is only rarely associated with 
anaemia, but the more likely explanation remains that malaria incidence is too low to 
have a prolonged effect on HCT levels. Vivax malaria has been associated with 
malnutrition (Williams et al., 1997), but this was not confirmed in this study. The risk to 
develop severe falciparum malaria was higher than in areas o f high transmission and 
when severe malaria occurred, the CFR was of similar magnitude than that reported in 
areas o f high transmission (Duren, 1951; Greenberg et al., 1989). The definition of 
severe malaria in this area differs from that of high malaria endemic regions. Most of 
the severe cases presented with hyperparasitaemia without vital organ dysfunction. But, 
this clinical feature has been shown to be associated with mortality in this population
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(Luxemburger et al., 1997). This previous work also gave more reliable CFR than the 
estimation obtained in this cohort, in which numbers were small. The present work 
confirmed that falciparum malaria is rare in infants from this population, but when it 
does occur, the risk o f developing severe disease and death is high.
As noticed previously in the study area (Luxemburger et al., 1996) and in all 
places where P.vivax co-exists with P.falciparum (Khan & Talibi, 1972; Genton et al., 
1995; Maitland et al., 1996), vivax malaria developed earlier in infancy than falciparum 
malaria. The mechanisms of this phenomena remain unexplained. Infection with P.vivax 
did not influence the course of subsequent P.falciparum, in term of severity, but 
numbers were very small.
The children were protected against malaria in early infancy (<3 months) and 
were 5 times more likely to have a clinical malaria attack later in life (3-12 months). 
Protection of young infants against clinical malaria is widely recognized (Akanmori et 
al., 1989; Velema et al., 1991; Petersen et al., 1994; Binka et al., 1994; Kuate Defo, 
1995; Achidi et al., 1996a; McGuiness et al., 1998; Snow et al., 1998; Wagner et al., 
1998), but the current work is the first report in a low malaria endemic area, and 
regarding P.vivax as well as P.falciparum. Protection against malaria in the first 3 
months of life was independent from malaria history during pregnancy. Moreover, 
maternally derived antibodies were likely to vary widely, as it has been described 
previously in areas o f  low malaria transmission (Collins et al., 1987). Thus this work 
supported the hypothesis that other factors may act with maternal transmitted antibodies 
to protect against malaria in early infancy.
The stage at which malaria occurred in pregnancy influenced malaria in infancy. 
Children bom to mothers who had their first falciparum episode in early pregnancy 
were more likely to have malaria during infancy than those bom to mothers who had 
malaria later in pregnancy or no malaria. This remained true when analysis was 
restricted to women without P.vivax infection, in order to avoid potential interactions 
between P.falciparum and P.vivax. Half o f the episodes o f  falciparum malaria that 
occurred during the first trimester o f pregnancy were detected prior to the registration of 
the women in ANC (i.e. they were detected passively), whereas the majority of episodes 
occurring later in pregnancy were detected during ANC follow-up (i.e. by a
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combination of weekly active detection and passive detection if the women attended the 
clinic with fever in between two visits). This may have lead to a higher proportion of 
symptomatic episodes during the first trimester and thus higher parasite densities that 
could induce a different matemo-foetal immuno-reaction. But, among the first detected 
falciparum malaria infections, the proportions of symptomatic and/or severe malaria 
episodes were comparable in each trimester o f pregnancy.
These results could be the first clinical support to the hypothesis that early in 
utero exposure to malaria antigens leads to tolerance towards malaria during infancy 
(Rasheed, 1994). Soluble P.falciparum antigens are transferred to the foetus (Druilhe et 
al., 1976; Jakobsen et al., 1998), whereas this has not been reported, and indeed never 
studied, for P.vivax. If only P.falciparum antigens reached the foetus, this could explain 
that the timing o f  vivax malaria during pregnancy did not influence malaria in infancy. 
Surprisingly, falciparum malaria in early pregnancy was associated with a higher risk of 
malaria by either species during infancy. If the hypothesis of tolerance is retained, this 
findings imply that early in-utero exposure to falciparum malaria antigens induces a 
non-specific cross-species immuno-tolerance. Further studies are urgently needed in 
order to support or refute this hypothesis, because it could modify the policy of 
interventions against malaria during pregnancy. In most areas, women are reached only 
late in pregnancy, whereas if the hypothesis of tolerance against malaria when the 
exposure occurs in early pregnancy is true, prevention should start much earlier.
Another hypothesis to explain this finding is linked to behaviour and 
environmental factors. Pregnant women who had falciparum malaria in early pregnancy 
were also more likely to have a past history of malaria. They were therefore either more 
mobile, or living closer to a vector breeding site, than other pregnant women. Although 
it could not be demonstrated, it is possible that children bom to these women were also 
at higher risk o f malaria than their counterparts, because at this age they stay with their 
mothers (including going to the forest) and therefore share their behaviour and 
environment. Similarly, the excess of malaria in Karen children compared to those 
from other ethnic group was more likely to be related to the life of these infants than to 
genetic differences. Karen women regularly go to the forest, which is a risk factor for 
infection with malaria (Luxemburger et a!., 1996), and they take their infants with them,
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whereas Black Karen women and their babies are more likely to stay in the camp where 
they have shops.
9.4.3. Infant anaemia
Anaemia increased with age and reached 20% in 12 month old infants. Studying 
the HCT profiles revealed that infants from the cohort had an HCT level only slightly 
lower than that of a reference population (Saarinen et al., 1978) until 2 months of age, 
but they did not recover from physiological anaemia. From 3 months onwards, HCT 
levels regularly decreased. This phenomenon was even more marked in LBW infants. 
Anaemia in LBW infants is a  well-reported fact, but is usually related to prematurity 
(Stockman & Oski, 1978) and not well-described for full-term LBW infants. In this 
study, LBW was associated w ith anaemia throughout infancy. Infant anaemia was thus 
an indirect consequence of malaria during pregnancy. Nevertheless, as age increased, 
SES (time spent in Thailand, father’s education) and other factors (ethnic group, gender) 
became more important determinants of infant anaemia than LBW.
Contrary to the findings of Redd et al. (1994) and Comet et al. (1998) there was 
no direct relationship between malaria during pregnancy and anaemia in early infancy. 
But the authors of these studies reported an association between placental malaria and 
infant anaemia. They suggested that physical alterations of the infected placentas may 
decrease nutritional exchanges or that immunologic mechanisms were responsible for 
haemolysis. Although placental malaria is sometimes detected by histological 
examination in our study site, the parasite burden does not reach the level seen in areas 
of intense malaria transmission. This may explain why malaria during pregnancy was 
not associated with infant anaemia in this study. Nevertheless, malaria in early 
pregnancy possibly had an effect on infant anaemia through an increase in infant 
malaria.
From 6 months onwards, SES factors and infant malaria history were related to 
infant anaemia. The time spent in the camp was inversely associated with the risk of 
developing anaemia. Recent refugees were likely to have a lower income and food 
diversity, as time is needed to  find work and establish a garden, and a different approach
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towards health structure. They were usually in poorer health than families already living 
in the camps for many years. Infant malaria was related to infant anaemia at 6 months 
but was no longer related at 12 months. Malaria during infancy was not common 
enough to explain the important drop in HCT levels during late infancy. Hookworm 
infestation was also rare (4% in a survey conducted in the cohort in 1996). Thus a more 
likely explanation for these poor HCT levels was nutritional deficiency, mainly iron 
deficiency, although this could not be confirmed biologically. But, a recent nutritional 
survey conducted in the camps (BBC, 1997) concluded that the refugee’s food ration 
contained only 50% of the daily requirement in iron. Thus pregnant and lactating 
women, who need double that amount, did not have adequate iron intake. Most infants 
were fully breast-fed for the first few months and then received weaning food with poor 
iron contents (rice, banana). Most infants were probably iron-deficient. Further studies 
should be conducted in order to assess the effects o f iron supplementation in these 
infants.
Male infants were more likely to be anaemic at 1 year o f  age than female. This 
sex-difference was described in previous studies (Seijeant et al., 1980; Hassan et al., 
1997; Paracha et al., 1997) without clear explanation. Boys from the cohort had also 
more morbid episodes than girls, but it was difficult to define which one, between 
anaemia and morbidity, was the cause or the consequence o f the other.
Karen infants were more often anaemic than Black Karen. This seemed 
independent o f their higher risk of developing malaria during infancy. Again, the most 
likely explanation was nutritional. The Muslims community has a more diverse diet, for 
cultural and economic reasons. While Karen usually eat large amounts of rice with few 
vegetables and fish paste, the diet of Black Karen contains various recipes, close to that 
of South Asia. Moreover, they own the shops and are less poor.
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9.5 Infant growth
Growth of this birth cohort was constantly lower than that of the NCHS/WHO 
reference population. They even did not catch-up temporarily at 3 months of age, like in 
other population from developing countries (Cohen et al., 1995; Asefa et al., 1996; 
Kolsteren et al., 1996). By the age of one year, 42% of the infants from the cohort were 
stunted, a proportion similar to the estimation from WHO for South-East Asia (WHO, 
1992). Their attained weight and length at one year of age were in the same ranges as 
those of a neighbouring population from another ethnic group in rural Thailand 
(Gershoffe/a/., 1977).
Mother’s morbidity during pregnancy did not influence growth directly, but 
again was indirectly associated with impaired growth (underweight and/or stunting), for 
which LBW was the strongest risk factor. The growth curves of LBW Infants never 
caught up relative to those o f  their NBW peers. Most o f the surviving LBW children in 
this cohort were growth-retarded rather than premature, and small-for-gestational age 
infants remained lighter and smaller throughout infancy, compared to children bom with 
appropriate weight-for-age (Adair, 1989; Kedebe & Larson, 1994; Cohen et al., 1995). 
SES was associated with impaired growth, as it was with anaemia. Children bom in 
1995 and 1996 were more often stunted than those bom in other years. This corresponds 
to birth in the new camp, in which population movements were restricted and where the 
number of gardens and poultry was low. Refugees living in this camp could not 
supplement their food ration, as it was the case in other camps.
Infant’s morbidity was also not associated with attained weight and length at one 
year of age. This result was similar to that of a study conducted in Indonesia, in which 
morbidity did not affect growth performance (Kolsteren et al., 1997). Nevertheless, 
male infants were more often stunted at one year o f age than female and a possible 
explanation for this was that they had more morbid episodes, especially from ARI, than 
the girls. Moreover, the number of morbid events during the first year of age was 
associated with wasting. The analysis of attained growth by 6 and 12 months was 
possibly insufficient to demonstrate the relationships between morbidity and growth 
during infancy.
188
Chapter 9: Discussion
9.6. Summary and conclusions
This thesis reported the results of the first cohort of mothers and infants 
conducted from the beginning of pregnancy until the end o f  the first year of life, in 
order to assess the effects of malaria and anaemia during pregnancy on the survival, 
morbidity and growth of the infants. Malaria was an important determinant of LB W due 
to growth retardation rather than prematurity. Most of the effects of malaria during 
pregnancy on infant health were mediated through the reduction in birthweight. LBW 
infants were more likely to die during the neonatal period, and those who survived had a 
higher incidence o f morbid events during infancy, compared to infants weighing more 
them 2500g at birth. LBW children developed anaemia by three months of age and 
remained anaemic throughout infancy, although in the second half of infancy SES and 
environment seemed to become more important risk factors for anaemia than LBW. 
Similarly, LBW infants never catch-up in term of growth and remained lighter and 
shorter than NBW infants, but SES factors were important determinants of stunting at 
one year o f age.
Malaria during pregnancy had also an effect on infant survival, when an attack 
occurred close to term. Fever (due to malaria, AR1 or LTTI) in the week prior to birth 
was responsible for 10% of the premature births, and prematurity was the main risk 
factor for neonatal deaths. Fever prior to birth had an additional direct effect on infant 
deaths during the first three months o f life.
The reduction in birthweight due to malaria during pregnancy has been 
demonstrated for a long time (Brabin, 1991). It was assumed that malaria had therefore 
an indirect effect on infant mortality and that prevention o f  malaria during pregnancy 
might reduce this effect (Greenwood el al., 1989). This study clearly showed that 
malaria from both species, were important determinants o f  LBW, even after adjustment 
for SES, and had indirect effect on infant survival. Nevertheless, as growth-retarded 
infants were less likely to die than premature, and that only a small proportion of the 
latter were due to the fever associated with malaria, the overall impact of malaria on 
mortality was more limited than expected. Thus very effective large-scale interventions 
against malaria might be needed in order to reduce infant mortality.
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Contrary to previous studies (Brabin et al., 1990a; Dolan et al., 1993; Nosten et 
al., 1994a) maternal anaemia during pregnancy had no independent effect on infant 
survival. SES might have be confounders in the previous studies. Other hypotheses 
were that maternal anaemia was too moderate in the women of this cohort, or that the 
reduction of infant mortality over time might have led to a lack of power for the study to 
be able to demonstrate the association.
Infants bom to mothers who had falciparum malaria in early pregnancy were 
more likely to develop malaria from any species during infancy, when compared to 
children whose mothers had malaria later in pregnancy or who did not had malaria. 
Although the existence of exposure behaviours common to the mother and her child 
could not be ruled out, these results were the first epidemiological report supporting the 
hypothesis o f immuno-tolerance in infants exposed to malaria antigens early in utero. 
Similar studies need to be conducted in areas of different endemicity in order to 
compare the results.
In conclusion, this work demonstrated that the effects of malaria during 
pregnancy are not limited to the live newborn but extend during the entire infancy. 
LBW results in higher mortality and morbidity, and impaired growth, and a quarter of 
LBW is due to maternal malaria during pregnancy. Moreover, malaria during early 
pregnancy is associated with an increased risk of developing malaria in infancy. Thus, 
the current work not only confirms that preventing malaria during pregnancy is a major 
public health goal in malarious areas, but also that interventions against this parasitic 
infection should be implemented as early as possible during pregnancy.
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A p p en d ix  1
CB: I__I__I__I
MOTHER'S MORBIDITY DURING PREGNANCY
CODE: CB I I I I OS CODE: I I I I ANC CODE: 1 I I I I
NAME .........................................................  AGE: I I I
HOUSE: I I I I SECTION: I I I
GRAVIDITY: I I I PARITY: I I I
DATE OF FIRST CONSULTATION: |___
DATE OF DELIVERY: |____|____ |____ |
NUMBER OF CONSULTATIONS: I I I
MALARIA HISTORY
MALARIA BEFORE PREGNANCY: YES / NO 
MALARIA ATTACKS BEFORE ANC ATTENDANCE:
NO DATE SPECIES COUNT SYMTOMS TRE AMENT STUDY CODE
MALARIA ATTACKS DURING ANC ATTENDANCE:
NO DATE SPECIES COUNT SYMTOMS TRE AMENT STUDY CODE
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CB: I I I !
HAEMATOCRIT
HCT ON ADMISSION: I I 1.1 _ | LOWEST HCT: I I I. |_J 
HCT AT DELIVERY: I I 1.1 _ |
NUMBER OF WEEKS WITH HCT<30%: I I I 
NUMBER OF WEEKS WITH FFA: I I I
TRANSFUSION: YES / NO IF YES, DATE: |____ |____ |____|
B1 HISTORY
B1 SYMPTOMS: YES / NO IF YES: 1. NUMBNESS
2. CARDIAC SIGNS
3. NEUROLOGICAL SIGNS
NUMBER OF WEEKS WITH B1 TREATMENT: I I I
OTHER MORBIDITY
DATE DIAGNOSIS TREATMENT
DELIVERY
IN HOSPITAL: YES / NO
NORMAL: YES / NO IF NO, SPECIFY:
POST-PARTUM
NORMAL: YES / NO IF NO, SPECIFY:
PREVIOUS CHILD:
TIME SINCE LAST BIRTH (MONTHS): I I I 
SURVIVED ONE YEAR: YES / NO
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CB: |__|__|__|
SOCIO-ECONOMICAL QUESTIONNAIRE
Code: |__|__|__| Name:........................................................................
Age: |__|__| Ethnic group:.................................................  |__|
House number: |__|__|__| Section: |__|__|
1. When did you arrive in Thailand: |__|__| years.
2. Where did you live before you arrived in Thailand?
1. village in Karen Side:............ |__|
2. township or big city : ............
3. Which activity did you have before you arrived in Thailand?
1. farmer I__|
2. home work
3. student
4. other (specify):................
4. How many years did you go to school? |__|__|
5. Standard level: |__|__|
6. What languages do you speak? (one or many answers):
1. po karen 4. English |__|
2. sgaw karen 5. other (specify)
3. burmese
7. What languages do you write? (one or many answers):
1. po karen 4. English |__|
2. sgaw karen 5. other (specify)
3. burmese
8. Which work did you do during your pregnancy?
1. house work only I__|
2. teacher/ nurse/ lab technician
3. rice field/ forest
4. other (specify):................
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CB: |__|__|__|
9. Did you get for this work:
1. some money
2. some food
3. other (specify)
4. no answer
u
10. Is your husband usually:
1. living in the camp
2. working outside
3. in the front line
4. other (specify):................
u
11. If he is working, does he get:
1. some money
2. some food
3. other (specify)
4. no answer
u
12. Which activity did he have before he arrived in Thailand?
1. farmer
2. student
3. other (specify):................
u
13. How many years did your husband go to school? |__|__|
14. Standard level: |__|__|
15. What languages does he speak? (one or many answers):
1. po karen 4. English
2. sgaw karen
3. burmese
5. other (specify)
16. What languages does he write? (one or many answers):
1. po karen 4. english
2. sgaw karen
3. burmese
5. other (specify)
17. What is your religion?
1 buddhist
2 Christian
3 muslim
4 other
u
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CB: I__L J __I
18. How many of the following do you own?:
1. chicken: |__|__|
2. pig or goat: |__|__|
3. cow: |__|__|
4. radio: |__|__|
5. watch: |__|__|
19. Do you grow your own fruit or vegetables? YES / NO
20. How many people are usually living at your home: |__|__|
21. How many refugee’s food ration do you get: |__|__|
Interviewer’s impression:
22. General appearance of the visited house:
1. rich |__|
2. average
3. poor
4. very poor
25. Is the house:
1. very tidy | |
2. tidy
3. dirty
26. Is the house built with:
1. bamboos and leaves only |__|
2. bamboos, leaves and pieces of wood
3. leaves only (roof and walls)
27. What furnitures are there (table, chair, cupboard, bed):
Interviewer's name: 
D ate:............
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CB: | | | |
Home visitor's nam e:.................
CB code:......
Child's nam e:..........................................................Mother's name:.....................................
Date Present
(YIN)
111
(YIN)
Date Present
(YIN)
ill
(YIN)
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INFANT OPD CONSULTATION
CB: |__|__|__|
Name:............................................
Date: ............................................
Symptoms:
* Fever : Y / N / DK
* Convulsions : Y / N / DK
* Sucking w ell: Y / N / DK 
(or eating)
* Vomiting : Y / N / DK
* Diarrhoea : Y / N / DK
Consultation number: |__|__|
days
times
days
........days
.times/day
........days
. times/day
type (bloody, watery..):
* Abdominal pain: Y / N / D K ........................................... days
* Runny nose : Y / N / D K ..................................................days
* Coughing : Y / N / DK ................................................. days
sputum: Y / N / DK
type (white, green, blood):.......
* Difficulties to breathe: Y / N / D K ...................................... days
Other symptoms (specify):...........................................................
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CB: | | | |
Physical examination:
T em p ............ OC weight.....................Kg
Spleen .......... cm Liver .......................cm
Anemia Y / N / DK
R R ................ P u lse ..................................................
Lungs..........................................
Ears ............................................  Throat:.................................................
Tonicity:..................................... Dehydration:......................................
Other signs:
L aboratory results:
malaria smear: ........................................................... Hct: .................... %
WBC :..................................
PI:..........................................
Other:
Diagnosis: Diagl:..........................  Diag2:...........................
In case of malaria: severe Y / N specify: 
failure Y / N
Treatment: T tl.
Tt2
Tt3
Date:...........
Signature:
photocopy of IPD chart in case of transfert to MSF hospital
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CB: I I I I
AGE 7 M. 8 M. 9 M. 10 M. 11 M. 12 M.
D ATE
W E IG H T
H E IG H T
H EA D
ARM
TEM P.
PU LSE
RR
SPLE EN
L IV E R
RE M A R K S
IM M U N .
D A TE
B1
M O TH E R
B1 C H IL D
H C T
AGE SIT: |_ |_ J  MONTHS AGE CRAWLER : I I I MONTHS
AGE WALKER: I I I MONTHS
LOST: Y / N IF YES, REA SO N :........................
DATE: |___ |___|___|
DEAD: Y / N IF YES, DIAGNOSIS..........................................
DATE. |___ |___|___|
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CB: l i l i
INFANT FOLLOW-UP; 6 MONTHS-OLD BABIES
NAME:----------------------------------------  DATE: |____ |____|____|
I-GROWTH MONITORING
1. Line aspect: 1. regular increase within normal range
2. regular increase under the lower line
3. growth temporary stopped followed by regular increase
4. growth stopped for ...................weeks/months
5. other
2. Percentage weight for height:
»-DEVELOPMENT
Is the baby: 3. sitting with help Y / N
4. babbling Y / N
5. reaching for toys Y / N
6. playing with toes Y / N
III-NUTRITION
7. Is the baby breast-fed Y / N If not: 8. at what age breast feeding was stopped?
9. what milk is now given to the child?...........
Does the baby eat:
10. rice Y /N 11. age beginning:
12. fruits Y /N 13. age beginning:
14. vegetables Y / N IS. age beginning:
1 6 .eggs Y /N 17. age beginning:
IV-CARE AND HEALTH FOLLOW-UP
18. Who is taking care o f the child: 1. mother
2. grand-mother
3. sister/ aunty
4. other, specify
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19. Is the child immunized?
1. complete immunization for age
2. incomplete immunisation for age
3. vaccine card lost, BCG scare+ mother history
4. not immunized
When the child is sick, is the gardian:
20. bringing him to the MSF hospital/dispensary Y / N
21. bringing him to the SMRU dispensary Y / N
22. bringing him to the Thai hospital Y / N
23. buying medicines in shops Y / N
24. calling a private medic Y / N
25. using traditional medicines Y / N
26. Is the mother going to the weekly feeding and B1 distribution from 
MSF
Y /N
27. Number o f visits in the CB study:..........................monthly follow-up
28. Number o f consultations in the CB study: ............................OPD consultations
V-MORBIDITY
(mother interview confirmed by health card whenever possible; document every 
pathological episodes on separate forms )
29. How many times did the child get fever:.......
30. How many times did he had a blood smear taken.....
How many times did he get: 31. malaria:.........
32. ARI....................
33. diarrhoea:.......
34. other relevant disease:.............
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VI- Physical examination
35. general appearance:.....................
36. cardiac auscultation:...................
37. pulmonary auscultation:.................
38. spleen:..................................
39. liver:...................................
40. other:...................................
Physician ‘s signature:
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